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  Dear colleagues,
 
On behalf of the Organizing Committee of the Y-Mind São Paulo School of Advanced Science for 
Prevention of Mental Disorders, funded by the State of São Paulo Research Council (FAPESP), 
I am very pleased to have the honor of welcoming you to this exciting event to be held at 
the Federal University of São Paulo.  The global burden of Mental, Emotional and Behavioral 
disorders (MEB) is high, surpassing that of cancer and cardiovascular diseases.  MEB are today 
understood as neurodevelopmental brain disorders shaped by complex gene-environment 
interplay. Although a large proportion of MEB cognitive and emotional impairments start early 
in life, they have largely been overlooked in public health. Prevention is the most effective 
way to reduce the burden: however limited biological knowledge, poor treatment and service 
effectiveness, as well as stigma hamper the prevention of MEB. The Y-Mind School has been 
structured to foster prevention of MEB by selecting projects worldwide in the following areas: 
1) Epidemiology and Risk Factors;  2) Translational research – Animal Models; 3) Neurobiology, 
Neurodevelopment and Brain Circuits in early stages of MEB disorders; 4) Effective Interventions 
to prevent MEB; and 5) Services, Stigma & Awareness. The Y-Mind School was planned to 
attract the most prestigious academics and young researchers worldwide who have embraced 
prevention of MEB at the forefront line of global psychiatry. I wish all of you -- academics, 
nationals, and foreign students at the Y-Mind School-- a very pleasant stay in Brazil, enjoying 
the culture, friendship and hospitality. I hope the Y-Mind School will be a friendly and virtuous 
learning environment to promote exchange among participants in different areas of knowledge, 
in order to approach MEB prevention from a global perspective. In regards to young researchers 
in particular, we expect they can interact and build up international partnerships to embrace 
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- Center for Mental Disorders Prevention 8:30 - 9:10
Bruce Cuthbert
Toward the Future of Psychiatric 




The ontogenesis of psychosis in the general population:  
perspectives of diagnosis, treatment and prevention
9:10 - 9:50
Stan Kutcher
International school mental health: global approaches, global 
challenges, and global opportunities
Chair: Acioly Lacerda
10:45 - 11:30 OPENING CEREMONY
10:10 - 10:50
Helen Herrman
Promoting the mental health of young people: Prevention, 
mental health promotion and early intervention
10:50 - 11:30
Maria Oquendo
Estimating risk for suicide attempt and development of 
prevention strategies
11:30 - 12:20




Genome-wide association studies for psychiatric disorders
12:20 - 13:00  Lunch 12:00 - 13:00  Lunch
13:00 - 14:30  Poster discussion 13:00 - 14:30  Poster discussion




Preventing Mental Illness and Promoting Mental Health: 
Concepts and evidence 
Joan Kaufman 
 Understanding how epigenetic mechanisms can translate early-life experiences into 
lasting cellular memories at the root of mental disorders
Bruce Cuthbert
Toward the Future of Psychiatric Diagnosis: The NIMH Research 
Domain Criteria Project
James Frauenthal 
Mathematical Modeling in Epidemiology
David Pauls
Genetic mechanisms for the manifestation of complex  
developmental behavioral disorders. 
Brian Rush
Evaluation of Mental Health Services and Systems
5wednesday i 27.3 thursday i 28.3 friday i 29.3
Time Chair: Andrea Jacowski Chair: Marcelo Feijó Chair: Mirian Hayashi
9:00 - 9:40
Myrna Weissman
Translational epidemiology in psychiatry: linking 
population to clinical and basic sciences
Ronaldo Laranjeira
Brazilian National Alcohol and Drugs Survey 
Vanessa Abilio
The Spontaneously Hypertensive Rat (SHR) 
strain: how animal models can help us 




Genetic mechanisms for the manifestation of 
complex developmental behavioral disorders 
Marcelo Feijo Mello
Early Trauma and Post-Traumatic Stress 
Disorder
Gustavo Turecki
The Early Life Environment: Adversity, Genomic 
Plasticity and Psychopathology
Chair: Sintia Belangero Chair: Rodrigo Bressan Chair: Isabel Bordin
10:45 - 11:30
Guilherme Polanczyk
The National Institute of Developmental 
Psychiatry for Children and Adolescents: where 
we are, where we are going
Cristiane Duarte
Context and the Development of 
Psychopathology in Children
John Ronning
Early intervention improves cognitive and 
behavioral development of children born 
prematurely
Jose Alexandre Crippa
The use of cannabidiol, a Cannabis sativa 
constituent, in neuropsychiatry
Rodrigo Bressan
At Risk Mental State for psychiatric disorders
Flavio Kapczinski
Staging and neuroprogression in psychiatry
11:30 - 12:20
Ricardo Araya
School intervention and mental health in 
adolescents
Yanki Yazgan
Preventive Developmental Approaches from 
Turkey: Increasing Father Involvement, School 
Based Prevention and Public Awareness
Luis Augusto Rohde
Neurobiological evidences for ADHD as a 
neurodevelopmental disorder
12:20 - 13:00  Lunch
13:00 - 14:30  Poster discussion




Modern genetic epidemiology in psychiatry
Stan Kutcher
Mental Health Curriculum in High School
Gustavo Turecki 
Behavioral epigenetics
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brUce cUtHbert, Ph.D., 
is Director of the Division of Adult 
Translational Research and Treatment 
Development (DATR) at the National 
Institute of Mental Health (NIMH). 
He also coordinates the NIMH 
Research Domain Criteria project to 
develop neuroscience-based criteria 
for studying mental disorders. Dr. 
Cuthbert returned to NIMH in January 2010, following four years as a professor 
of clinical psychology at the University of Minnesota.  He previously served as 
Chief of the Adult Psychopathology Research Branch at NIMH, after seventeen 
years on the faculty at the University of Florida. Dr. Cuthbert received his Ph.D. 
in clinical psychology and psychophysiology from the University of Wisconsin-
Madison. He is known for his research on the psychophysiology of emotion, 
and translational research on the psychopathology of anxiety disorders. He was 
elected president of the Society for Psychophysiological Research in 2004 and 
is a fellow of the Association for Psychological Science.  
coNfereNce | toward tHe fUtUre of PSycHiatric 
diagNoSiS: tHe NiMH reSearcH doMaiN criteria 
Project 
While major revisions are underway to the two major psychiatric manuals (DSM 
and ICD), the fundamental nature of these nosologies remains based upon 
presenting signs and symptoms. Research increasingly reveals that current 
definitions do not reflect relevant neurobiological and behavioral systems 
–impeding not only research on etiology and pathophysiology, but also the 
development of new treatments.  The NIMH began the Research Domain Criteria 
(RDoC) project in early 2009 to develop a research classification system for 
mental disorders based upon dimensions of neurobiology, cognitive function, 
and observable behavior. The RDoC project is intended for research purposes, 
with the aim of conducting studies that examine fundamental biobehavioral 
dimensions that cut across current heterogeneous disorder categories. This 
presentation summarizes the rationale, status, and long-term goals of the 
NIMH RDoC project, and major differences in conception and emphasis as 
compared to the DSM and ICD revisions. Future diagnostic systems cannot 
reflect ongoing advances in genetics, neuroscience, and cognitive science until 
a literature organized around these disciplines is available to inform the revision 
efforts. The goal of the RDoC project is to provide a framework for research to 
transform the approach to the nosology of mental disorders.
criStiaNe S. dUarte 
is Assistant Professor of Clinical 
Psychology in the Division of Child 
and Adolescent Psychiatry, Columbia 
University. She obtained her doctorate 
at the Department of Psychiatry, 
Federal University of São Paulo, Brazil 
and a Masters in Public Health (MPH) 
from Columbia University.  Her research is based on innovative and large-scale 
population-based studies designed to generate knowledge of high public 
health impact about mental disorders in children and adolescents. Using state-
of-the art sampling, recruitment and assessment methodologies, Dr. Duarte has 
been involved in studies that generate population-based, intervention-driven 
information to improve mental health outcomes among underserved, hard-to-
reach, frequently understudied, populations of children and adolescents in the 
US, Puerto Rico and Brazil. This work has been supported by agencies such 
as the US National Institute of Health (NIH), the National Alliance for Research 
in Schizophrenia and Depression (NARSAD) and the Robert Wood Johnson 
Foundation (RWJF).  As part of her work in Brazil, Dr. Duarte has formed many 
active partnerships aiming to generate empirical evidence related to mental 
health services for children, with emphasis on evolving Brazilian public health 
strategies of worldwide interest, such as the Family Health Program. Part of 
this work is currently being supported by the US National Institute of Mental 
Health (NIMH). Dr. Duarte is also a member of the Violence and Child Rights 
Research Consortium, a Brazilian-Norwegian collaboration geared towards the 
examination of longitudinal patterns of service utilization by youth with mental 
disorders living in a violent area. Besides her work in Brazil, Dr. Duarte is involved 
in international collaborations addressing topics of importance in global mental 
health such as child mental health awareness, exposure to trauma, obesity and 
mental health, or cultural experiences and mental disorders. She reviews and 
publishes articles in journals in the areas of psychiatry, psychology, public 
health, and pediatrics.
coNfereNce | coNtext aNd deVeloPMeNt of 
PSycHoPatHology iN cHildreN
 Children grow up in diverse contexts, interacting with different social, 
cultural and familial environments. Interest in the role of contextual factors 
in the development of psychiatric disorders has been recently renewed due 
to growing evidence supporting previously unknown pathways relating 
contextual stressors such as neighborhood environment, discrimination and 
child maltreatment to psychiatric disorders. In the last few years, novel evidence 
has reinforced the notion that most mental disorders originate early in life and 
that mechanisms such as neuroendocrine responses and epigenetic changes 
are likely links between contextual stressors and psychopathology. Interest in 
specific contextual factors has also been motivated by their malleability and 
potential for translation into large-scale public health intervention strategies. 
However, advances in knowledge about biological mechanisms involved in the 
etiology of psychiatric disorders have not always been closely accompanied 
by refinement in conceptualization, measurement and design of studies of 
these contextual factors in the field of developmental psychopathology. 
We will illustrate the advantages of emphasizing contextual factors for the 
development of child psychopathology using three large-scale ongoing 
longitudinal studies of three distinct populations: children of arrested parents, 
children of World Trade Center exposed parents and children from a minority 
ethnic group (Puerto Ricans) living in a highly deprived context in the US (South 
Bronx), as compared to children from the same ethnic group living in their 
context of origin (Puerto Rico). Based on these examples, future perspectives 
and directions for the study of context in childhood and psychiatric disorders 
later in life are proposed. 
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daVid PaUlS was the founding 
director of the Psychiatric and 
Neurodevelopmental Genetics Unit 
(PNGU). On July 1, 2011 he stepped 
down as director.  Prior to coming to 
Harvard in September 2001, he was the 
Professor of Psychiatric and 
Neurobehavioral Genetics in the Child 
Study Center at Yale University. Over 
the past 30 years, his research has focused primarily on the genetics of child 
neuropsychiatric disorders. Research under his direction has led to a better 
understanding of the inheritance of the Gilles de la Tourette Syndrome (GTS), 
Obsessive Compulsive Disorder (OCD), specific reading disability and the autism 
spectrum disorders. Until recently, he led three separate international consortia 
of investigators devoted to finding genes for GTS, OCD, trichotillomania and 
related conditions. The focus of Dr. Pauls’ research has been on elucidating the 
underlying etiologic mechanisms important for the expression of human 
behavior. His primary goal has been to understand the both genetic and non-
genetic factors that underlie the manifestation of specific behaviors that begin 
in childhood and continue over the life course.  His research has focused on five 
different developmental neuropsychiatric disorders: the Gilles de la Tourette 
syndrome, obsessive compulsive disorder, high functioning autism/Asperger’s 
syndrome, specific reading disability and trichotillomania and related disorders. 
Dr. Pauls is the author of over 270 peer-reviewed articles, 60 book chapters and 
one book.  Most of his work was funded by grants from the National Institutes 
of Health.
coNfereNce | geNetic MecHaNiSMS for tHe 
MaNifeStatioN of coMPlex deVeloPMeNtal 
beHaVioral diSorderS.
It has become clear over the last decade that the underlying genetic 
mechanisms for developmental disorders is significantly more complex that 
was originally thought.  It this course we will review the various genetic models 
that have been proposed and summarize recent findings on the genetics of 
childhood onset mental disorders including Gilles de la Tourette syndrome, 
obsessive compulsive disorder, attention deficit hyperactivity disorder and 
autism spectrum disorders.
fláVio KaPcziNSKi is a full 
professor at the Federal University of 
Rio Grande do Sul, Director of Research 
at Hospital de Clínicas de Porto Alegre 
and Head of the National Institute for 
Translational Medicine. He is a 
consultant for the National Council for 
Scientific and Technological 
Development (CNPq) and member of 
the Brazilian Academy of Sciences. His research is centered on the investigation 
of the pathophysiology of bipolar disorder as well as innovative treatments for 
this condition. His research has been funded by organs of the Brazilian Federal 
Government, such as CNPq and CAPES as well as by non-profit international 
organizations, including the Brain & Behavior Institute and Stanley Medical 
Research Institute. His intellectual production includes over 300 published 
papers, with over 4600 citations and an H-index of 35. He is editor in-chief of 
Trends in Psychiatry & Psychotherapy and is currently on the editorial board of 
several high-impact journals, including the Journal of Psychiatric Research, 
Acta Psychiatrica Scandinavica and the Journal of Psychiatry and Neuroscience.
coNfereNce | StagiNg aNd NeUroProgreSSioN iN 
PSycHiatry
The apparently progressive nature of a considerable proportion of cases of 
bipolar disorder has been acknowledged in recently proposed clinical staging 
models. Their common feature is placing the illness in a continuum progressing 
from a latent or asymptomatic form (stage 0 or latent) to a chronic, unremitting 
presentation (stage IV or unremitting). This has been part of an attempt to 
facilitate and refine diagnosis, treatment selection, and establish a prognosis. 
The study of the progressive nature of some cases of bipolar disorder has given 
rise to the hypothesis of neuroprogression, which postulates that different stages 
of bipolar disorder are associated with distinct neurobiological underpinnings. 
Of note, the duration of inter-episode intervals seems to be reduced with 
the recurrence of acute episodes, and progression of bipolar disorder may 
also be associated with several other unfavourable clinical outcomes: lower 
responsiveness to treatment, especially with lithium and cognitive behavioral 
therapy, worse treatment outcome of family psychoeducation, higher rates of 
comorbidity, functional impairment, increased cognitive dysfunction, and an 
augmented risk of suicide and hospitalization. Given that bipolar disorder may 
be intimately associated with chronic stress response and coping mechanisms 
over the course of illness, we propose that cellular resilience mechanisms 
may play a key role in the neuroprogression in bipolar disorder. Cellular 
resilience mechanisms seem to be less efficient at later stages of BD, especially 
mitochondrial and endoplasmic reticulum related responses to stress. These 
insights may help in developing staging models of BD, with a special emphasis 
on the search for biomarkers associated with illness progression.
gUilHerMe V. PolaNczyK 
is Assistant Professor of Child and 
Adolescent Psychiatry at University of 
São Paulo (USP). He completed the 
Adult Psychiatry and the Child and 
Adolescent Psychiatry Programs at 
Hospital de Clinicas de Porto Alegre, 
and the MSc and PhD Programs at 
Universidade Federal do Rio Grande do 
Sul. He worked as a post-doctoral researcher at the SGDP Centre Institute of 
Psychiatry London, and Duke University focused on the developmental origins 
of mental disorders at the Dunedin and E-Risk Studies. Currently, he directs the 
Early Diagnosis and Intervention Program at the Institute of Psychiatry, Hospital 
das Clinicas FM-USP, and the Research Center on Neurodevelopment and 
Mental Health at USP. His research interests are early presentation and risk 
factors for later mental disorders, specifically ADHD and disruptive behavior 
disorders. His work is funded by NARSAD, CNPq and FAPESP and was awarded 
8coNfereNceS of tHe y-MiNd Sao PaUlo ScHool of 
adVaNced ScieNce for PreVeNtioN of MeNtal diSorderS
by professional associations. He has more than 60 papers published in peer-
reviewed journals, 1400 citations and h-index 18.
coNfereNce | tHe NatioNal iNStitUte of 
deVeloPMeNtal PSycHiatry for cHildreN aNd 
adoleSceNtS: wHere we are, wHere we are 
goiNg
The National Institute of Developmental Psychiatry for Children and Adolescents 
(INPD) was created and funded by CNPq and FAPESP to foster the development 
of research, training and education on childhood mental disorders in Brazil. 
The Institute is composed of a network of research teams from Brazil, the USA 
and Europe, and responsible for conducting 16 original projects. Projects are 
centered on the tenet that childhood mental disorders are the result of deviant 
neurodevelopmental processes that begin very early in life. Because available 
treatments have limited effectiveness and do not change the natural course of 
disorders, more efforts should be directed toward preventive strategies. At the 
same time, it is imperative to better understand the specific distribution and 
risk factors for the disorders in our context and to invest in professional training 
at all levels. This lecture will address the main projects and results obtained so 
far and discuss future directions for the Institute and more broadly for the field 
in Brazil.
gUStaVo tUrecKi MD PhD is 
Professor of Psychiatry and Human 
Genetics at McGill University, Montreal, 
Canada, where he leads a research and 
clinical career focusing on depression 
and suicide. Dr. Turecki obtained his 
medical degree (1989) and specialty in 
psychiatry (1994) from UNIFESP, Sao 
Paulo, Brazil, and a PhD in neurosciences 
with concentration in genetics from McGill University, Canada (1999). He 
currently holds a William Dawson Chair, and is the director of the McGill Group 
for Suicide Studies, the Quebec Suicide Brain Bank, and the FRSQ-funded 
Quebec Suicide Research Network. In addition, he is the Vice-Chair of Research 
and Academic Affairs of the Department of Psychiatry at McGill University. Dr. 
Turecki’s research has focused on the study of biomedical risk factors for suicide 
and depression. He has made important contributions to our understanding of 
the suicide phenotype, conducting multidisciplinary studies on suicide, 
integrating biomedical, clinical and psychosocial information. More recently, 
his work has focused on epigenetic mechanisms, and has conducted pioneering 
research leading to our understanding of how early-life adversity stably 
impacts the genome and increases long-term risk for suicide. Dr. Turecki has 
authored over 250 publications, including book chapters and research articles 
in peer reviewed journals such as Nature Neuroscience, Molecular Psychiatry, 
Archives of General Psychiatry, among others, and is the recipient of several 
scientific awards, including the NARSAD Michael Kaplan Investigator Award, 
the American Foundation for Suicide Prevention Distinguished Investigator 
Award and their 2012 Career Science Award, as well as the Radio-Canada 
Researcher of the Year in 2010. He also serves, or has served, in the advisory 
boards of several scientific journals. 
In addition to a busy scientific career, Dr. Turecki is an engaged clinician. 
He heads the Depressive Disorders Program at the Douglas Mental Health 
University Institute, where he treats patients with refractory major depressive 
disorder. On a personal note, Gustavo is married and has 3 teenage sons. When 
he is not working, he can be found driving his sons to hockey practice and 
games, and whenever he has a bit of time for himself, he can be found in the 
woods feeding his second passion – mycology. 
coNfereNce | tHe early life eNViroNMeNt: 
adVerSity, geNoMic PlaSticity aNd 
PSycHoPatHology
The environment in which we live, and especially the early life environment, 
shapes our behavior. Adversity during early life is strongly associated with 
problems in behavioral regulation and psychopathology in adulthood. Until 
recently, the mechanisms responsible for behavioral changes induced by early 
life adversity were not clear. However, recent evidence suggests that early-life 
environment induces behavioral changes through epigenetic mechanisms 
controlling the expression of genes involved in the regulation of behavior. 
As such, the epigenome mediates the effects of environmental variability on 
behavioral, physiological and pathological responses. In this talk, I will present 
data from genome-wide methylation studies in human postmortem brain 
tissue as a function of history of environmental adversity. Implications for 
behavioral development and risk of psychopathology will be considered.
HaKoN HaKoNarSoN, M.D., 
Ph.D., is an Associate professor of 
Pediatrics at The University of 
Pennsylvania School of Medicine. He’s a 
physician-scientist and Director of The 
Children’s Hospital of Philadelphia’s 
Center for Applied Genomics (CAG), a 
high-throughput highly automated 
genotyping facility founded to identify 
the genetic causes of complex medical disorders in children, such as autism and 
cancer, with the objective of developing new therapies. The Center represents a 
$40 million commitment from CHOP to genotype approximately 100,000 
children a research undertaking that has gained nationwide attention, including 
news features in the Wall Street Journal, New York Times, Time Magazine, 
Nature and Science. Dr. Hakonarson has an extensive track record in human 
genetics and has developed an international reputation amongst his peers. He 
has served previously in several senior posts in the biopharmaceutical industry, 
including as the director of Inflammatory and Pharmacogenomics Research and 
the vice president of Clinical Sciences and Development and CSO. Dr. Hakonarson 
has also been the principal and co-principal investigator on several NIH-
sponsored grants, and has published numerous high-impact papers on 
genomic discoveries and their translations in some of the most prestigious 
scientific medical journals, including Nature, Nature Genetics and The New 
England Journal of Medicine. Time Magazine listed Dr. Hakonarson’s autism 
gene discovery reported in Nature, 2009, among the top 10 medical 
breakthroughs of that year. With over ten years of experience in pioneering 
genomics research and genome-wide mapping and association studies, Dr. 
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Hakonarson has intimate knowledge of the complexities of large-scale 
genomics projects and has put together the necessary infrastructure and 
workflow processes to unravel these complexities.
coNfereNce | geNoMe-wide aSSociatioN StUdieS 
for PSycHiatric diSorderS
The Center for Applied Genomics at CHOP is focused on developing innovative 
genomics-based approaches to identify subpopulations of patients who share 
genetic substructure predicted to respond to specific therapies (test-and-treat 
paradigm to personalize management) of neuropsychiatric disorders. The 
Center was founded in 2006 to establish a pediatric biobank at CHOP, currently 
the largest of its kind in the world. The scientific and conceptual underpinnings 
of the center are based on findings with the vision to rapidly discover successful 
therapeutic alternatives to personalize treatment of neuropsychiatric disorders 
in a fast and cost-effective manner.  The initial focus on attention deficit-
hyperactivity disorder (ADHD), the most common psychiatric pediatric disorder 
characterized by inattention, hyperactivity, impulsivity, and executive function 
defects has resulted in a unique therapeutic development program moving 
forward. In the U.S., 15.6 million people are estimated to suffer from ADHD. 
Adolescents and young adults afflicted with ADHD are much more likely to have 
severe problems both in school and at work, and by age 25.  Using state-of-
the-art genomics, CAG has identified a distinct subset of ADHD patients that 
are suitable for targeted therapy with our lead candidate drug, NFT-1101. NFT-
1101 is a first-in-class drug using a personalized approach for ADHD and we 
have extended the genomics-based target discovery process and found that 
the neuro-receptor pathway targeted by NFT-1101 could also be therapeutic 
for a subset of patients with other neurodevelopmental/psychiatric disorders, 
including autism and schizophrenia. Thus, successful development of NFT-1101 
for ADHD will be an impetus to develop it for use for other indications. The CAG 
has made significant strides in identifying multiple biological pathways that 
are potential therapeutic targets for neurodevelopment/psychiatric disorders, 
some of which can be modulated by existing therapeutics that were originally 
designed for other indications. This work will be presented in the context of 
integrative academic program development.
HeleN HerrMaN is Professor of 
Psychiatry at Orygen Youth Health 
Research Centre and the Centre for 
Youth Mental Health, The University of 
Melbourne, and Director of the World 
Health Organization (WHO) 
Collaborating Centre for Mental Health 
in Melbourne. She is a National Health 
and Medical Research Council 
(Australia) Practitioner Fellow, and Honorary Fellow of the World Psychiatric 
Association (WPA), having served as WPA Secretary for Publications from 2005 
to 2011. In her role as WPA officer, she convened a taskforce that recommended 
international best practices in working with service users and family carers. She 
is President-Elect of the Pacific Rim College of Psychiatrists.  She led a global 
project for WHO in collaboration with the Victorian Health Promotion 
Foundation and the University of Melbourne on the evidence for mental health 
promotion, and editing of the report & book published in 2005: ‘Promoting 
Mental Health: Concepts, Evidence and Practice’. She is currently Chair of the 
Global Consortium for the Advancement of Promotion and Prevention in Mental 
Health. From 1992 to 2005, she was Professor and Director of Psychiatry in St 
Vincent’s Health Melbourne and The University of Melbourne, and led 
development of an integrated hospital and community mental health service in 
inner Melbourne under Australia’s national reform of mental health care. In 
2001-2002 she was acting regional adviser in mental health for the WHO’s 
Western Pacific Region. She is currently involved in research programs on 
youth, technology and wellbeing, on violence, gender and mental health, on 
depression in primary health care, and on improving mental health for young 
people in out of home care.
coNfereNce | ProMotiNg tHe MeNtal HealtH 
of yoUNg PeoPle: PreVeNtioN, MeNtal HealtH 
ProMotioN aNd early iNterVeNtioN
The age group 12-25 years is the peak time of onset for many mental disorders 
including mood, substance abuse and psychotic disorders. It is also a period of 
high prevalence of mental health problems. Yet in most countries there are few 
opportunities for young people and their families to gain access to treatment 
and care for mental ill-health and preventive interventions. Few countries 
give sufficient attention to supporting the mental health of young people and 
few have developed policies and programs to support this. This is especially 
important for young people exposed to trauma and adversity. Effective 
interventions in primary or specialist care are likely to be most cost-effective 
at this age; and opportunities exist to introduce evidence-based programs 
and policies promoting mental health in young people. Policy and practice 
changes suitable for each country have two essential starting points: improved 
understanding of youth mental health within communities; and involving 
young people and their families in decisions that affect them. New approaches 
to improving mental health of young people are being developed in several 
countries. Information technology is now used to assist care, and the internet 
is a setting for mental health promotion. These features of modern community 
and service development may be applied in many environments.
jair de jeSUS Mari took his 
medical degree in the Santo Andre ABC 
Medical Faculty in 1977 and completed 
his residency training in psychiatry at 
the Civil Servant State Hospital of São 
Paulo in 1979. In 1986 he concluded his 
Ph.D. in the Institute of Psychiatry, 
Kings College, London. In 1987, he 
became a tenure affiliated professor in 
the Department of Psychiatry, Federal University of São Paulo. In 1991 he spent 
one year at the McMaster University, Canada, as a post-doc, to study clinical 
epidemiology. He became full tenure professor in the Department of Psychiatry, 
at the Federal University of São Paulo in 1996.  Since his stay in London he has 
published more than 200 scientific papers and supervised several post-
graduation students. He is a top level researcher from the National Research 
Brazilian Council (CNPq) with studies in the areas of Psychiatric Epidemiology, 
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Systematic Reviews, Sociocultural Issues on the Course of Schizophrenia, Health 
Services Evaluation, Violence and Mental Health and Prevention of Psychiatric 
Disorders.   He was one of the editors of the Brazilian Journal of Psychiatry (RBP 
Psychiatry) from 1998 to 2008. Nowadays he is the head of the post-graduation 
program of the Department of Psychiatry of the Federal University of São Paulo, 
and Honorary Visiting Professor, in the Health Services and Population Research 
Department, Institute of Psychiatry, King’s College, London.
coNfereNce | tHe y-MiNd São PaUlo ScHool of 
adVaNced ScieNce for PreVeNtioN of MeNtal 
diSorderS 
The aged 10-24 years population is near 1.8 billion people, and 90% live in Low 
and Middle Income Countries. Neuropsychiatric disorders, which have largely 
been overlooked in public health, are the leading cause of disability in young 
people in every region of the planet. The leading global burden of diseases 
as measured by the Dalys in the age group 10-24 years are mostly related to 
mental health: Unipolar depressive disorders (8.2%), Road traffic accidents 
(5.4%), Schizophrenia (4.1%), Bipolar disorder (3.8%), Violence (3.5%), Alcohol 
Abuse (3.0%), HIV/AIDS (3.0%), and self-inflicted injuries (2.8%). Around 75% 
of people with a Mental, Emotional and Behavioral (MEB) disorder had an age of 
onset younger than 24 years. A truism that remains neglected is that psychiatry 
needs to follow general medicine and focus in preventive strategies to avert 
MEB disorders. Research on prevention is a major priority in the field, but 
several challenges have to be tackled to reach prevention of MEB. The Y-Mind 
São Paulo School of Advanced Science for Prevention of Mental Disorders is 
an initiative of Brazilian Academics funded by the State of São Paulo Research 
Funding Agency (Fapesp) to bring together students and faculty associates to 
discuss cutting edge projects in the area of prevention of MEB from a global 
perspective. To accomplish these objectives, the Y-Mind School will focus its 
activities in the following areas: a) Epidemiology and Risk Factors for MEB; b) 
Translational research; c) Neurobiology, Neurodevelopment and Brain Circuits 
of Early stages of MEB disorders; d) Effective Interventions to prevent MEB; and 
e) Services, Stigma & Awareness.  The Y-Mind School aims to integrate high 
standard clinical and scientific teams to constitute a global network that will 
impact the field of MEB prevention both in terms of its wide scope and of its 
multistage approaches to preventive mental health.
jiM VaN oS is Professor of 
Psychiatric Epidemiology and Chairman 
of the Department of Psychiatry and 
Psychology at Maastricht University 
Medical Centre, Maastricht, The 
Netherlands, and Visiting Professor of 
Psychiatric Epidemiology at the 
Institute of Psychiatry, London, UK. He 
trained in Psychiatry in Casablanca 
(Morocco), Bordeaux (France) and finally at the Institute of Psychiatry and the 
Maudsley/Bethlem Royal Hospital in London (UK) and after his clinical training 
was awarded a three-year UK Medical Research Council Training Fellowship in 
Clinical Epidemiology at the London School of Hygiene and Tropical Medicine. 
In 1995, he moved to Maastricht University Medical Centre. He is on the 
editorial board of several European and US psychiatric journals such as Acta 
Psychiatrica Scandinavica, European Psychiatry, Psychological Medicine, 
Schizophrenia Research, Schizophrenia Bulletin, Early Intervention in Psychiatry, 
Epidemiology and Psychiatric Sciences, Psychosis Journal, The Journal of 
Mental Health and the Sciences. He is also an Academic Editor at PLoS ONE. 
Jim van Os is coordinator of a €12M EU FP7 IP project on gene-environment 
interactions in schizophrenia, and is also active in clinical gene-environment 
interaction research in depression and bipolar disorder. He is a member of the 
Psychosis Group of the DSM-V Task Force, and was co-chair of the APA DSM/
ICD conference Deconstructing Psychosis.  In 2011, he was elected member of 
the Royal Netherlands Academy of Arts and Sciences (KNAW). He is Director of 
Psychiatric Services at Maastricht University Medical Centre and runs a service 
for treatment-resistant depression and first episode psychosis.
Contribution to brain research
Prof. van Os has strived to contribute to the area of brain-mind interface in 
a non-reductionist fashion, focusing on the distribution of mental states in 
the population as related to mental ill-health, and the gene-environment 
interactions underlying these. He has developed and validated the theory 
that expression of mental ill-health can be traced to variation in normal 
mentation, establishing experiential and aetiological links between normal and 
pathological mental states. In his recent paper in Nature (2010), he has argued 
that contextual neuroscience, focusing on the constant interactions between 
person and context, is the most appropriate way to conduct science in order to 
find solutions for patients with mental disorders. His current areas of interest 
include the clinical, cognitive and genetic epidemiology of bipolar disorder, 
schizophrenia and depression, in particular the study of variation in overlapping 
dimensions of these disorders in the general population and the underlying 
cognitive factors and gene-environment interactions driving this variation. 
Treatment studies focus on novel mobile health (M-Health) applications in 
the early treatment of mental disorders, novel diagnostic paradigms based 
on Experience Sampling mental state circuitries, implementation of Assertive 
Outreach and CBT in routine mental health settings, and aspects of patient-
professional carer communication. Bibliographic indices: Hirsch factor (Web of 
Science): 66; PubMed peer-reviewed publications: 556; PhD Theses directed by 
Prof. van Os at Maastricht University: 42 
Recent publications:
van Os, J. & Kapur, S. (2009) Schizophrenia. Lancet, 374, 635-645.
van Os, J., Kenis, G. & Rutten, B. (2010) The Environment and Schizophrenia. 
Nature, 468,  203-212.
van Os, J. (2009) ‘Salience syndrome’ replaces ‘schizophrenia’ in DSM-V 
and ICD-11: psychiatry’s evidence-based entry into the 21st century? Acta 
Psychiatrica Scandinavica, 120, 363-372.
van Os, J., Linscott, R.J., Myin-Germeys, I., Delespaul, P. & Krabbendam, L. 
(2009) A systematic review and meta-analysis of the psychosis continuum: 
evidence for a psychosis proneness-persistence-impairment model of psychotic 
disorder. Psychological Medicine, 39, 179-195.
coNfereNce | tHe oNtogeNeSiS of PSycHoSiS 
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iN tHe geNeral PoPUlatioN: PerSPectiVeS of 
diagNoSiS, treatMeNt aNd PreVeNtioN
The human brain has evolved as a highly context-sensitive system, enabling 
behavioural flexibility in the face of constantly changing environmental 
challenges. Bottom-up sensory stimuli interact with top-down cortical 
expectations, giving rise to affectively meaningful representations of the social 
world that motivate adaptive, goal-directed interactions. Multidimensional 
psychotic syndromes can be understood as an imbalance in the cycle of 
adaptation to the social context. At the symptom level, paranoid delusions 
express alterations in experience of the social environment, and cognitive 
impairments associated with psychotic disorder reflect difficulties in the 
ability to read the emotions and intentions of other people, contributing to the 
reduced social competence that accompanies symptoms. At the aetiological 
level, robust evidence exists that onset of psychotic disorder is associated 
with early life adversity, growing up in an urban environment, minority ethnic 
group and cannabis use. Together, these observations suggest a mechanism of 
exposures impacting on the developing “social” brain during sensitive periods. 
In addition, there is evidence for significant “mental causation” of syndromes, in 
that mental experiences have causal impacts on each other, resulting in person-
specific chains of events from which psychopathology arises. It is proposed to 
conduct longitudinal research on gene-environment-mental interplay driving 
variation in behavioural expressions of liability in the general population that 
subsequently may give rise to more severe and more ‘co-morbid’ expressions 
of psychopathology and need for care; to develop technology to directly assess 
situated phenotypes indexing dynamic, within-person environmental and 
mental reactivity as substrate for molecular genetic studies and diagnostic 
systems; and to increase the translational potential to study developmental 
social-reactive mechanisms associated with psychotic disorder.
joHN a. roNNiNg, professor dr. 
philos and specialist in clinical child 
psychology at the University of Tromso 
and University Hospital of North 
Norway, graduated from the University 
of Bergen in 1980, where-upon he 
worked as a NRC research fellow and 
later associate professor. From 1986 to 
1989 he served as a senior lecturer and 
participated in the development of a regional college (all countries in Southern 
Africa) for specialist teachers of the handicapped in Lusaka Zambia. In 1989 to 
1980 he planned the first Regional Centre for Child & Adolescent Psychiatry in 
Norway and headed the development of this institution for the first 10 years. 
One of his favourite professional areas has always been child development and 
early intervention, and in 1997 he initiated and headed the development of the 
premature project in Tromsø. Presently he is involved in and/or heading several 
research project both nationally and internationally, the latest being the NRC 
funded project “Child Rights and Violence in Brazil”.  He has published more 
than 80 scientific papers. 
coNfereNce | early iNterVeNtioN iMProVeS 
cogNitiVe aNd beHaVioral deVeloPMeNt of 
cHildreN borN PreMatUrely
Children born prematurely are at significant risk of delayed cognitive 
development and of suffering behavioural, emotional and social problems. 
One reason for this may be that the behaviour of these infants is less clear 
and consistent than their full-term counterparts. This may disturb the 
developmental transactions that take place between infant and parents and 
thus lead to poorer  development To test this hypothesis we embarked on a 
randomized clinical trial (n~140) in which ~ 70 pairs of parents were trained 
in hospital (7 hrs) and at home (4 hrs) to read their premature (<2000grams) 
infants’ behavioural cues and to react appropriately to these. A similarly sized 
reference group of infants born at term was also recruited. All families were 
subsequently followed at six months and at 1,2,3,5, 7 and 9 years with various 
medical, cognitive and psycho-social assessments from independent sources 
(mother, father, teacher, child), and blinded assessors. In all the asessments 
the participation rate was >90%. Positive results regarding parental stress 
have been documented from birth through age 3, more nurturant child-rearing 
attitudes and significantly better infant early social communication skills at one 
year, and improved behavioural and cognitive development at age five. Only 
three studies have followed early intervention effects up to age five, and only 
two of these further on. 
joSé alexaNdre S criPPa, 
MD, PhD
coNfereNce | tHe 
USe of caNNabidiol, 
a caNNabiS SatiVa 
coNStitUeNt, iN 
NeUroPSycHiatry
Cannabidiol (CBD), one of the main 
compounds of cannabis sativa plant 
was isolated from marijuana extract in 1940, but only in 1963 its exact chemical 
structure was elucidated by Mechoulam and Shvo. The few pharmacological 
studies on CBD reported before the early 1970’s, showed that CBD was unable 
to mimic the effects of Cannabis plant leading to the thought that it was an 
inactive cannabinoid. Therefore, during this period CBD received much less 
attention than delta-9-THC. This thought began to change with the observation 
that the activity in animals of several samples of Cannabis differed widely, a fact 
which could not be attributed only to the different delta-9-THC contents of the 
samples. It was then hypothesized that other cannabinoids, among them CBD, 
could be interfering with the delta-9-THC effects. The number of publications 
on Cannabis increased in 1970’s and then remained stabilized until the early 
1990’s when it has increased considerably. Nevertheless, although the number 
of publications about Cannabis in general and delta-9-THC in particular, has 
been continuously growing, the reports on CBD remained stable until the 
early 2000’s. However, this scenario has changed in the last few years with 
an explosive increase in publications on CBD − some contributions from 
our group − with the confirmation of a plethora of pharmacological effects, 
many of them with therapeutic potential. More recently, we have expanded 
our previous contributions now with emphasis on pharmacological advances, 
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as well as on novel mechanisms by mean with neuroimaging methodologies. 
We have demonstrated anxiolytic properties of CBD by several pre-clinical 
studies that employed different paradigms. Although these previous studies 
have shown that CBD possess anxiolytic properties, it has not been tested 
in pathological anxiety so far. Therefore, we recently investigate this in ten 
patients with Social Anxiety Disorder (SAD) using SPECT and in the simulated 
public speaking test paradigm. Since the early 1980’s, the antipsychotic-like 
properties of CBD have been suggested both in animals and humans. Recently, 
with the results of a study with 10 healthy volunteers using ketamine-induced 
psychotic symptoms model and open case reports of schizophrenic patients 
treated with CBD we further supported the proposal of the antipsychotic-
like properties of this cannabinoid. A possible therapeutic effect of CBD on 
movement disorders came from preliminary anecdotal reports of open trials, in 
the middle 1980’s. Afterwards, this field of research was apparently abandoned 
until recently, when CBD’s neuroprotective effects began to be reported in 
animal models of Parkinson’s disease (PD). In a recent study, we also observed 
that CBD can increase BDNF levels in some brain regions, thus reversing and 
preventing in an animal model the oxidative stress effects of chronic use of 
the indirect dopaminergic agonist d-amphetamine.  It is well-known that 
psychosis in PD is great challenge for clinicians’ management of and the need 
for new pharmacological intervention in such condition. Therefore, based in 
the previous antipsychotic and neuroprotective effects of CBD, we directly 
evaluated for the first time, the efficacy, tolerability and safety of CBD on PD 
patients with psychotic symptoms. In an open-label pilot study, six consecutive 
outpatients with the diagnosis of PD and who had psychosis for at least 
3 months were included. They received CBD in flexible dose for 4 weeks, in 
addition to their usual therapy. The psychotic symptoms showed a significant 
decrease under and CBD treatment and decreased the total scores of the Unified 
Parkinson’s Disease Rating Scale. These preliminary data suggest that CBD may 
be effective, safe and well tolerated for the treatment of the psychosis in PD. 
We are now running a randomized double-blind controlled assay of such 
cannabinoid on cognitive, motor, and psychiatric symptoms of PD. Due to its 
wide spectrum of action, CBD was tested on epilepsy, panic disorder, post-
traumatic stress disorder, other psychosis, sepsis, neuroprotection, tumors, 
sleep disorders, among other conditions. CBD may be of great therapeutic 
interest to neuropsychiatry; however, further controlled trials are necessary to 
confirm the existing findings and to establish the safety of such compounds.
lUiS a roHde is Professor of 
Psychiatry in the Department of 
Psychiatry at the Federal University of 
Rio Grande do Sul, Brazil, Director of the 
Program for Attention-Deficit/
Hyperactivity Disorder at the Hospital 
de Clinicas de Porto Alegre, and Vice-
Coordinator of the National Institute of 
Developmental Psychiatry, Brazil. He is 
currently Associate Editor of the Attention Deficit and Hyperactivity Disorder, 
Co-Editor of the European Child and Adolescent Psychiatry, and International 
Editor of the J Am Acad Child and Adolescent Psychiatry. He is President of the 
World Federation of ADHD, Vice-President of the International Association of 
Child and Adolescent Psychiatry and Allied Professions and member of the 
DSM-5 workgroup for ADHD and Disruptive Behavior Disorders.   Dr. Rohde’s 
research interests include ADHD epidemiology, genetics, pharmacogenetics, 
neuroimaging, and the effects of pharmacological and psychosocial treatments 
for ADHD. He has published extensively in peer review international and 
national journals (more than 170 papers), and has been an author or co-author 
in over 40 book chapters/books and editorials. He has 2365 citations and an H 
index = 24 in the Web of Science.
coNfereNce | NeUrobiological eVideNceS for 
adHd aS a NeUrodeVeloPMeNtal diSorder
Attention-Deficit/Hyperactivity Disorder (ADHD) is one of the most prevalent 
neurobiological disorders affecting individuals across the life-cycle. In this 
presentation, we first review some new epidemiological data from our lab 
addressing two clinically relevant questions: Are there evidences for an 
increase in ADHD prevalence in children and adolescents? What is the impact 
of the new DSM-5 definition of ADHD in the prevalence of the disorder in 
adults? For the first question, the evidence from a recent systematic review 
and meta-regression conducted by our group will be discussed. To address 
the second question, we will present data from the 1993 Pelotas Birth Cohort 
where the diagnosis of ADHD according to the DSM-5 criteria was assessed. 
Next, we will present data from our and other labs suggesting that ADHD is 
as a neurodevelopmental disorder based both on recent findings linking the 
disorder with genes involved in neurodevelopment and on neuroimaging 
data documenting different brain trajectories and modifications in resting 
state (default-mode network) connectivity comparing subjects with ADHD 
and those with typical development. Finally, we will discuss next steps in the 
field to increase characterization of ADHD as a neurodevelopmental disorder 
based on projects under development both in the National Institute of 
Developmental Psychiatry for children and adolescents and the 1993 Pelotas 
Birth Cohort. Specifically, we will present the conceptualization of two projects: 
a) the first trying to determine genetic and neuroimaging data predicting the 
trajectory from an at risk condition to a full ADHD diagnosis in children; b) the 
second searching for neurobiological data differentiating individuals in early 
adolescence with family and/or phenotypic characteristics associated with 
remission of ADHD in early adulthood from those with typical development 
and ADHD in early adolescence.                 
Marcelo f Mello is associate 
professor of clinical psychiatry at 
Federal University of Sao Paulo, 
graduated from the Santa Casa Medical 
School (SP-Brazil) in 1984, where-
upon he worked as a associate professor 
till 1998. His expertise is in diagnosis, 
pharmacologic treatment, and 
neurobiology of Post-traumatic Stress 
Disorder and Major Depression with an emphasis on suicidal behavior.  He has 
received an award as Social entrepreneur of future, from Schwab Foundation 
and Folha de Sao Paulo Group (2010), and from Associação Brasileira de 
Psiquiatria (1996).  Dr. Mello is principal investigator in three studies funded by 
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the State of São Paulo Funding Agency (FAPESP): a) Interpersonal Therapy 
Triage format depression in children; b)  The impact of violence on pre-
pubertal children: Clinical and biological factors; and c) Four year follow-up of 
a cohort with PTSD. Dr. Mello coordinated training for health professionals to 
detect and treat psychiatric disorders related to violence on war zone, in an 
association with the international red cross, in regions as Rio de Janeiro Slums, 
extreme violent neighborhoods in S. Paulo, and in Congo borders. He has 
authored or co-authored over 90 peer-reviewed articles.  
coNfereNce | early boNdiNg aNd SoMatic 
MarKerS: coNtribUtioNS to NeUrobiology of 
attacHMeNt
The aim of this conference was to examine the relationship between 
childhood maltreatment and PTSD development during adult life. Through a 
review of the relevant literature was possible to identify key and illustrative 
research findings, which showed that there is now a substantial body of 
preclinical and clinical evidence, derived from a variety of experimental 
paradigms, showing how early-life stress is related to many neurobiological 
dysfunctions which will disrupt psychological functioning, which in their 
turn would be related to development of high risk to PTSD during adulthood. 
Risk for adult PTSD and early life stress is related to a complex interaction of 
multiple experiential factors, as well as to susceptibility genes that interact 
with those factors.  Adaptive systems for human social environment need 
a long-term maturation and are highly dependent of early experiences 
initially with child’s mother and further with peers. The author will discuss 
hypothesis that could be linked to adaptive systems malfunctioning based on 
neurobiological findings. Research to date has identified multiple determinants 
of psychiatric disorders development in adults with a history of childhood 
maltreatment or other early-life stress. The author proposed hypothesis that 
could be testable empirically creating a field for future research.
Maria a. oqUeNdo, M.D. is 
Professor of Clinical Psychiatry and 
Vice-Chair for Education in Psychiatry 
at Columbia University and the New 
York State Psychiatric Institute.  Her 
expertise is in diagnosis, 
pharmacologic treatment, and 
neurobiology of Bipolar Disorder and 
Major Depression with an emphasis 
on suicidal behavior.  She has received many awards including the Simon 
Bolivar Award from the APA (2010) and has twice received the Exemplary 
Psychiatrist Award from  the National Alliance for the Mentally Ill.  She was 
named Honorary Professor, Universidad  Peruana Cayetano Heredia, Lima, 
Peru (2011).  Dr. Oquendo is principal investigator on a NIMH study of suicidal 
behavior in affective disorders and an R25 supporting translational research 
training in the residency training program.  She was recently awarded a T32 
grant to implement a research fellowship program in Global Mental Health. 
She has authored or co-authored over 220 peer-reviewed articles
coNfereNce | eStiMatiNg riSK for SUicide 
atteMPt aNd deVeloPMeNt of PreVeNtioN 
StrategieS 
Psychopathological, genetic, familial, behavioral and cognitive factors 
contribute to risk for suicide attempt.  As well, suicidal behavior has a well-
defined neurobiology, apart from that associated with psychiatric conditions in 
which suicidal behavior is observed.  Some of the neurobiological abnormalities 
are related to stress response dysfunction, neuroinflammation and changes 
in polyunsaturated fatty acids ratios, in addition  to changes in neuronal 
serotonergic function.  Understanding predisposing characteristics can assist 
in the identification of high risk individuals.  However, determining the exact 
timing of suicidal behavior remains an elusive goal.   Major prevention strategies 
can be classified as primary or universal, secondary or targeting high risk 
populations or tertiary, focused on mitigating untoward effects of suicidal acts. 
Educational approaches for populations or screening in schools are examples of 
primary prevention strategies.  Aggressive management of psychiatric conditions 
associated with suicidal behavior such as mood disorders and psychoses are 
secondary prevention strategies that can effectively decrease risk.  Prevention 
of recurrence of suicidal behavior using safety planning and other interventions 
specific to suicidal behavior are tertiary measures that are being tested for efficacy 
in the stemming of suicidal behavior in those who  have already engaged in 
suicidal acts or in those who are at chronic risk for suicidal behavior.
MyrNa weiSSMaN is a 
Professor of Epidemiology in Psychiatry, 
College of Physicians and Surgeons and 
the Mailman School of Public Health at 
Columbia University and Chief of the 
Division of Epidemiology at New York 
State Psychiatric Institute (NYSPI). 
Until 1987, she was a Professor of 
Psychiatry and Epidemiology at Yale 
University School of Medicine and Director of the Depression Research Unit. 
She received a Ph.D. in epidemiology from Yale University School of Medicine in 
1974. Her research is on understanding the rates and risks of mood and anxiety 
disorders using methods of epidemiology, genetics, neuroimaging, and the 
application of these findings to develop and test empirically based treatments 
and preventive intervention.  Her current Interest is in bringing psychiatric 
epidemiology closer to translational studies in the neurosciences and genetics. 
She directs a 3-generation study of families at high and low risk for depression 
who have been studied clinically for over 25 years and who are participating in 
genetic and imaging studies.  She directs a multi-center study to determine the 
impact of maternal remission from depression on offspring.  She is one of the 
PIs in a multi-centered study to find biomarkers of response to the treatment of 
depression.  She was one of the developers of Interpersonal Psychotherapy, an 
evidenced-based treatment for depression. Dr. Weissman is a member of the 
Institute of Medicine, National Academy of Science.    She has been the author 
or a co-author of over 600 scientific articles and chapters, and 11 books and the 
recipient of numerous grants.  In April 2009, she was selected by the American 
College of Epidemiology as 1 of 10 epidemiologists in the United States who 
has had a major impact on public policy and public health.  The summary of her 
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work on depression appears in a special issue of the Annals of Epidemiology, 
Triumphs in Epidemiology. 
coNfereNce | traNSlatioNal ePideMiology iN 
PSycHiatry: liNKiNg PoPUlatioN to cliNical aNd 
baSic ScieNceS
Translational research generally refers to the application of knowledge generated 
by advances in basic sciences research translated into new approaches for 
diagnosis, prevention, and treatment of disease. This direction is called bench-
to-bedside. Psychiatry has similarly emphasized the basic sciences as the 
starting point of translational research. The term translational epidemiology for 
psychiatry research can also be bidirectional in which the knowledge generated 
from the bedside or the population can also be translated to the benches of 
laboratory science. Epidemiologic studies are primarily observational but can 
generate representative samples, novel designs, and hypotheses that can be 
translated into more tractable experimental approaches in the clinical and basic 
sciences. This bedside to-bench concept has not been explicated in psychiatry, 
although there are an increasing number of examples in the research literature. 
This lecture describes selected epidemiologic designs, providing examples 
and opportunities for translational research from community surveys and 
prospective, birth cohort, and family-based designs. Rapid developments in 
informatics, emphases on large sample collection for genetic and biomarker 
studies, and interest in personalized medicine — which requires information 
on relative and absolute risk factors—make this topic timely. The approach 
described has implications for providing fresh metaphors to communicate 
complex issues in interdisciplinary collaborations and for training in 
epidemiology and other sciences in psychiatry.
ricardo araya, has been 
involved in mental and primary health 
care research for almost three decades 
with projects in Chile, Brazil, Peru, 
Colombia, Lebanon, India, Nigeria, 
Zimbabwe, and United Kingdom.  I 
have received grants in open 
competition from the European Union, 
US National Institute of Mental Health, 
Wellcome Trust, UK Medical Research Council, UK National Institute of Health 
Research as well as other funding institutions. I have conducted several large 
randomized controlled trials as well as large epidemiological surveys in diverse 
countries and settings. Most importantly I have a long history of successful 
research and training collaboration with people across all continents.  I have 
nearly 200 scientific publications including 8 papers in Lancet.  I am a co-
founder member of the Global Mental Health Movement and member of the 
Global Health Trials Committee convened by the Wellcome Trust and the 
Medical Research Council in the UK. I have participated in several capacity 
building exercises in other countries. I have advised governments and worked 
at the Ministry of Health in Chile holding high-responsibility posts.  I lead as a 
Co-PI (with Professor Paulo Menezes from USP) a Mental Health Hub in Latin 
America focusing on the integration of management of chronic diseases. 
coNfereNce | ScHool iNterVeNtioNS aNd MeNtal 
HealtH iN adoleSceNtS
Depression can have devastating effects unless prevented or treated early 
and effectively. Schools offer an excellent opportunity to intervene with 
adolescents presenting emotional problems. A two-arm, cluster RCT was used 
to test the effectiveness of a school-based intervention to reduce emotional 
symptoms among low-income secondary school students in Santiago, 
Chile. 2,512 secondary school students from 22 schools and 66 classes 
participated. Students in the intervention arm attended 11 one-hour weekly 
and two booster classroom sessions of an intervention based on cognitive-
behavioral models. The intervention was delivered by trained non-specialists. 
Schools in the control arm received the standard school curriculum. The self-
administered BDI-II at 3 and 12 months after completing the intervention was 
the main outcome measure.  Primary outcome data were available for 82% 
of participants. There was no evidence of any clinically important difference 
in mean depression scores between the groups [-0.19 (95% Confidence 
Intervals:  -1.22 to 0.84)] or indeed for any of the other outcomes at three 
months after completing the intervention. No differences were found in any 
of the outcomes at 12 months. The UK study compared the effectiveness of 
classroom based cognitive behavioural therapy with attention control and 
usual school provision for adolescents at high risk of depression. This 3-arm 
cluster RCT took place in 8 UK secondary schools, involving 5,030 adolescents 
aged 12-16 years. The groups received either CBT, attention control, and usual 
school provision. The primary outcome was symptoms of depression assessed 
at 12 months by the SMFQ among those identified at baseline as being at high 
risk of depression. 1064 (21.2%) adolescents were identified at high risk of 
depression: At 12 months adjusted mean scores on the SMFQ did not differ for 
cognitive behavioural therapy versus attention control (−0.63, 95% confidence 
interval −1.85 to 0.58, P=0.41) or for cognitive behavioural therapy versus 
usual school provision (0.97, −0.20 to 2.15, P=0.12). There is growing evidence 
that universal school interventions may not be sufficiently effective to reduce 
or prevent depressive symptoms.
roNaldo laraNjeira, M.D., 
Ph.D., is a full professor at Federal 
University of São Paulo (UNIFESP), 
Director of the Alcohol and Drugs 
Research Unit – UNIAD from February 
1995. Visiting Professor in the 
Department of Psychiatry from the 
Federal University of São Paulo, from 
1996 to 2002. Consultant of the World 
Health Organization from April 1996. Tenure Professor in the Department of 
Psychiatry from May 2002.  Consultant of the United Nations Office on Drug and 
Crime from September 2007. Full Professor in the Department of Psychiatry in 
the Federal University of São Paulo, from June 2008. Head of the Program of 
Clinical Psychiatry in the Department of Psychiatry in the Federal University of 
São Paulo from February 2008. Consultant of the Pan American Health 
Organization from February 2008. Director of the National Institute of Public 
Policies on Alcohol and Drugs – INPAD from January 2009. After earning his 
Ph.D, supervised by Prof. Griffith Edwards at the Addiction Unit of  IoP-KCL, he 
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established the most important center to combat addictions (UNIAD) in Brazil. 
His center was responsible for training more than 500 mental health 
professionals on alcohol and drug addiction. He is the most important academic 
regarding alcohol and drug policies in the country, participating in TV 
discussions, radio and newspaper interviews. He is the head of the National 
Institute of Science and Technology for Alcohol and Drugs Policies (INPAD) 
which has a major role in the Brazil’s drug and alcohol policies.  
coNfereNce | braziliaN NatioNal alcoHol aNd 
drUgS SUrVey 
The Second Brazilian National Alcohol and Drugs Survey (BNADS / LENAD) is a 
nationally representative repetitive cross-sectional study. It estimated patterns 
of alcohol, tobacco and illicit substances use. Risk factors for addiction were also 
assessed. Both surveys were organized by the National Institute of Alcohol and 
Drug Policy (INPAD) of the Federal University of Sao Paulo (UNIFESP), which is 
a research organization funded by the Ministry of Science, and conducted by 
Ipsos Public Affairs. Both surveys used a probability multistage cluster sample 
designs to select Brazilians 14 years of age and older from the household 
population of Brazil. In both surveys, face to face interviews of about an hour 
were carried out by trained interviewers. Sampling methods were identical in 
each survey. The multistage sample had 4 stages, as follows: counties, within 
counties census areas, households, and at the last stage a randomly selected 
respondent within the household. No substitutions were allowed. In 2006, the 
selected sample was composed of 2,346 interviews with adults aged 18 years 
and more, plus 661 with respondents between 14 and 17 years of age. In 2012, 
the survey interviewed 3,295 respondents 18 years of age and older and 908 
respondents between 14 and 17 years of age. The response rate in 2006 was 
66% and in 2012 it was 77%. The survey’s alcohol assessment instrument was 
a version of the questionnaire used in the Hispanic Americans Baseline Alcohol 
Survey (HABLAS). The Severity of Dependence Scale (SDS) was used to assess 
cannabis and cocaine dependence and other 10 scales were used to assess risk 
factors such as depression, quality of life, physical health, pain, diet, physical 
activity, adverse early life events, domestic violence, recent negative life events 
and social support. The questionnaire underwent a process of adaptation to the 
socio-cultural reality of the Brazilian population. Preliminary results show that 
there was a small increase in abstinence rates (48% to 50%), but the proportion 
of respondents drinking once a week or more increased from 42% to 53%. 
This increase was statistically significant among women (from 27% to 38%). 
The frequency of binge drinking (5 or more for men, 4 or more for women) 
increased from 45% to 58% in the population: from 54% to 66% among men, 
and from 34% to 48% among women. Alcohol abuse decreased among men, 
from 4.56% in 2006 to 3.25% in 2012, but this decrease was not significant 
among women (from 0.86% to 0.62%). Alcohol dependence also decreased 
significantly among men (from 13.6% to 10.5%) and increased slightly among 
women (from 3.38% to 3.63%). Over 6% of the Brazilian population have tried 
cannabis at least once in their lives, 3% reported use in the last twelve months. 
Among adolescents (under 18 years old) the rates were 4% and 3% for lifetime 
and last year use respectively. Over half of the users (62%) tried the substance 
before 18 years old. Dependence rates were 37% among last year users and 
over half of the participants reported daily use. Cocaine lifetime use was 
reported by 4% of the adult population and 2% among adolescents. Last year’s 
use of cocaine was 2% for adolescents and adults. Smoked cocaine was tried 
by 1.4% of the adult population, and 1% used it in the last year. The prevalence 
for lifetime and last year use of smoked cocaine was 0.2 among adolescents. 
Nearly half of the users (45%) have tried some form of cocaine before 18 years 
old. Injected cocaine was experimented by 14% of the users. These data show 
therefore a mixed and complex picture for trends in alcohol consumption and 
alcohol use disorders in Brazil. Even though Brazil is not among the main 
consumers of cannabis in the world, our study showed that Brazil is the second 
largest cocaine market in the world with regard to the sheer number of users. 
rodrigo breSSaN, professor 
at UNIFESP, is the Coordinator of 
Integrative Neuroscience Lab. After 
earning his Ph.D in molecular 
neuroimaging at IoP-KCL, he returned 
to lead the most prestigious 
Schizophrenia Research Program 
(PROESQ) in Brazil. He has funded one 
of the most productive cutting-edge 
clinical neuroscience labs (LiNC) with an interdisciplinary team of internationally 
trained researchers performing animal and human integrative translational 
neuroscience research using functional, structural and molecular neuroimaging, 
genetics, cognition, and neuroplastic, oxidative stress and inflammatory 
molecules. His group has pioneered studies on children at risk for MD and 
adolescents in ultra-high risk for psychosis and bipolar disorder. He has 
implemented anti-stigma strategies with patient protagonism and school 
mental health awareness. He is an Honorary Professor at the IoP-KCL and is part 
of the EUGEI – European Networks of National Schizophrenia Networks of 
Gene-Environment Interactions. Dr. Bressan is a leading and enthusiastic 
researcher in the new generation of clinical neuroscience.
coNfereNce | at riSK MeNtal State for 
PSycHiatric diSorderS
The psychiatric research field is currently walking a long road to enhance the 
understanding of etiological mechanisms involved in psychiatric disorders with 
special interest in the neurodevelopmental processes. In the last two decades, 
several international initiatives have focused on the childhood and early 
detection of individuals at risk for severe mental disorders, such as schizophrenia 
and bipolar disorder (BD). This approach has been very prolific with new insights 
on the transition to psychosis and innovative early interventions to prevent the 
disorders. Dr Bressan will present the developments of the field and current 
exciting cohorts with 2,500  6-12 years-old children (early developmental signs 
in enriched for psychopathology community-based cohorts, INPD), school-
based intervention strategies to inform teachers and students about mental 
health, and an clinical-research approach to Ultra-High Risk for Psychosis and 
Bipolar Disorder (PRISMA). He coordinates a large multiphase, multimodal 
and translational platform of investigation of psychosis and BD (PRONEX), 
which brings together several Brazilian neuroscientists to investigate the 
neurodevelopmental processes to provide information towards prevention of 
severe mental disorders. 
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StaN KUtcHer MD, FRCPC, 
FCAHS, Sun Life Financial Chair in 
Adolescent Mental Health, Dr. Kutcher 
is an internationally-renowned expert 
in the area of adolescent mental health 
and a national and international leader 
in mental health research, advocacy, 
training, policy, and services innovation 
working at the IWK and Dalhousie 
University. He currently holds the Sun Life Financial Chair in Adolescent Mental 
Health where he applies knowledge translation techniques to advance 
adolescent mental health promotion, education, research and training locally, 
nationally and internationally. He currently directs the World Health 
Organization Collaborating Center in Mental Health at Dalhousie and recently 
ran as the federal Liberal candidate for Halifax. He has served as Department 
Head of Psychiatry and Associate Dean for International Health at Dalhousie 
University. Dr. Kutcher has received numerous awards and honors locally, 
nationally and internationally for his work including: a Best Doctor in Canada; 
Doctors Nova Scotia Health Promotion Award; Dr. John Savage Memorial Award 
for outstanding humanitarian contributions to global health; Canadian College 
of Neuropsychopharmacolgy Gold Medal; Lifetime Achievement Award of the 
Canadian Psychiatric Research Foundation. He is a Distinguished Fellow of the 
Canadian Psychiatric Association and a Fellow of the Canadian Academy of 
Health Sciences.  He has been honored by the Canadian Psychiatric Association 
with the JM Cleghorn Award for his contribution to mental health research and 
the Paul Patterson Award for his innovations in psychiatric education. He is and 
has been a member of numerous boards and national organizations including 
the Institute of Neuroscience, Mental Health and Addictions of the CIHR; 
Interhealth Canada; Mental Health Commission of Canada (CYAC committee); 
the Canadian Society for International Health; the Canadian Coalition for Global 
Health Research, the Sandbox Project. He is the author of more than 200 
scientific papers and the author/co-author of numerous medical textbooks. 
Locally he contributes to the work of Laing House,  Immigrant Services and 
Integration Services and the Boys and Girls Clubs.  . One of his recent projects 
was leading the development of a national child and youth mental health 
framework for Canada: Evergreen. Currently his focus is on knowledge 
translation pertaining to improving youth mental health and mental health 
care in schools and primary care.
coNfereNce | iNterNatioNal ScHool MeNtal 
HealtH: global aPProacHeS, global 
cHalleNgeS, aNd global oPPortUNitieS
School mental health is increasingly being recognized as an important issue 
with many different components, ranging from mental health promotion to 
provision of mental health care.  In some jurisdictions various interventions are 
applied, while in other jurisdictions similar or different interventions are found, 
many of which demand fidelity to specific program use.  Application of various 
interventions may be useful but not necessarily lead to substantive population 
mental health improvements on their own as they are often not integrated 
into a comprehensive public health framework addressing youth mental 
health care needs.  A recently described model that links school based mental 
health beginning with mental health literacy through identification of youth 
with mental health problems/mental disorders to mental health care and on-
going school based support is being applied in various Canadian settings.  This 
presentation provides an overview of the model (Pathways to Mental Health 
Care) and some of the field test and early program evaluation data pertaining 
to its application.  The relevance and applicability of the model as an example of 
a flexible framework not embedded in a fidelity paradigm and its suitability for 
use in various international settings will be described and discussed.
VaNeSSa c. abilio is a 
professor at the Department of 
Pharmacology / Federal University of 
Sao Paulo since 2006. She coordinates 
the laboratory of Animal Models in 
Neuropsychiatric diseases from the 
Interdisciplinary Laboratory of Clinical 
Neuroscience (LiNC). Her research is 
mainly focused in pre-clinical 
investigations of schizophrenia. Her group has recently suggested a new animal 
model to study this disease and is currently evaluating the role of dopamine, 
endocannabinoid and glutamate systems as well as neuroinflammation in the 
pathophysiology of schizophrenia and potential new treatment and prevention 
strategies. She graduated in Biomedicine from  Federal University of São Paulo 
(1995) and got her master’s degree  (1998) and Ph.D (2003) in Pharmacology at 
the same University. 
coNfereNce | tHe SPoNtaNeoUSly HyPerteNSiVe 
rat (SHr) StraiN: How aNiMal ModelS caN HelP 
US adVaNce tHe treatMeNt aNd PreVeNtioN of 
NeUroPSycHiatric diSeaSeS 
Investigations in individuals at high risk for developing psychiatric disorders 
are essential, but they have methodological and ethical limitations that make 
the use of animal models a powerful tool. We have recently suggested the SHR 
strain as a new animal model of schizophrenia with good face, predictive and 
construct validities. Currently, this animal model has been used to investigate 
the pathophysiology of schizophrenia and, importantly, to evaluate new 
preventive and therapeutical approaches. In this sense, data will be presented 
to illustrate how the use of good animal models can advance our knowledge 
about the neurobiology of the disease and propose innovative treatment and 
preventive strategies.  
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yaNKi yazgaN, M.D. received his 
child and adolescent psychiatry 
training (1995) at the Yale Child Study 
Center of Yale School of Medicine 
where he also completed a research 
training track in early onset 
neuropsychiatric disorders. Dr Yazgan 
has taught and conducted research at 
the Marmara University School of 
Medicine (as a full professor since 2001) in Istanbul. He also holds a clinical 
appointment at the Yale Child Study Center.  In addition to his academic/
medical career, Dr Yazgan speaks to and writes for professionally diverse 
audiences on everyday applications of cognitive neuroscience findings and his 
clinical experience as a psychiatrist, for the purpose of public understanding of 
science. www.yankiyazgan.com
coNfereNce | PreVeNtiVe deVeloPMeNtal 
aPProacHeS froM tUrKey: iNcreaSiNg fatHer 
iNVolVeMeNt, ScHool baSed PreVeNtioN aNd 
PUblic awareNeSS 
Preventive work in child and adolescent mental health includes strengthening 
families, building resilience and creating supportive contexts such as schools 
for children’s development and well-being. Parents are the first line partners in 
preventive mental health since young children’s immediate environments play 
a crucial role by fostering their ability to achieve their developmental potential. 
After the first a few years, teachers and educational system, as well as the social 
environment all play key roles. Early childhood development (ECD) parenting 
education programs are interventions that train and support caregivers of young 
children to improve parental skills (e.g., parenting knowledge, attitudes and 
beliefs, parental practices) and parent and child relationships.  Since schools are 
involved in care for children we must aim to integrate efforts from the family 
and the school emphasizing the function of teachers who when trained and 
empowered, enhance their roles in order to take responsibility for children’s 
psychological relief and prevention. Fragile contexts such as disadvantaged 
geographical regions are the places where research has demonstrated that 
some of the poor psychosocial outcomes common among young children 
can be minimized through participation in ECD intervention programs. School 
based teacher mediated preventive interventions in disaster affected areas 
have been effective in reducing and preventing psychosocial morbidity I will 
talk about examples from two domains of childhood mental health prevention 
in Turkey. In ECD domain, Mother-Child Education Foundation’s (AÇEV) Father 
Support Program,  in addition to its Mother and Child Education Program 
specifically target families who have no access to preschool education or 
mental health services in their communities to reduce risk factors that hinder 
children’s health and wellbeing. In school based intervention domain, post-
earthquake school based studies and their derivatives for preventing disruptive 
behavior will provide examples of partnering with schools and teachers as 
mediators of preventive mental health.
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briaN rUSH is a Senior Scientist 
and Head of the Health Systems and 
Health Equity Research Group and 
Director of the Performance 
Measurement and Implementation 
Science Department at the Centre for 
Addiction and Mental Health in 
Toronto. He is a   Professor in the Depts. 
of Psychiatry and the Dalla Lana School 
of Public Health at the University of Toronto.  He holds an MA in Psychology and 
Ph.D. in Epidemiology and Biostatistics and has worked for 35 years in a 
research and evaluation capacity in the substance abuse and mental health 
fields. He is on the editorial board of the Journal of Substance Abuse Treatment. 
Brian’s research and development portfolio includes the field of co-occurring 
disorders with an emphasis on epidemiology in general and service populations, 
service and system level integration, and screening and assessment tools. 
Related work is focused on treatment evaluation, outcome assessment and 
dissemination of evidence-based practices for mental health, substance abuse 
and co-occurring disorders. 
coUrSe | eValUatioN of MeNtal HealtH SerViceS 
aNd SySteMS
Considerable effort and resources are directed at planning and implementing 
a comprehensive and well-balanced mental health system, including 
substance use services. At the same time, however, considerably less attention 
is given to evaluating the efficiency, effectiveness and equity of the policies 
and services that comprise the system. Mental health services research, 
performance measurement and program/policy evaluation are closely related 
area of endeavor that aim to understand a mental health system for purposes 
of quality improvement, accountability and knowledge development and 
exchange. In the two parts of the course devoted to this topic participants will 
gain an  understanding of different models of evaluation - objectives-oriented, 
stakeholder-based, and system evaluation –  each one contributing unique 
perspectives and which can be effectively combined in any given evaluation 
context. Going beyond evaluation theory participants will learn a stepped 
approach to planning, implementing and reporting an evaluation project in 
a mental health service or system. This will include an understanding of the 
role and limitations of program logic models in focusing on specific evaluation 
questions; complementary approaches to understand and incorporate internal 
and external context into these evaluation questions; and various methods 
to design and answer these questions. The importance of planning for the 
utilization of the evaluation results is also emphasized.
brUce cUtHbert, Ph.D., is 
Director of the Division of Adult 
Translational Research and Treatment 
Development (DATR) at the National 
Institute of Mental Health (NIMH). 
coUrSe | toward tHe fUtUre of PSycHiatric 
diagNoSiS: tHe NiMH reSearcH doMaiN criteria 
Project 
Background:  Major revisions are underway to the two major psychiatric 
manuals (DSM and ICD), but the fundamental aspects of these nosologies 
remain based upon presenting signs and symptoms. Research increasingly 
reveals that current disorder definitions do not reflect relevant neurobiological 
and behavioral systems –- impeding not only research on etiology and 
pathophysiology, but also the development of new treatments.
Discussion:  The National Institute of Mental Health began the Research Domain 
Criteria (RDoC) project in early 2009 to develop a research classification system 
for mental disorders based upon dimensions of neurobiology, cognitive 
function, and observable behavior. The RDoC project is intended for research 
purposes, with the aim of conducting studies that examine fundamental neural 
systems and the behavioral functions that these systems implement (such 
as fear or working memory) that cut across current heterogeneous disorder 
categories. These dimensions are studied with a multi-systems approach that 
integrates genetics, molecular and cellular processes, neural circuit activity, and 
behavioral and self-report measures of functioning.  This course will summarize 
the rationale, status, and long-term goals of the NIMH RDoC project, and 
outline the major differences in conception and emphasis from the DSM and 
ICD revisions.
daVid PaUlS was the founding 
director of the Psychiatric and 
Neurodevelopmental Genetics Unit 
(PNGU). On July 1, 2011 he stepped 
down as director.  Prior to coming to 
Harvard in September 2001, he was the 
Professor of Psychiatric and 
Neurobehavioral Genetics in the Child 
Study Center at Yale University. Over 
the past 30 years, his research has focused primarily on the genetics of child 
neuropsychiatric disorders. Research under his direction has led to a better 
understanding of the inheritance of the Gilles de la Tourette Syndrome (GTS), 
Obsessive Compulsive Disorder (OCD), specific reading disability and the autism 
spectrum disorders. Until recently, he led three separate international consortia 
of investigators devoted to finding genes for GTS, OCD, trichotillomania and 
related conditions.  The focus of Dr. Pauls’ research has been on elucidating the 
underlying etiologic mechanisms important for the expression of human 
behavior. His primary goal has been to understand the both genetic and non-
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genetic factors that underlie the manifestation of specific behaviors that begin 
in childhood and continue over the life course.  His research has focused on five 
different developmental neuropsychiatric disorders: the Gilles de la Tourette 
syndrome, obsessive compulsive disorder, high functioning autism/Asperger’s 
syndrome, specific reading disability and trichotillomania and related disorders. 
Dr. Pauls is the author of over 270 peer-reviewed articles, 60 book chapters and 
one book.  Most of his work was funded by grants from the National Institutes 
of Health.
coUrSe | geNetic MecHaNiSMS for tHe 
MaNifeStatioN of coMPlex deVeloPMeNtal 
beHaVioral diSorderS.
It has become clear over the last decade that the underlying genetic 
mechanisms for developmental disorders is significantly more complex that 
was originally thought.  It this course we will review the various genetic models 
that have been proposed and summarize recent findings on the genetics of 
childhood onset mental disorders including Gilles de la Tourette syndrome, 
obsessive compulsive disorder, attention deficit hyperactivity disorder and 
autism spectrum disorders.
geroMe breeN, is a Senior 
Lecturer in the MRC Centre for Social, 
Genetic and Developmental Psychiatry 
at the Institute of Psychiatry, King’s 
College London. He is funded by the UK 
NIHR (the UK NHS Research Council) 
and is theme lead (unit leader) at the 
NIHR Biomedical Research Centre (BRC} 
for Mental Health and the South 
London and Maudsley NHS Trust. He leads Bioresource (biobanking) activities 
at the BRC for Mental Health and a core for Genomics & Biomarkers in the NIHR 
BRC for Mental Health, managing a team of postdocs, lab staff and collection 
staff (25 members). Externally, he chairs the Network and Pathway Analysis 
Group of the Psychiatric Genomics Consortium (PGC) and is also an active 
member of the Major Depressive Disorder PGC group. For the UK NHS he sits on 
the National NIHR Bioresource Steering Group, Neuroscience Group and 
Genome Sequencing committees. His core work has been on common mental 
disorders such as depression and manic depression. He and his team are 
currently working (with collaborators) on mood disorders in the form of GWAS, 
linkage and whole genome sequencing studies as well as methods for GWAS 
bioinformatics and pathway analyses of psychiatric disorders and miRNA. His 
two main research focuses are on finding rare variants underlying risk for mood 
disorders via family based genomic studies with an additional stream of related 
experimental medicine and biomarker projects within the framework of the 
Biomedical Research Centre at IOP.
coUrSe | ModerN geNetic ePideMiology iN 
PSycHiatry.
This course will review the basic concepts that are informing modern genetics 
studies of complex disorders in psychiatry and will review how genomics is 
contributing to clinical practise and the drug development. Genetic variation 
comes in many different falvours and it is very important to understand the 
different sources of genomic information and variation. The conceptual 
framework for case-control and families studies will review and we will review 
a number of case studies in mood disorders and psychosis. 
gUStaVo tUrecKi MD PhD is 
Professor of Psychiatry and Human 
Genetics at McGill University, Montreal, 
Canada, where he leads a research and 
clinical career focusing on depression 
and suicide. Dr. Turecki has authored 
over 250 publications, including book 
chapters and research articles in peer 
reviewed journals such as Nature 
Neuroscience, Molecular Psychiatry, Archives of General Psychiatry, among 
others, and is the recipient of several scientific awards, including the NARSAD 
Michael Kaplan Investigator Award, the American Foundation for Suicide 
Prevention Distinguished Investigator Award and their 2012 Career Science 
Award, as well as the Radio-Canada Researcher of the Year in 2010. He also 
serves, or has served, in the advisory boards of several scientific journals. 
coUrSe | beHaVioral ePigeNeticS
Epigenetics refers to the study of the epigenome, i.e., the chemical and physical 
organization of the DNA that functionally regulate the genome, and allow for 
genomic plasticity. This takes place, in part, as responses to physical and social 
environmental signals.  Three main types of epigenetic processes are currently 
known: DNA methylation and hydroxymethylation, chromatin modifications 
and non-coding RNA. This course will review basic epigenetic concepts and 
review key animal and human research studies that were clear breakthroughs 
in our understanding of how the social environment regulates genomic factors 
underlying behavior development and possibly psychopathology.
HeleN HerrMaN is Professor of 
Psychiatry at Orygen Youth Health 
Research Centre and the Centre for 
Youth Mental Health, The University of 
Melbourne, and Director of the World 
Health Organization (WHO) 
Collaborating Centre for Mental Health in 
Melbourne. She is a National Health and 
Medical Research Council (Australia) 
Practitioner Fellow, and Honorary Fellow of the World Psychiatric Association 
(WPA), having served as WPA Secretary for Publications from 2005 to 2011.
coUrSe | PreVeNtiNg MeNtal illNeSS aNd 
ProMotiNg MeNtal HealtH: coNcePtS aNd 
eVideNce 
Prevention and promotion in mental health have been advocated for more than 
100 years. The social determinants of mental health and the risk factors for 
mental illnesses are becoming better understood. As for public health more 
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broadly, multiple interventions at different levels across health and non-health 
sectors are needed to: Promote mental health in different populations and 
settings, reduce the incidence of mental illnesses in populations and settings, 
and prevent the onset of cases (‘high-risk strategy’). Research evidence 
illustrates the effectiveness of a variety of public health and social interventions. 
Interventions that promote mental health may also improve the broader health 
and function of individuals and communities because of the close interaction 
between mental health, physical health and behaviour. Most evidence has been 
obtained in high-income countries although the need is greater in low-income 
countries. Innovation, adaptation and evaluation are required, supported by 
international collaboration. The workshop will consider examples of the role of 
promotion and prevention in improving mental health. Promoting the mental 
health of vulnerable women includes an emphasis on empowering women 
and tackling violence in the home and community through mental health 
and social policy as well as community development. Preventing depression 
occurs through population interventions and through ‘high-risk strategies’. 
Improving mental health after a disaster includes support for human rights 
and promoting mental health.  Human rights abuses are closely interconnected 
with poor mental health, poor physical health and social disadvantage. Finally, 
the workshop will address the concept of resilience: an interactive concept, 
referring to a person’s relative resistance to environmental risk experiences, 
or the overcoming of stress or adversity. Resilience after disasters or adverse 
childhood events is related intimately to a person’s personal characteristics and 
life circumstances, as well as wider factors, including social conditions, safety, 
participation, and access to education and work.  
jaMeS c. fraUeNtHal received 
a B.S. in Mechanical Engineering from 
Tufts University and a Ph.D. in Applied 
Mathematics from Harvard University. 
He did a Post-Doctoral Fellowship at 
the Center for Population Studies, a 
division of the Harvard School of Public 
Health   He was next a professor in the 
Department of Applied Mathematics 
and Statistics at Stony Brook University where he was granted tenure after one 
year and was awarded the New York State Chancellor’s Award for Excellence in 
Teaching.  He left Stony Brook to become a Member of Technical Staff at Bell 
Telephone Laboratories.  He then worked as a Senior Technical Leader at Cisco 
Systems.  He is currently an adjunct professor in the Department of Mathematics 
at the New York University Polytechnic Institute where he teaches graduate 
courses on graph theory and mathematical model building.  During the course 
of his career, Dr. Frauenthal has applied mathematics to a wide range of fields 
including fluid and solid mechanics, human demography, water resource 
planning, harvesting of fisheries and forests, queuing models of telephone 
traffic and voice response systems, audio quality and network echo control.  In 
addition to his scientific research publications, he has more than a dozen US 
patents issued or pending, has published a number of expository monographs 
on mathematical modeling of human and animal populations and epidemiology 
and has taught short courses around the world on mathematical model building. 
coUrSe | MatHeMatical ModeliNg iN 
ePideMiology
The purpose of this course, Mathematical Modeling in Epidemiology, is to 
introduce researchers and clinicians to the concepts and methods that are used 
in epidemiology.  This will be accomplished by means of a series of examples. 
While it will be assumed that the audience for the course is scientifically 
sophisticated, the material presented will be accessible to individuals who do 
not have a strong background in mathematics, computer science or statistics. 
Epidemiology is the study of the patterns, causes and effects of disease in 
populations.  Many people think narrowly about epidemiology as the study 
of infectious diseases using statistical data analysis.  The course will discuss a 
wide range of epidemiological ideas and techniques, with particular attention 
to two important directions: using predictive mathematical and computational 
models along with statistical models and doing so to understand a broad 
range of aliments, conditions and diseases that go beyond the outbreak 
and subsidence of an infectious disease. The current use of mathematical, 
statistical and computational methods in epidemiology will be illustrated 
using examples selected from a variety of areas. These will include models 
such as social networks and artificial intelligence to analyze topics such as 
substance abuse, sexually transmitted diseases and body image.  The course 
will provide participants with an introduction to how they might participate 
most productively in scientific research that advances the analytic description 
of ailments.
joaN KaUfMaN, PhD is an 
Associate Professor in the Department 
of Psychiatry at Yale University School 
of Medicine, and Director of the Child 
and Adolescent Research and Education 
(CARE) Program.  The CARE Program 
focuses on two areas of investigation: 
1) Studies in support of the National 
Institute of Mental Health’s Research 
Domain Criteria (RDoC) initiative which aims to develop the necessary database 
to derive a new psychiatric nomenclature informed by neuroscience, genetics, 
and psychology; and 2) Research on risk and resilience in maltreated children. 
These two lines of research are synergistic and interrelated, with the study of 
maltreated children having a number of advantages for the RDoC project, 
including: the study of a subset of patients that are frequently treatment 
resistant to standard clinical interventions; examination of a relatively 
homogenous sample with the onset of psychopathology proposed to be 
associated with stress-related mechanisms; and well-established relevant 
animal models to facilitate translational research.  Dr. Kaufman and colleagues 
utilize clinical assessment, neuroimaging (e.g., structural, fMRI fear conditioning 
paradigm, resting state connectivity), and genetics (e.g., polymorphisms, 
epigenetic markers) research methods, with many of the clinical assessments 
collected at a day camp devised specifically for their research purposes.
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coUrSe | UNderStaNdiNg How ePigeNetic 
MecHaNiSMS caN traNSlate early-life 
exPerieNceS iNto laStiNg cellUlar MeMorieS at 
tHe root of MeNtal diSorderS
Worldwide, approximately 40 million children are subjected to child abuse each 
year. Child abuse is a non-specific risk factor for multiple psychiatric disorders, 
including Posttraumatic Stress Disorder, Major Depression, and Alcohol and 
Substance Abuse Disorders. How do experiences of early abuse confer risk for 
later psychiatric disorders?  Epigenetics has been proposed as one possible 
mechanism. Epigenetics refers to functionally relevant modifications to the 
genome that do not involve a change in DNA nucleotide sequence. These 
modifications regulate gene activity and play a role in acute regulation of genes 
in response to changes in the environment.  This course reviews results of recent 
preclinical and clinical research studies examining epigenetic mechanisms and 
markers associated with psychiatric disease; and results of a genome wide 
methylation association study that found individual differences in methylation 
of CpG sites in genes involved in fear conditioning, synaptic plasticity, and 
myelination/circuitry formation predicted individual differences in depression 
ratings in maltreated children. Epigenetic profiling has transformed diagnosis, 
treatment planning, and drug development in other areas (e.g., cancer) of 
medicine, and it appears to hold promise in psychiatry as well. Epigenetic 
changes are often long-lasting, but they need not be permanent.   Implications 
for prevention and promising intervention approaches will also be discussed.
StaN KUtcHer MD, FRCPC, 
FCAHS, Sun Life Financial Chair in 
Adolescent Mental Health, Dr. Kutcher 
is an internationally-renowned expert 
in the area of adolescent mental health 
and a national and international leader 
in mental health research, advocacy, 
training, policy, and services innovation 
working at the IWK and Dalhousie 
University. He currently holds the Sun Life Financial Chair in Adolescent Mental 
Health where he applies knowledge translation techniques to advance 
adolescent mental health promotion, education, research and training locally, 
nationally and internationally. He currently directs the World Health 
Organization Collaborating Center in Mental Health at Dalhousie and recently 
ran as the federal Liberal candidate for Halifax.
coUrSe | MeNtal HealtH cUrricUlUM iN HigH 
ScHool
The theme for the sessions will be “How can the pathway to best quality mental 
health care be improved using the school as part of the process?”  The sessions 
will be very interactive and will require participants to WORK.  The students 
will need to bring their laptops to each session so we will need to have internet 
access in the venue.
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acioly l. t. lacerda, M.D., 
Ph.D., is a Professor of Psychiatry and 
Clinical Neurosciences at the 
Department of Psychiatry, Federal 
University of Sao Paulo (UNIFESP), Sao 
Paulo, Brazil. He is also Director of the 
Center for Research and Clinical Trials 
Sinapse-Bairral, where he has worked 
since its foundation. He received his 
M.D. degree at the Federal University of Pernambuco and completed psychiatric 
residency training at the State University of Campinas. In 2000, he received his 
Ph.D. degree at the State University of Campinas. In 2001-2002, he completed 
postdoctoral fellowships at the Neurochemical Brain Imaging Laboratory and 
Neuroimaging Laboratory, University of Pittsburgh, where he was named 
Visiting Professor and Associate Researcher in 2003. Dr. Lacerda is closely 
involved in research on neurobiology of severe mental disorders and has 
published several papers, books, and book chapters mainly on neuroimaging 
and neuropsychology fields. He currently holds grants in different research 
fields. To that end, he is PI of recently funded projects on management of 
treatment resistant depression and role of neuroprotective agents in treatment 
of severe mental disorders. Dr. Lacerda has had his research published in peer 
reviewed articles in such prestigious journals at British Journal of Psychiatry, 
Biological Psychiatry, and Neuroimage.
Currently, he serves as a referee for various high-impact factor journals and is 
member of the Editorial Board of the Brazilian Journal of Psychiatry.
aNa c. cHaVeS is Affiliated Professor 
at the Department of Psychiatry at the 
Faculty of Medicine of the Federal University 
of São Paulo (UNIFESP-EPM).  Her research 
has focused for more than 20 years on 
Schizophrenia and related psychotic 
disorders. Over the last decade her interest 
has been on the initial phases of psychotic 
disorders, mainly on first episode 
psychosis. She is currently head of the First Episode Psychosis Program, coordinator of 
the Psychiatry Residency Program and work as a clinician at the University Psychiatry 
Ward of São Paulo Hospital.
aNdrea a. feijó Mello 
graduated from Santa Casa Medical 
School in 1990 and she was a resident 
in Psychiatry at the Hospital do Servidor 
Público Estadual, São Paulo State 
(1990-93). She obtained her Master 
Degree from the Federal University of 
São Paulo (UNIFESP) in 2001; and her 
PhD, a four-year program from the 
same University, with a one-year fellowship (2003) at Brown University, Rhode 
Island under the supervision of Dr Lawrence H. Price, in 2006. Dr. Mello began 
a post doctoral research under the supervision of Dr Jair Mari in 2009, and since 
then she is co-orienting students from the post-graduation of the department 
of Psychiatry from UNIFESP, where she is employed as a Psychiatrist. She is the 
responsible for the outpatient clinic for the treatment of depression and stress 
at PROVE (violence and stress research program). Dr Mello’s researches and 
publications in journals and book chapters are related to stress and mood 
disorders. Her present post-doctoral study with maltreated children is related to 
risk factors, mainly the influence of violence, in the development of mental illness.
aNdrea ParoliN jacKowSKi 
holds a degree in Biology, MSc and 
Ph.D in Medical Sciences. Her 
postdoctoral fellowship was in 
Neuroimaging at Yale University. Her 
main areas of interest concentrate in 
interdisciplinary research projects in 
structural neuroimaging and risk factor 
for mental disorders.  She is currently 
an assistant professor at the Department of Psychiatry at  Universidade Federal 
de São Paulo (UNIFESP-Brazil), where she is the coordinator of the Neuroimaging 
unit of the Laboratório Interdisciplinar de Neurociências Clínicas (LiNC). 
aNgélica M. claUdiNo is a 
psychiatrist and supervisor at the Post-
Graduation Program in Psychiatry at 
the Department of Psychiatry, Federal 
University of São Paulo (UNIFESP). She 
has over 20 years of experience in the 
field of Eating Disorders and is head of 
PROATA/UNIFESP (Eating Disorders 
Program) since 1994, where she is 
supervisor of clinical work and conducts research, with a main focus on 
diagnosis, neurobiology and treatment (randomized controlled trials and 
systematic reviews) of Eating Disorders. Dr Claudino did her post-doctoral 
training at the Institute of Psychiatry, King s´ College London, UK. She 
is a member of the Academy of Eating Disorders and of the editorial boards of 
scientific journals in the field of her expertise. She is Chair of the Eating 
Disorders Consultation Group, World Health Organization, for the revision of the 
ICD-10 Mental and Behavioral Disorders.
aNtÔNio teixeira is Associate 
Professor of Internal Medicine and 
Neurology at the Department of 
Internal Medicine, School of Medicine, 
Universidade Federal de Minas Gerais 
(UFMG), Belo Horizonte, Brazil. He 
graduated in Medicine from UFMG, and 
did residency in Psychiatry, Internal 
Medicine and Neurology (2001-2003) 
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at the University Hospital, UFMG. He also got MSc and PhD degrees in Cellular 
Biology. He is member of the Brazilian Academy of Sciences, the Brazilian 
Academy of Neurology and the Brazilian Psychiatric Association. 
Besides clinical, teaching, and administrative activities, he develops research in 
two main areas: neuropsychiatry and neuroimmunology. In neuropsychiatry, 
his research has focused the development and/or validation of clinical 
instruments to assess behavioral syndromes (e.g. depression, anxiety) in 
neurological diseases, such as epilepsy, migraine and Parkinson’s disease. The 
main objective of this line is to provide clinical tools to help busy physicians 
to identify significant psychiatric disorders. He has also been involved 
in community-based studies to assess the impact of headaches (Capela 
Nova Study) and cognitive disorders (Pietà Study) in the population of the 
countryside of Brazil. Now he is especially interested in translational research 
aiming to understand the involvement of inflammatory/immune mechanisms 
in behavior and cognition. For this purpose, he conducts basic (animal models of 
central nervous and systemic inflammation) and clinical studies. One secondary 
objective of this line of investigation is to search for inflammatory biomarkers of 
human diseases, including neglected ones (e.g. leprosy ).
clariSSa SeVeriNo gaMa, 
is Professor of Psychiatry at Universidade 
Federal of Rio Grande do Sul (UFRGS), 
Porto Alegre, Brazil. She received the 
degrees of MD (1995), Psychiatrist 
(1999), M.Sc. (2001) and PhD (2004) by 
UFRGS. She has taken a Post-Doctorate 
(2007-2008) at Department of Clinical 
and Biomedical Sciences, Barwon 
Health, University of Melbourne, Geelong (VIC), Australia. Professor Gama work 
has shed light in the biological underpinnings of the decline in cognition and 
physical health that takes place among patients with schizophrenia and bipolar 
disorder. It emphasizes the pathophysiological involvement of different biomarkers 
related to oxidative stress, neurotrophins and inflammation as new therapeutic 
targets. She has published over 60 peer-reviewed papers and has around 900 
citations, with an h-index of 16 (Gama CS*, Scopus). 
cleUSa P. ferri is a psychiatrist 
and is currently an affiliated professor 
at the Federal University of Sao Paulo, 
working in the departments of 
Psychobiology and Psychiatry on their 
post graduation programs. For 10 years 
Dr Ferri worked at the Institute of 
Psychiatry, King’s College London 
where as well as her teaching activities 
Dr.Ferri developed research in the areas of ageing, dementia and other chronic 
conditions. She is part of the 10/66 Dementia Research Group working with 
health professionals from around the world and has developed other 
collaborations in this area with UK and Brazil based colleagues. Dr Ferri assisted 
in the Global Burden of Disease 2010 Project as an international specialist in 
dementia and in the same capacity was also involved with the MHGap project 
with the WHO. She also has an interest in the areas of addiction and the 
implications of violence on women’s health.
criStiaNe SilVeStre de 
PaUla is a psychologist, with Master 
(concluded in 2001) and PhD 
(concluded in 2005) from the 
Department of Psychiatry at Federal 
University of São Paulo (UNIFESP), 
focused in Clinical Epidemiology. In 
2002/2003 she spent 9 months as a 
visiting scholar at the School of Public 
Health at the Johns Hopkins University, Baltimore, US. 
Since 2005, she is an Associate Professor at the Developmental Disorder Post 
Graduation Program at the Mackenzie University in Sao Paulo and Researcher 
at the Social Psychiatry Division of the Department of Psychiatry at UNIFESP. 
Dr de Paula is also Member of two international networks of Epidemiology: 
International Clinical Epidemiologic Network (INCLEN), since 1998, and 
International Autism Epidemiology Network (IAEN), since 2007.
Her main research interests are: (a) epidemiological studies related to child and 
adolescent mental health and violence, (b) child and adolescent mental health 
services research, and (c) research in Autism Spectrum Disorder.  
Currently, she is the PI of 3 research projects: 
(1) The Epidemiological Study of Mental Health among Brazilian School 
Children, the first Brazilian multicenter epidemiological study of child mental 
health to establish the frequency psychiatric disorders, to identify psychosocial 
risk factors and to describe mental health service use in representative samples 
of four Brazilian regions. 
(2) Training in Child Mental Health for Health Professional from the five 
Brazilian regions to develop and assess a Brazilian version of the “Mental 
health communication skills for child and adolescent primary care” (originally 
developed at the Johns Hopkins University). 
(3) Autism Spectrum Disorder and Developmental Delay in Day Care children: a 
pilot study, to establish ASD frequency rates in children aged 18 a 36 months in 
public day care centers from a typical Brazilian city and to promote orientation 
to family and to day care professionals of the detected cases.
deboraH SUcHecKi, is an 
Adjunct Professor of 
Psychopharmacology, Graduated in 
Biomedicine with a Master’s degree in 
Pharmacology and Ph.D. in 
Psychobiology. Deborah Suchecki was 
a post-doc fellow in Stanford University, 
working in the Laboratory of 
Developmental Psychobiology in the 
Department of Psychiatry and Behavioral Sciences. For more than 20 years she 
has been working with the impact of stress in physical and mental health, 
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especially in animal models of depression and anxiety. Currently she is a teacher 
at Universidade Federal de São Paulo, leading a group of young scientist 
focused on studying the consequences of stressors, such as sleep deprivation 
and of early life stress on memory, metabolism, immune system and as risk 
factors for the development of anxiety and depression in adolescents and 
adults. She studies the role of neuropeptides and hormones as mediators of 
these effects, in particular, neuropeptide Y, prolactin, oxytocin, orexin and 
glucocorticoids. Deborah is an ad hoc reviewer in the State and Federal funding 
agencies, is a member of the boarding committee of the journals Sleep and 
Frontiers in Sleep and Chronobiology, and has reviewed manuscripts to several 
journals, such as Biological Psychiatry, Neuroscience and Biobehavioral 
Reviews, Psychoneuroendocrinology, etc. 
deNiSe razzoUK is medical 
psychiatrist, graduated by the Faculty 
of Medicine, University of São Paulo 
(USP) in 1986, with residency in 
psychiatry at the Institute of Psychiatry 
from FMUSP (1987-1990). Completed 
the Master›s Degree and a Doctorate in 
Medicine (Psychiatry) by the 
Department of Psychiatry at the Federal 
University of S Paulo (UNIFESP) in 2001. Held post-doctoral studies in 
Economics in Mental Health in Center of Economic Mental Health, Institute of 
Psychiatry, King›s College, University of London in 2008. Currently, is Affiliated 
Professor of the Department of Psychiatry, Federal University of São Paulo 
(Unifesp), coordinator of the Center of Economy in Mental Health and supervisor 
and professor in  graduate program of the Department of Psychiatry, Unifesp, 
Currently, develops projects in the economics of Mental Health, including 
assessment and planning of mental health services, psychiatric reform, 
economic analysis of health services and interventions in mental health and 
socio-economic impact of mental disorders
eVaNdo coUtiNHo graduated 
in Medicine at the University of the 
State of Rio de Janeiro - UERJ (1979). 
MSc  in Public Health at the Oswaldo 
Cruz Foundation - Fiocruz (1987), MSc 
in Epidemiology at the London School 
of Hygiene and Tropical Medicine - 
LSHTM (1994) and PhD in Public Health 
at the Federal University of Bahia - 
UFBa (1995). He is currently Senior Researcher in Epidemiology at Fiocruz and 
Senior Lecturer in Epidemiology in the Institute of Social Medicine - UERJ. 
Former editor of the Cochrane Schizophrenia Group. His main interests are 
epidemiology of mental disorders, clinical trials and meta-analysis.
Main publications since 2010:
Silveira H, Moraes H, Oliveira N, Coutinho ESF, Laks J, Deslandes A. Physical 
Exercise and Clinically Depressed Patients: A Systematic Review and Meta-
Analysis. Neuropsychobiology; 67: 61-8, 2013.
Reis T, Brandao CO, Freire Coutinho, ES, Engelheardt E, Laks J. Cerebrospinal 
fluid biomarkers in Alzheimer’s disease and geriatric depression: preliminary 
findings from Brazil. CNS Neuroscience & Therapeutics; 18: 524-29, 2012.
Souza WF, Figueira I, Mendlowicz MV, Volchan E, Portella CM, Mendonça-de-
Souza ACF, Coutinho ES. Posttraumatic Stress Disorder in Peacekeepers. The 
Journal of Nervous and Mental Disease; 199: 309-12, 2011.
Bezerra ABC, Coutinho ES, Barca ML, Engedal K, Engelhardt E, Laks J. School 
attainment in childhood is an independent risk factor of dementia in late life: 
results from a Brazilian sample. International Psychogeriatrics; 4:1-7, 2011.
Reichenheim ME, Coutinho ES. Measures and models for causal inference in cross-
sectional studies: arguments for the appropriateness of the prevalence odds ratio 
and related logistic regression. BMC Med Res Methodol. Jul 15;10:66, 2010. 
eliSa brietzKe is psychiatrist 
and professor of Psychiatry and Mental 
Health at Federal University of São 
Paulo, where is also scientific 
coordinator of the program for 
Recognition and Intervention in 
Individuals in At-Risk Mental States. 
She develops researches 
in neurobiology of bipolar disorder 
and inflammation in psychiatric disorders with a special focus in early stages of 
bipolar disorder and psychosis.
gerardo Maria de araUjo 
filHo, M.D., Ph.D., is Professor of 
Psychiatry at the Department of 
Psychiatry and Medical Psychology, 
State Faculty of Medicine of São José do 
Rio Preto (FAMERP), Sao Paulo, Brazil, 
and Affiliated Professor of Psychiatry 
and Clinical Neurosciences at the 
Department of Psychiatry, Federal 
University of Sao Paulo (UNIFESP), Sao Paulo, Brazil. He received his M.D. 
degree at the Federal University of Ceará in 2000 and completed psychiatric 
residency training at UNIFESP. In 2009, he received his Ph.D. degree at the 
UNIFESP. In 2011-2013, he completed postdoctoral fellowships at the 
Neuroimaging and Cognition Interdisciplinary Laboratory, UNIFESP. In 2009-
2012, he was the Technical Director of a specialized mental health service (AME 
Psiquiatria Vila Maria, São Paulo, Brazil) and technical assistant for mental 
health of Vila Maria district, São Paulo, Brazil. Dr. Gerardo is closely involved in 
research on neurobiology of severe mental disorders; psychiatric disorders 
associated with Epilepsy and mental health services. He has published several 
papers, and book chapters mainly on neuroimaging and neuropsychology 
fields. Currently, he serves as a referee for various high-impact factor journals. 
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HUdSoN de carValHo is a 
psychologist (UFMG), holds MSc in 
Developmental Psychology (UFMG) 
and Ph.D in Psychiatry (UNIFESP). His 
main areas of interest concentrate in 
interdisciplinary research projects in 
psychiatric nosology, websurveys and 
individual differences in temperament 
and personality. Currently, he is a full 
time professor of Clinical Psychology at the Federal University of Pelotas (UFPel) 
and an associated researcher of the Brazilian Internet Study on Temperament 
and Psychopathology (BRAINSTEP).  
iSabel alteNfelder 
SaNtoS bordiN, MD, MSc, PhD 
Child and adolescent psychiatrist, 
researcher in Clinical Epidemiology 
applied to Child and Adolescent Mental 
Health, and head of Social Psychiatry 
Division at the Department of 
Psychiatry, Federal University of São 
Paulo (UNIFESP), Brazil. After 
completing a two-year research training at McMaster University, Canada, and 
obtaining a master degree in Clinical Epidemiology (1995), I became a member 
of the International Clinical Epidemiology Network (INCLEN), and started to 
develop collaborative projects. After obtaining a doctoral degree in Psychiatry 
at UNIFESP (1996), I had the opportunity of becoming the first thesis supervisor 
in the field of Child and Adolescent Mental Health at UNIFESP. My responsibilities 
at the Department of Psychiatry, UNIFESP include research and teaching/
training activities (supervision of post-graduate students). My main research 
interests are related to at-risk children and adolescents for mental health 
problems, such as those living under disadvantaged circumstances, exposed to 
poverty and domestic violence. Additional research interests include anti-social 
behavior, crime involvement, pregnancy in adolescence, and barriers to receive 
mental health care. In the past 20 years, I had the opportunity of developing 
Brazilian versions of international screening and diagnostic questionnaires in 
child/adolescent mental health, and of participating in national and 
international research initiatives.
joão ricardo Sato holds a 
degree in Statistics (2002), MSc (2004) 
and Ph.D. (2007) from the University of 
São Paulo. His areas of interest 
concentrate mainly in interdisciplinary 
research projects involving the 
following topics: statistical modeling 
and computational neuroscience, 
neuroimaging, functional mapping of 
the human brain, methods of pattern recognition, time series analysis, 
biostatistics, statistical and nonparametric regression models. JRS is an 
assistant professor at the Universidade Federal do ABC (Brazil), where he is the 
coordinator of the Cognition Research Unit. 
leoNardo baldaçara, 
M.D., Ph.D. is Associate Professor of 
University of Tocantins Medical School, 
Brazil. He is also President of the 
Medical Residency State Comission of 
Tocantins and member of the  Federal 
Comission of Medical Residency of the 
Ministry of Education in Brazil. 
Baldaçara received the Master›s 
Degree in Sciences in 2008 and the Doctorate in the Sciences in 2011 by the 
Psychiatry and Medical Psychology Postgraduate Program of Federal University 
of São Paulo with the theme «The cerebellum and psychiatric 
disorders». Furthermore, due to the studies of the cerebellum he has published 
many articles and has received several awards as «The best paper on any 
psychiatric topic by the Brazilian Association of Psychiatry in 2012», «Article 
among the 10 most cited in the Brazilian Journal of Psychiatry in 2012», 
«Geriatric Psychiatry Prize by Brazilian Association of Psychitry in 2008» and 
«Better presentation of original study by Federal University of São Paulo in 
2008». He is also the author of two books and several chapters in 
psychiatry and neurosciences. Dr. Baldaçara has presented many lectures and 
has been teaching medical students, medical residents and students of post 
graduation. He is member of the Brazilian Association of Psychiatry and of the 
Interdisciplinary Lab. of Clinical Neurosciences of Federal University of São 
Paulo. He also has experience in psyschiatric emergencies and was coordinator 
of the Emergency Psychiatric Service of Santa Casa the São Paulo were he 
organized the Emergency Psychiatric Course for health profissionals. He 
published one of the few articles that compared usual forms of rapid 
tranquilization in agitation.
lUíS ferNaNdo tófoli 
graduated in Medicine at the University 
of São Paulo (1996), completed his 
medical residency in Psychiatry (2000) 
at the Institute of Psychiatry, University 
of São Paulo Medical School, and his 
Ph.D. in Medicine (Psychiatry) at the 
University of São Paulo (2004). He is 
currently an associateprofessor at the 
Medical School of the Federal University of Ceará, Sobral Campus, working in 
the School of Medicine since 2002 and the Post-Graduate Program in Family 
Health since 2009. He is expected to become a professor at the State University 
of Campinas Medical School, São Paulo. He has experience in mental health, 
acting on the following subjects: primary care mental health, community 
mental health, medically unexplained symptoms (somatic distress), and 
ayahuasca.
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lUiz r. raMoS MD PhD. 
Graduated in Medicine in 1976 at the 
Escola Paulista de Medicina (EPM) 
in São Paulo. Received a MSc in 
Community Medicine at the London 
School of Hygiene and Tropical 
Medicine in1981, and a PhD in 
Gerontology at the same institution in 
1987. Started his academic carrier at 
EPM in 1984, in the Preventive Medicine Department (PMD). In 1990,founded 
the discipline of Geriatrics at EPM and became its chief until 1995. In 1996 went 
to the Geriatric Division of Harvard Medical School as a visiting professor, to 
develop the epidemiology of cognitive impairment in the elderly. In 1997 
received the title of “Livre-Docencia” in Geriatrics at EPM. In 2004 became Full 
Professor of Preventive Medicine at EPM and was Head of the DPM from 2005 
to 2011. Also coordinated the postgraduation program in Public Health at the 
Universidade Federal de Sao Paulo (UNIFESP) from 2006 to 2010. Since 1991 
coordinates the first population based cohort study with elderly people 
in Brazil, based on the Center for the Study of Aging  of UNIFESP. So far, has 
supervised 52 MSc dissertations and 19 PhD thesis throughout his carrier and 
published 112 papers in peer-reviewed journals.
Maria carMeN ViaNa, 
Graduated as Medical Doctor (MD) at 
the Federal University of São Paulo in 
1984, has undertaken Residency 
training in Psychiatry in the Department 
of Psychiatry at the Federal University 
of São Paulo (1985-1986), and 
specialization in Epidemiology and 
Medical Statistics at the London School 
of Hygiene and Tropical Medicine, University of London (1988). Trained in 
clinical psychiatry as Visiting Registrar in Psychiatry at the Maudsley Hospital 
and Bethlem Royal Hospital, University of London (1992/1993), and obtained a 
PhD degree in Medicine/Psychiatry in the Institute of Psychiatry/Kings College, 
University of London (1995). In 2009, developed a Post-Doctoral Project at the 
Section of Psychiatric Epidemiology in the Department and Institute of 
Psychiatry, São Paulo University, funded by FAPESP.
Has clinical and research experience in Psychiatry, especially in clinical 
psychiatry, psychiatric epidemiology, women’s mental health, and violence in 
the context of mental health.
Is one of the Principal Investigators of the “São Paulo Megacity Mental Health 
Survey”, which is part of the World Mental Health Survey, an international 
initiative launched by the World Health Organization and Harvard University.
Member of the International Consortium in Psychiatric Epidemiology (ICPE), 
International Federation of Psychiatric Epidemiology (IFPE ), World Mental 
Health Survey Initiative (WHO-WMHS), Brazilian Psychiatric Association 
(ABP), Espirito Santo Psychiatric Association (APES), founding-member of the 
Brazilian Association of Bipolar Disorder (ABTB), and international member of 
the American Psychiatric Association (APA).
Is currently Associate Professor in the Department of Social Medicine and in 
the Post-Graduate Program in Collective Health in the Federal University of 
Espírito Santo (UFES), and collaborating researcher at the Section of Psychiatric 
Epidemiology in the Institute of Psychiatry, São Paulo University. 
Maria coNceição do 
roSário, psychiatrist, is an 
Associate Professor at the Child and 
Adolescent Psychiatry Unit (UPIA) at 
the Department of Psychiatry at Federal 
University of São Paulo (UNIFESP). She 
is also an Adjunct Professor at the Child 
Study Center at Yale University. Her 
expertise is in child and developmental 
psychiatry, and she has conducted research on obsessive compulsive disorder 
(OCD), tic disorders and attention deficit hyperactivity disorder (ADHD). Dr. 
Rosario’s major interests are dedicated to better understanding the phenotype 
of these disorders and their genetic and environmental interactions. Dr. Rosario 
is also interested in producing and disseminating educational information and 
training programs for mental health professionals with the main goals of 
improving early identification of psychiatric symptoms; implementing 
prevention strategies and early referral for adequate treatment; and developing 
state-of-the-art and easy to understand information on psychiatric disorders 
for reducing mental health stigma. 
Maria iNêS qUiNtaNa is a 
psychiatrist by background working 
with psychiatric epidemiology. She is 
Associated Professor at the Psychiatric 
Department of the Faculty of Medicine, 
Federal University of São Paulo 
(UNIFESP), and researcher of the Center 
for Applied Statistics and 
Methodology (NEMAP) and 
collaborative member of the WHO Collaborating Center – Composite 
International Diagnostic Interview Training Center (CIDI WHO) since 1998. Her 
research interests focus on the design and conduct of community-based 
epidemiological studies and, especially in relation to common mental disorders 
in primary care, psychiatric disorders during pregnancy, mental health of 
incarcerated populations, PTSD, sexual abuse and psychotropic drugs use.
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Mario f. jUrUeNa graduated 
in Medicine from Pontifical Catholic 
University, Southern Brazil. He did his 
residency training in psychiatry and 
completed interdisciplinary course for 
specialization in Mental Health School 
Porto Alegre, Brazil. He received his 
MPhil. at the Department of 
Psychobiology, Federal University of 
Sao Paulo; MSc. in Affective Neuroscience, Universiteit Maastricht, the 
Netherlands and .his PhD in Psychiatry from University of London. He is also a 
specialist in adult psychiatry in the UK according Medical Royal Colleges and 
General Medical Council. He completed training in cognitive psychotherapy at 
Beck Institute for Cognitive Therapy and Research, Philadelphia-USA. Most of 
his studies are related to the neurobiology, diagnosis and treatment of affective 
disorders and their relationship to stress. He is currently the Associate Editor of 
BioMed Central (BMC) Psychiatry-UK. He was awarded by British Association 
for Psychopharmacology with “The Senior Clinical Psychopharmacology Award 
2007” and also received the Robert W. Kerwin Psychopharmacology Prize in 
2010 from the Royal College of Psychiatrists for the best article published on 
the subject in the British Journal of Psychiatry. He is currently the head of the 
Stress and Affective Disorders (SAD) Programme, Prof. Dr. at the Department of 
Neurosciences and Behavior, University of São Paulo and Honorary Senior 
Lecturer at the Institute of Psychiatry, Kings College London.
MigUel roberto jorge is 
an Associate Professor of the 
Department of Psychiatry at the Federal 
University of São Paulo Medical School 
(UNIFESP/EPM), where he got his 
Medical Doctor (M.D.) degree, a 
Masters of Science (M.Sc.) and a 
Philosophical Doctor (Ph.D.) degrees in 
Pscyhopharmacology, and a Full 
Professorship (“Livre-Docência) in Clinical Psychiatry. At the UNIFESP, Prof. 
Jorge hold different positions, including Chairman of the Department of 
Psychiatry, Academic Director of the Medical School, and Dean for 
Undergraduate Studies.
During his career, Prof. Jorge was President of the Brazilian Association of 
Psychiatry (ABP), Secretary for Sections of the World Psychiatric Association 
(WPA), Regional Vice-President of the World Federation for Mental Health, a 
Council Member of the World Medical Association (WMA), and he currently is 
the Director of International Affairs of the Brazilian Medical Association (AMB). 
He is also a distinguished member of the World Psychiatric Association, the 
American Psychiatric Association, the European Psychiatric Association, and of 
the World Health Organization Panel of Experts on Mental Health.
Prof. Jorge’s main interests are General Medical and Psychiatric Education, 
and on issues such as Psychiatric Diagnosis and Classification, Transcultural 
Psychiatry and Psychiatric Epidemiology, and Stigma Related to Mental 
Disorders. He has published and lectured extensively on these topics in Latin 
America, Europe, USA, Australia, and Japan. 
MiriaN HayaSHi is a professor 
at UNIFESP and the Coordinator of 
Technology Transfer (TT). With a 
degree in pharmacy and biochemistry, 
she did several post-doctoral 
fellowships abroad (Japan, France, 
USA, Argentina), which provided her a 
strong background in the development 
of new mechanisms of action and 
targets for drug discovery. She worked in the private sector in the pharmacology 
and biophysics department of Hoffman La Roche New Drugs Development 
Center in Japan (1989-1993). During her career, she has been awarded several 
governmental grants, which supported her studies and led to several patents 
applications. She is also an effective member of the Scientific Counseling Board 
and the manager of Innovation and Technology Transfer of the Office of 
Technology Transfer of   UNIFESP (‘Núcleo de Propriedade Intelectual e Gestão 
da Ciência e Tecnologia’ (NUPI-NIT).
PaUlo r. MeNezeS is a 
psychiatrist by background with more 
than 20 years experience of working 
with Psychiatric Epidemiology. He is 
Associated Professor at the Department 
of Preventive Medicine at the Faculty of 
Medicine, University of São Paulo 
(FMUSP) and the co-leader of the 
Research Group on Psychiatric 
Epidemiology (EPSI), certified by the National Research Council-Brazil since 
1997. Paulo is  member of editorial boards of scientific journals and of the 
Academy of Sciences of the State of São Paulo, Brazil. His research interests 
focus on the design and conduct of community-based observational studies 
and randomized trials, especially in relation to depression and common mental 
disorders in primary care, depression during pregnancy, first episode psychosis, 
and mental health in old age.
qUiriNo cordeiro jUNior, 
Professor and Head of the Department 
of Psychiatry, Santa Casa Medical 
School, São Paulo, Brazil. Director of the 
Center for Integrated Mental Health 
Care of the Santa Casa Hospitals. 
Medical degree, psychiatry residency 
and PhD from the University of São 
Paulo Medical School. 
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roSeli g. SHaVitt has received 
the following degrees from the 
University of São Paulo School of 
Medicine, Sao Paulo, Brazil: Medical 
Doctor (1987); Residency in Psychiatry 
(1988-1989); Master of Science (1990-
1993 / Field of research: Consultation-
liaison psychiatry - Interactions 
between agoraphobia/panic disorder 
and asthma); PhD (1998-2002 / Field of research: Predictive factors of short-
term response
to treatment in Obsessive Compulsive Disorder); Post-Doctoral Researcher 
(2007-2010 / Field of research: Predictive factors of long-term response to 
treatment in Obsessive Compulsive Disorder). Currently she has the following 
academic activities: Mentor of post-graduate students at the Department 
of Psychiatry, University of São Paulo School of Medicine. Field of research: 
Obsessive-compulsive spectrum disorders. Director, Obsessive-Compulsive 
Spectrum Disorders Program. Department & Institute of Psychiatry, University 
of Sao Paulo School of Medicine. Associate Director of the International College 
of Obsessive-Compulsive Disorders (ICOCS) since September, 2010. She has 
over 50 publications in peer-reviewed journals and has just edited the second 
edition of a book about OCD for the lay community in Brazil. She is also in private 
practice in adult psychiatry, with emphasis on mood and anxiety disorders.
SaNdra forteS is Psychiatrist 
and Associate Professor on Mental 
Health and Medical Psychology in the 
Medical Sciences School of the 
University of Rio de Janeiro State(UERJ). 
MSc in Psychiatry by the Institute of 
Psychiatry/Federal University of Rio de 
Janeiro and PhD in Public Health 
(epidemiology) by the Social Medicine 
Institute/UERJ, she coordinates the Interdisciplinary Laboratory for Primary 
Care Research(LIPAPS)/UERJ. She is specialized in Mental Health(MH) in 
Primary Care(PC) and General Hospital Psychiatry, being head of the Research 
Group “Mental Health in Primary Care”/CNPq, studying integrated health 
system organization, interdisciplinary professionals training, epidemiology 
(specially associated psychosocial factors  related to mental health distress in 
PC and medically unexplained symptoms) and therapeutic interventions in 
primary care. She also coordinates the Mental Health Service in Policlinica 
Piquet Carneiro/UERJ, integrated to the National Health System (SUS) in Rio de 
Janeiro city, working within the collaborative care system (matrix support 
teams) with the Family Health Strategy, where Family Medicine and Psychiatry 
Residents and Psychologists specialization students´  are trained for 
interdisciplinary interventions on health promotion, disease prevention and 
therapeutic intervention in mental health on Primary Care. Member of the Mental 
Health Working Party of WONCA and the Primary Care Working Group for ICD-11/
WHO, she has several papers and book chapters published on these issues. 
SaNdra SciVoletto, Graduated 
in Medicine (1991) and obtained her 
PhD (1997 - FMUSP) with adolescent 
drug abuse. She has the specialist 
degree in Psychiatry by the Brazilian 
Association of Psychiatry (1997) and 
certificate in Child and Adolescent 
Psychiatry by the same Association 
(1998). In 1993, she deployed the 
outpatient clinic for treatment of adolescent drug users on IPq-HC-FMUSP, 
which she has been coordinating until now. From 2001 to 2006, she coordinated 
the Interdisciplinary Group of Studies on Alcohol and Drugs -IPq-HC FMUSP. In 
2005, she started working with neglect children; since 2007 she has coordinated 
the Equilibrium Program, an innovative project that is the result of a partnership 
between the Department of Psychiatry of FMUSP and São Paulo City Hall. The 
program is a community-based but protected activity center with recreational 
and multi-professional services focused on reintegration of maltreated children 
and adolescents, in an academic research context. In 2008, she was approved 
in the contest for Professor of Child and Adolescent Psychiatry at Department of 
Psychiatry at FMUSP. Currently, she is the head of the Child and Adolescent 
Psychiatric Service (SEPIA) and responsible for the residence training-program 
in Child and 
Adolescent Psychiatry at the IPq-HC-FMUSP. She is also professor and mentoring 
for MD and PhD students at the Department of Psychiatry a t the FMUSP. Her 
line of research is in the area of Child and Adolescent Psychiatry, with emphasis 
on addiction, child maltreatment, post-traumatic stress disorder, changes in 
child development caused by mistreatment, adolescents, depression, conduct 
disorder and comorbidities.
Sergio b. aNdreoli, 
graduated in Medicine at the Federal 
University of São Paulo (1983), MSc 
(1993) and Ph.D. (1997) in Psychiatry 
and Medical Psychology at the Federal 
University of São Paulo. Postdoctoral 
University of Quensland, Australia 
(1999). He is adjunct professor at the 
Federal University of São Paulo, 
professor at the Catholic University of Santos and director of the Center for 
Statistics and Methodology applied, Department of Psychiatry, Federal 
University of São Paulo. He has published 111 papers in journals, 14 book chapters 
and one book. He was supervisor one postdoctoral student, 8 PhD students, and 
14 MSc students. Has experience in Public Health with emphasis in the following 
areas: mental health, mental disorders, health care, service evaluation and 
population survey. 
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Sergio blay, Graduation in 
Medicine at   Escola Paulista de 
Medicina – Federal University of 
Medicine in São Paulo  (1976),  Medical 
Training and Residency  in Psychiatry at 
Escola Paulista de Medicina – Federal 
University of Medicine  (1978) and PhD 
in Psychiatry at Escola Paulista de 
Medicina – Federal University of 
Medicine  (1988). Currently is Associate Professor at the Department of 
Psychiatry at  Escola Paulista de Medicina – Federal University of Medicine . 
The major focus of interests and research are : old age psychiatry, psychiatric 
epidemiology and  treatment evaluation methods. Research investigator of the 
Brazilian National Council for Scientific and Technological Development (CNPq). 
SHeila c. caetaNo is a child 
and adolescent psychiatrist. She is an 
Assistant Professor at the Department 
of Psychiatry at the Faculty of Medicine, 
Federal University of São Paulo 
(UNIFESP) and the co-coordinator of 
the Child and Adolescent Psychiatry 
Unit (UPIA) at UNIFESP. Her main 
research areas are neuroimaging and 
mood disorders. Her currently research interests focus on children and 
adolescents with and at risk for mood disorders and irritability.
SiNtia i. belaNgero is 
geneticist with experience of working 
with Human Genetics and Psychiatric 
Genetics. She is Adjunct Professor at 
the Department of Morphology and 
Genetics, Federal University of São 
Paulo (UNIFESP) and Coordinator of 
Genetic Area of Interdisciplinary 
Laboratory of Clinical Neuroscience 
(LINC). Her research interests focus on mental disorders, especially in 
Schizophrenia, and diseases related to 22q11.2 deletion.
wagNer SilVa ribeiro, 
psychologist with a PhD degree from 
the Federal University of Sao Paulo, 
Brazil (UNIFESP), Department of 
Psychiatry. As a researcher at the 
Department of Psychiatry of UNIFESP, 
I’ve been developing research on 
psychiatric epidemiology, violence and 
mental health services. After 
completing a two-year research training at the Institute of Psychiatry (IoP), 
King s´ College London, I became an associate researcher at the IoP. After 
finishing my Ph.D. (May, 2011), I became a research fellow at the Section of 
Social Psychiatry, Department of Psychiatry of UNIFESP, in an International 
Scientific Consortium between the Federal University of Sao Paulo and 
University of Tromsø (Norway). Besides being the project coordinator in the 
Norway-Brazil Consortium, I’ve developed other research activities in the fields 
of epidemiology, service evaluation, research methods and systematic review, 
as well as teaching activities in the Post-Graduate Program at the Department 
of Psychiatry – UNIFESP, where I coordinate an English Spoken Journal club, 
which is the first discipline entirely delivery in English.
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I started Medical School at Buenos Aires University in 11997 and Graduated 
with Honors as a Medical Doctor at the age of 24. During my studies I made 
several rotations in Dublin and Barcelona. I completed first year Internal 
Medicine Residence at the “Alfredo Lanari Institute of Medical Investigations” 
in Buenos Aires. 
After that I decided to dedicate myself to clinical research and completed an 
Advance Course in Biostatistics at the Epidemiological Studies Centre (National 
Academy of Medicine, Buenos Aires, Argentina). I finished my Residence 
in Psychiatry at the “J. M. Ramos Mejía Hospital” (Buenos Aires, Argentina). 
During the last year of my Residence I attended the Mood Disorders Program 
at Tufts Medical Centre (Boston, United States) under Nassir Ghaemi MD MPH 
supervision as an intern for two months (February to May, 2009). 
After finishing my Residence I started my private practice and started 
working (and currently are) as a Clinical Researcher in Mood Disorders for the 
Neuroscience Institute at Favaloro University (Buenos Aires, Argentina) under 
the supervision of Sergio Strejilevich MD. 
Likewise, I am currently involved as a Clinical Rater in the Clinical Trials 
Department at the Cognitive Neurology Institute (INECO. Buenos Aires, 
Argentina). Two years ago I was accepted as a postgraduate student at the 
Calculus Institute, School of Mathematics, Buenos Aires University.  (Buenos 
Aires,Argentina) for a Specialization in Statistics for Health Professionals. 
Language wise, I am fluent in English and have basic level of Portuguese and 
French. To date, I have published 7 papers in refereed journals
SUMMARY PROJECT:
SUMMARY. Different antidepressants (AD) present different adverse events: 
at behavioral level, moral judgment, social and work functioning. Serotonin 
Selective Reuptake Inhibitors (SSRIs) and bupropion resent different mechanism 
of action that may account for differences in emotional recognition and the 
aforementioned. This research aims to describe differences between these ADs 
to better understand their mechanism of action and improve specific indication 
for each patient and development of new compounds.
BACKGROUND: More refined research on the manner in which AD modify 
EP would have practical applications for those being design and a deeper 
understanding of the mechanism of action of those already being used. Most 
of drugs used during treatment of affective episodes modify DA levels which 
regulates EP, and it accounts for qualitative differences between different AD. 
SSRIs, have an indirect antagonic dopaminergic effect in cortical-subcortical 
circuitry, decreasing EP. Bupropion is the only noradrenalin and DA reuptake 
inhibition (IRDNA) augmenting dopaminergic neurotransmission at the nucleus 
accumbens and prefrontal cortex, without effect over serotonin. RELEVANCE 
FOR THE FIELD AD are different in their mechanisms of action, but there has 
been no reports regarding differences in its efficacy nor are specific indications 
for each one. Further knowledge regarding the mechanism of action through 
which they attain recovery, and differences regarding their effect at a behavioral 
level is vital.
MAIN OBJECTIVES: To Compare long-term impact of SSRIs and bupropion as 
far as emotional processing, moral judgment, social and work functioning and 
general adverse effects are concerned in patients who have reached clinical 
remission from major depressive episode.
METHODOLOGY: Transversal study, comparing measures of emotional 
processing, moral judgment, anhedonia, apathy, global functioning and adverse 
effects in patients under remission from a depressive episode. Procedure. 
-Clinical evaluation: YMRS, HAM-D, functioning status as reported by FAST, 
BDI II, MDQ, Apathy Inventory, Olivares Auto Assessment, UKU adapted version. 
-Cognitive Assessment. - Social Cognition Evaluation: Emotional Morphing Test 
& Emotional Inference.
EXPECTED RESULTS SSRIs and bupropion present with different profile of 
effects affecting emotion recognition, social cognition, moral judgment, social 
and work functioning, apathy, anhedonia and adverse effects that find their 
explanation in there different mechanism of action. Patients under treatment 
with SSRIs will present with higher prevalence of apathy, anhedonia, and 
emotional recognition impairment. Patients under treatment with bupropion 
will present less or no effects on the aforementioned areas due to the fact that 
this AD has no action over serotonin levels and thus, over EP. To the best of our 
knowledge, this will be the first research conducted in subjects under remission 
from a major depressive episode. Most studies on this area have involved 
healthy volunteers or have had a descriptive approach to these phenomena.
EXPECTED OUTCOMES: Differences in AD`s mechanisms of action has not 
proven to influence their efficacy of both groups of AD`s, but will account for 
differences in their adverse effects profile as well as in the patient` s social and 
work functioning, EP, anhedonia and apathy.
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Mr. Jesse Young is Canadian National who commenced his academic studies at 
The University of Victoria (Canada) where he completed his Bachelor of Science 
(BSc.) degree graduating with Distinction, Majoringin Psychology with a Minor 
in Biology.  After completing his undergraduate degree, Mr. Young began his 
research career as a Research Assistant at the Centre of Addictions Research 
of British Columbia (Canada) where he contributed to several national mental 
health and substance use monitoring studies. He recently completed his Masters 
of Public Health at The University of Western Australia (UWA) graduating with 
High Distinction specialising in epidemiology, biostatistics, and linked-data 
analysis.  As an early career researcher, Mr. Young is currently employed as 
a Research Officer at the Centre for Health Services Research at UWA where 
he is examining the health outcomes of prisoner subpopulations utilising a 
mixedmethods, multijurisdictional approach. Mr. Young also currently holds 
an Adjunct Research Officer position at the National Drug Research Institute 
at Curtin University, a World Health Organisation Collaborating Centre for 
the prevention of alcohol and drug abuse, located in Perth, Australia and is 
a member of the International ADHD and Substance Use Disorder Prevalence 
(IASP) Research Group coordinated by the Trimbos Institute located in Utrect, 
The Netherlands. In his previous research positions at the National Drug Research 
Institute and the Centre for Addictions Research of British Columbia, Mr. Young 
has contributed to multiple national and international research studies during 
his five-years of professional experience in the mental health and addictions 
research field.  His primary research interests include the epidemiological 
analysis of substance use disorders, investigating the comorbid relationship 
between substance use disorders and other mental health disorders, offender 
health, and examining the effect of social supply networks on substance use.
SUMMARY PROJECT: 
DOES ATTENTION DEFICIT HYPERACTIVITY DISORDER (ADHD) AMONG 
DEPENDENT SUBSTANCE USERS INCREASE RISK-TAKING BEHAVIOUR?
Evidence has implicated ADHD as a pronounced risk factor in the development 
of substance use disorders (SUDs). Additionally, adult ADHD is overrepresented 
in SUD populations and has been associated with a variety of risk-taking 
behaviours suggesting an inflated public health burden experienced due 
to this mental health comorbidity. However, currently there is a paucity of 
empirical evidence regarding the outcomes of concurrent adult ADHD and SUD. 
This study aimed to conduct an epidemiological analysis of comorbid adult 
ADHD in substance dependent populations to assess the extent that ADHD is 
attributable to increased substance use, and elevated risk-taking behaviour in 
the criminal justice, HIV risk-taking, and driving domains. A 30-minute cross-
sectional survey was administered to a convenience sample of 490 adults 
(≥18 years) receiving treatment for SUD in Australian metropolitan substance 
use treatment centres between 1st September 2010 and 31st August 2011. 
Associations between ADHD status and outcomes corresponding to a range of 
substance use behaviours, justice system contact, HIV risk-taking behaviour, 
and driving-related risk-taking behaviour were assessed. Overall, 55.4% 
(n=271) of participants screened positive for adult ADHD. ADHD status was 
associated with HIV risk-taking and driving-related risk-taking behaviours with 
no significant association found between ADHD status and criminal offending 
behaviour. The findings support the hypothesis that concurrent ADHD and SUD 
increases substance use severity, HIV risk-taking and driving-related risk-taking 
behaviours. Increased screening for adult ADHD and the implementation of 
integrated interventions for concurrent ADHD and SUD patients in substance 
use treatment centres is recommended. This research was coordinated by the 
National Drug Research Institute (Curtin University) and the National Drug 
and Alcohol Research Centre (University of New South Wales). This research 
received funding from a Curtin University Strategic Faculty Grant.
Helal UddiN aHMed
POSITION TITLE:
Assistant Professor, Department of 
Psychiatry, Kasturba Medical College, 
Manipal, Karnataka, India
INSTITUTION AND  
LOCATION
DEGREE FIELD OF STUDY
Central Institute of Psychiatry, 
Kanke, Ranchi, Jharkhand, India
Medical Doctor Psychiatry
Central Institute of Psychiatry, 
Kanke, Ranchi, Jharkhand, India 
DPM Psychiatry
Gauhati Medical College & 
Hospital, Guwahati, Assam, India
MBBS Medicine
BIO SKETCH:
Samir Kumar Praharaj is currently working as Assistant Professor at Department 
of Psychiatry,Kasturba Medical College, Manipal, India. He has studied Medicine 
from Gauhati Medical College & Hospital, Guwahati, India and post-graduate 
diploma and degree in Psychiatry from Central Institute of Psychiatry, Ranchi, 
India. For his work on transcranial magnetic stimulation, he has received the 
Samuel Gershon Junior Investigator Award in 2008. He has also worked on 
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life events and disability in psychiatric disorders. Currently, he is studying the 
role of life events in alcoholic relapse. He has authored and coauthored several 
articles in indexed journals.
SUMMARY PROJECT: 
Alcoholics experiencing psychosocial stress following treatment are more likely 
to relapse than those not experiencing such stress. In this pilot study, the role 
of life events was examined in 20 patients presenting with alcoholic relapse. 
The median number of life events in past one year was 3 (IQR 2.75), which 
was higher than 2 stressful life events in past one year that are considered as 
threshold for producing mental illness. The number of undesirable life events 
was higher than desirable events and the most common life events reported 
included financial loss and large loan. The severity of alcohol dependence 
negatively correlated with age of onset of problem drinking (rs = 0.6), and 
positively correlated with the degree of familial alcoholism (rs = 0.41). However, 
neither the number of life events nor the perceived stress was associated with 
either the severity of alcohol dependence or the degree of familial alcoholism. 
As the sample size was small in this pilot study, larger sample would provide 
further information regarding the nature and temporal relationship of the 
stressful life events in the relapse of patients with alcohol dependence.
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BIO SKETCH: 
I am currently a fourth-year doctoral student in the Clinical Psychology 
program at Michigan State University. Over the last five years, I have been 
pursuing a program of research on cross-cultural psychopathology. In 
particular, I have been interested in advancing areas of mental health research 
that have been neglected by the mainstream in two fields: examining ethnic/
racial minority mental health in the U.S. and examining mental health outside 
of the US. In addition, I am also committed to examining how culture influences 
psychopathology; how psychological disorders are expressed, experienced, 
diagnosed, and treated among ethnic/racial minorities in the U.S. and in 
other countries. My other interests include successfully adapting existing 
psychological prevention and intervention programs to meet the needs of 
populations that underutilize services.
I have been involved in various research projects that examine cross-cultural 
psychopathology. In 2009, I worked as a research assistant on a study that 
examined barriers and facilitators of treatment for depression among Latinos 
(Uebelacker, Marootian, et al., 2011). Subsequently, I collaborated with my 
advisor, Dr. Frederick Leong on a few research papers that examined depression 
among Asian Americans (Kalibatseva & Leong, 2011), culture and depression 
(Leong, Kalibatseva & Molchanova, 2012), cross-cultural measurement 
equivalence of the assessment of depression symptoms among Asian Americans 
and European Americans (Kalibatseva, Leong, & Schmitt, under review), cross-
cultural barriers to mental health services among racial and ethnic minorities 
(Leong & Kalibatseva, 2011a), cultural adaptation of psychotherapy to increase 
its effectiveness for Asian Americans (Leong & Kalibatseva, 2011b), and specific 
cultural adaptations that make depression treatments culturally sensitive for 
racial and ethnic minorities (Kalibatseva & Leong, under review). My long-
term research career goals are to identify and eliminate barriers to receiving 
mental health services and to make these services (i.e., prevention, therapy, 
assessment) more culturally appropriate for racial and ethnic minorities.
SUMMARY PROJECT: 
CULTURALLY-SPECIFIC PROTECTIVE AND RISK FACTORS FOR DEPRESSION, 
ANXIETY, AND SUBSTANCE ABUSE AMONG LATINO AND ASIAN AMERICAN 
IMMIGRANTS
Zornitsa Kalibatseva, M.A., Frederick T. L. Leong, Ph.D., and Yong S. Park, Ph.D.
This project examines culturally-specific protective and risk factors for 
depression, anxiety, and substance abuse among Latino and Asian American 
immigrants using the National Latino and Asian American study, a nationally 
representative community sample. The development of prevention and 
intervention programs largely relies on research that identifies protective and 
risk factors for specific populations. In this study, we examined protective 
factors, such as social networking, ethnic identity, family cohesion, and 
bilingualism that may prevent the development of mental disorders among 
immigrants. Additionally, we examined risk factors, such as limited language 
proficiency, discrimination, acculturative stress, family conflict, and low socio-
economic status (SES), which may increase the threat of mental disorders 
among the samepopulations.
Among Latino/a immigrants, the results indicated that low levels of social 
network and ethnic identity and high levels of discrimination and family 
conflict were risk factors for depressive and substance-related disorders. The 
only risk factors associated with anxiety disorders was high discrimination and 
acculturative stress. High family cohesion, low discrimination, and low family 
conflict served as protective factors against some of the disorders. Language 
proficiency and income were not associated with the occurrence of mental 
illness among Latino/a immigrants. Among Asian American immigrants, 
low levels of social network and family cohesion and high levels of family 
conflict were associated with an anxiety disorder in the past 12 months. Being 
bilingual, experiencing low levels of acculturative stress, discrimination and 
family conflict were associated with lower prevalence of depressive disorders 
among Asian American immigrants. Finally, substance-related disorders were 
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associated with low levels of ethnic identity. A careful consideration and a 
thorough assessment of the psychological risk and protective factors unique 
to the immigrant’s experience are necessary in order to provide culturally 
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BIO SKETCH: 
Yifeng Wei is a researcher and school mental health coordinator of Sun Life 
Financial Chair in Adolescent Mental Health team (the Chair) at the IWK 
Health Centre and Dalhousie University. Her research interests are knowledge 
translation in school mental health and youth mental health, with specific 
focuses on promoting mental health literacy in schools. She is currently on the 
third year of her PhD program in school mental health and is the recipient of 
Canadian Institutes of Health Research Doctoral Research Award in 2011.
As a researcher and school mental health coordinator of the Chair team, 
Yifeng has played a key role in the school mental health research and program 
development activities and has made significant contributions to the work 
of the Chair team. This includes developing, implementing, and researching 
mental health programs for youth in the secondary school setting; initiating 
and coordinating new school mental health projects with schools; and working 
with government agencies to facilitate system change to address youth mental 
health needs. Her responsibilities have also extended to other knowledge 
translation and health promotion activities, such as developing and managing 
international school mental health projects, funding application development 
and supervision of junior team members.
As a result of her work in school mental health, Yifeng has co-authored and 
published ten academic papers, and presented at the local, regional, national, 
and international level at scientific meetings and program development forums.
 
SUMMARY PROJECT: 
This project will advance the work in school mental health literacy by examining 
and developing the constructs of mental health literacy, and developing and 
validating a mental health literacy scale to evaluate the effectiveness of school-
based mental health interventions in secondary schools. 
There are two stages involved to conduct the research. The first stage is 
to examine and develop mental health literacy constructs, and to develop 
a mental health literacy scale for adolescents. Theories in health literacy 
(including mental health literacy), health education, and health promotion will 
be reviewed to form the draft constructs of mental healthy literacy. Available 
measurement tools in mental health literacy will be identified and analyzed 
for inform the construct development. Following this, a Delphi consensus 
approach will be used to finalize the definition and the constructs/items of the 
measurement tool.
The second stage is to test the measurement tool on its reliability and validity in 
a sample of mental health professionals, educators and adolescents. Two types 
of reliability will be examined, including testretest reliability and Cronbach’s 
alpha. This research will also investigate the validity of the scale. The content 
validity will be built into the measurement tool development from the outset 
through the choice of appropriate items. Furthermore, the construct validity 
will be established by testing the hypothesis: Mental health literacy level should be 
higher among mental health professionals than the general public, e.g. youth and 
educators. Therefore, their mean scores on the test scales should be significantly 
higher than those of youth and educators.
This research will establish the first mental health literacy scale of its kind in the field.
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BIO SKETCH:  
Danielle S. Cha is currently a Graduate Student under the supervision of Dr. Roger 
S. McIntyre at the Mood Disorders Psychopharmacology Unit, completing her 
Master’s in Medical Science at the Institute of Medical Science, University of 
Toronto, Toronto, Canada. 
Danielle has been involved in multiple research endeavours at the Mood 
Disorders Psychopharmacology Unit under Dr. McIntyre’s supervision, which 
have primarily aimed to characterize the association between mood disorders 
and medical comorbidity.  This research involves elucidating the impact of 
medical comorbidity on the course and treatment of mood disorders, and the 
effect of glucose homeostasis on neurocognition.  
The primary aim of the project to be presented to the Sao Paulo School of 
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Advanced Science for the Prevention of Mental Disorders is to provide the 
rationale for hypothesizing that adjunctive intranasal insulin will exert an 
antidepressant effect when compared to placebo in adults with treatment 
resistant Major Depressive Disorder (MDD). Three secondary aims of the study 
include: (1) determine whether adjunctive intranasal insulin will alter emotional 
processing; (2) determine whether early changes in emotional processing 
(i.e., after a single dose of 40 IU intranasal insulin) predicts symptomatic 
improvement at endpoint; and (3) to determine the effect of intranasal insulin 
on neurocognitive performance (e.g., learning and memory) in individuals with 
MDD insufficiently responsive to antidepressant therapy.
SUMMARY PROJECT: 
Background: The interaction between emotional stimuli and cognitive 
processes (e.g. automatic processing, attention, memory and learning) is 
defined as affective cognition, which describes the interface at which emotional 
and cognitive processes are integrated to generate behaviour. Impairments 
associated with the cognitive affective interface are recognized as a core and 
specific feature of mood disorders, particularly major depressive disorder 
(MDD). For example, it has been amply documented that individuals with MDD 
are biased toward negative emotional stimuli (independent of medication 
status). Notwithstanding, pharmacological interventions have been reported 
to influence the pre-attentive stage and “shift” emotional processing to reduce/
eliminate negative affective bias despite the absence of change in subjective 
ratings of mood and/or anxiety.
Rationale: Available evidence indicates that the acute administration of 
intranasal insulin enhances cognition in individuals with Alzheimer’s disease, 
mild cognitive impairment, and healthy subjects. Improved mood and 
decreased hypothalamic-pituitary-adrenal (HPA) axis activity have been 
reported following intranasal insulin treatment in both healthy, normal 
weight, and obese subjects. Hence, reduced central nervous insulin sensitivity 
may represent a pathophysiological link between obesity, peripheral insulin 
resistance, cognitive dysfunction and mood disorders. We aim to evaluate the 
acute and subchronic effects of intranasal insulin administration in persons with 
MDD on overall mood/emotional processing and neurocognitive outcomes.   
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Paul Kudlow is currently a fourth year medical student at the Schulich School 
of Medicine and Dentistry, at Western University. He is originally from Toronto, 
Canada and completed a Bachelor of Science with a double major in Physiology 
and Management. Paul will complete his medical degree in April 2013, and 
plans to begin residency training in Psychiatry at the University of Toronto 
starting July 2013. 
Paul has completed substantial academic work in psychiatry and neuroscience. 
Most recently, he was first author on a paper, published in the Canadian Journal 
of Psychiatry that examined the clinical utility of early symptomatic relief while 
on antidepressant therapy. Paul has also been featured in the New England 
Journal of Medicine for his work on the functional outcomes of survivors of 
the Acute Respiratory Distress Syndrome. Paul has published several other 
articles in high impact journals on a variety of subjects and currently works as a 
freelance news writer for the Canadian Medical Association Journal. 
Paul’s current interests lie in the interactions between the nervous and immune 
systems, and how this may relate to the possible etiology of psychiatric and 
metabolic diseases. His current research efforts focus on sleep architecture 
variation and its effects on the risk of developing mood and metabolic 
disturbances. He is actively involved in numerous other research projects 
under the supervision of Dr. Roger McIntyre, as well as other leading academic 
psychiatrists across Canada and the United States. 
Aside from Paul’s passion for academic psychiatry, he also has a keen interest 
for health informatics. He is currently the Co-Founder and President of 
trendMD (www.trendmd.com), a medical search/trending engine that delivers 
personalized, high-impact research articles to healthcare practitioners. He 
has built a start-up team in Toronto, Canada and is in the process of securing 
first-round venture capital funding. In his leisure time, Paul loves to travel and 
try exotic food. He has climbed Mount Kilimanjaro (Tanzania), Mount Meru 
(Tanzania), Mount Urus (Peru), and Everest Base Camp (Nepal).   
SUMMARY PROJECT: 
SLEEP ARCHITECTURE VARIATION: A MEDIATOR OF METABOLIC DISTURBANCE 
IN INDIVIDUALS WITH MAJOR DEPRESSIVE DISORDER
*Kudlow PA1, Cha DS2, Lam RW3, McIntyre RS4
1 Medical Student, Mood Disorders Psychopharmacology Unit, University 
Health Network, Toronto, Ontario; Medical Student, Schulich School of Medicine 
and Dentistry, Western University, London, Ontario
2 Student, Mood Disorders Psychopharmacology Unit, University Health 
Network, Toronto, Ontario; Student, Institute of Medical Science, University of 
Toronto, Toronto, Ontario
3 Professor and Head, Mood and Anxiety Disorders Program, Department of 
Psychiatry, University of British Columbia (UBC) and Mood Disorders Centre of 
Excellence, UBC Hospital, Vancouver, Canada
4 Professor of Psychiatry and Pharmacology, University of Toronto, Toronto, 
Ontario; Head, Mood Disorders Psychopharmacology Unit, University Health 
Network, Toronto, Ontario.
Background: Significant proportions of individuals diagnosed with major 
depressive disorder (MDD) have co-morbid metabolic disturbances (i.e. obesity, 
type 2 diabetes mellitus (T2DM), hypertension, and/or dyslipidemia) and 
vice versa. Accumulating evidence suggests that common pathophysiologic 
pathways, such as a chronic, low-grade pro-inflammatory state, mediate this 
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frequent co-occurrence. However, it remains unclear what traits precede the 
onset, and increase the risk of these pathologic states. The aim of this review is 
to evaluate the evidentiary base supporting the hypothesis that the increased 
hazard for metabolic disturbance in MDD subpopulations (and vice versa) is 
mediated, in part, by endophenotypic variations in sleep architecture. 
Methods: We conducted a PubMed search of all English-language articles with 
the following search terms: sleep disturbance, circadian rhythm, inflammation, 
metabolic syndrome, obesity, MDD, mood disorder, prodrome, T2DM, cytokine, 
interleukin, hypertension, dyslipidemia, hypercholesterolemia.
Results: Longitudinal and meta-analysis data indicate that for a subpopulation 
of individuals, specific variations in sleep architecture (i.e. decreased slow 
wave sleep [SWS], increased rapid-eye movement [REM] density) precede the 
onset of depressive symptoms. The same sleep architecture variations are also 
associated with obesity, T2DM, and hypertension. Decreased SWS and increased 
REM density is correlated with an increase in pro-inflammatory cytokines (e.g. 
interleukin-6, tumour necrosis factor, etc.). This proinflammatory state has been 
independently shown to be associated with MDD and metabolic disturbances.
Conclusions: Taken together, this review suggests that sleep architecture 
variation of increased REM density and decreased SWS may be an 
endophenotypic trait that serves to identify a subpopulation at increased risk 
of depressive symptomatology and metabolic disturbances. Future research is 
needed to discern the predictive value, sensitivity and specificity of using sleep 
architecture variation as a biomarker for MDD and metabolic disturbances. 
Validation of this marker would have broad clinical implications, such primary, 
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Currently, I am a post-doctoral fellow at Sunnybrook Health Sciences Centre in 
Toronto in the Brain Sciences Program. My research focuses on the relationship 
between vascular pathology and cognitive symptoms in later life. As a clinical 
pharmacologist, I have a particular interest in the neuroimmunological 
intersection between neurodegenerative and cardiometabolic disorders as an 
avenue to explore biomarkers, vulnerability factors and potential treatments. 
The present study examines how genetic vulnerability factors interact 
with cerebrovascular disease, depression and physical activity to predict 
hippocampal volume and cognitive performance in patients with coronary 
artery disease. My previous work in this population has provided pertinent 
background, identifying some of the relevant phenomenology and biomarkers.
SUMMARY PROJECT:
Determinants of susceptibility to cerebrovascular disease
1,2,3Krista L. Lanctôt, 1,2,3Sandra E. Black, 1,2Bradley J. MacIntosh,1,2Nathan 
Herrmann, 4Paul R. Albert, 1,2,3Paul I. Oh, 1,2Alexander Kiss
1Sunnybrook Research Institute, 2University of Toronto, 3Toronto Rehabilitation 
Institute, 4Ottawa Health Research Institute (Neuroscience)
Post-doctoral funding: Toronto Rehabilitation Institute; Centre for Stroke 
Recovery.
Operating funding: Canadian Institutes of Health Research; Centre for Stroke 
Recovery; Physicians Services Incorporated Foundation 
Cerebrovascular disease can lead to subtle ischemia and neuroinflammation, 
which may initiate neurodegenerative cascades and precipitate mood and 
cognitive symptoms in susceptible individuals. Components of neural risk 
can be attributed to both genetic and behavioral factors. We aim to better 
understand cognitive vulnerability to subtle vascular brain pathology (i.e. 
white matter hyperintensities [WMH]) in patients with coronary artery disease. 
This study will quantify brain atrophy and compare it to WMH volumes of 
in subgroups of patients defined by susceptibility genotypes (e.g. the brain 
derived neurotrophic factor [BDNF] val66met polymorphism). We will 
determine which brain structures show increased volume, microstructural 
integrity and blood flow in patients with greater cardiopulmonary fitness and 
determine if these associations are uniform across BDNF genotypes. We will 
also examine whether the BDNF genotype interacts with depression to predict 
poorer cognitive function.
In our preliminary samples, cerebrovascular disease was associated with 
loss of hippocampal volume inpatients carrying at least one copy of the met 
allele of the BDNF polymorphism, but not in val/val subjects(n=40). BDNF 
seemed to couple cardiopulmonary fitness to hippocampal volume (n=40) 
and verbal memory performance (n=156), since these relationships were 
absent in met carriers. Depression interacted with the BDNF genotype such 
that depressed but not non-depressed patients carrying the met allele showed 
poorer verbal memory performance (F=4.064, p=.046, n=141). In conclusion, 
BDNF-mediated neural resilience may determine cognitive relationships with 
cerebrovascular disease, fitness and depression in later life.
iNterNacioNal StUdeNtS of 




Phd student in Neurobiology of mood 
disorders: King’s college of London 
(2011-2015)
INSTITUTION AND  
LOCATION











I started my undergraduate studies in 1996 at The Pontifical Catholic University 
of Chile. There I obtained my Bachelor degree in Sciences. After achieving one 
of the best grades in that school, I was allowed to relocate in the career of 
Medicine at the same University, which is regarded by numerous researches as 
the best in Chile.
Immediately after graduating as an MD at the Catholic University, I entered 
a national contest for Psychiatric residency programmes and I was accepted 
to the Fellowship at the Clinical Psychiatry Unit of the University of Chile, 
considered to be the top university in Chile in that field of knowledge.
During my Psychiatric Resident fellowship, I was invited to participate as a 
Young Psychiatrist at meetings in several Chilean and European Congresses. 
Afterward, I was invited to participate at the 16th European Congress of 
Psychiatry in Nice, France in 2008, where I gave an oral presentation entitled 
“Comparison of Functional Alterations on SPECTS of Patients with Depression 
and with Alcohol Comorbidity”. This paper was well received by the Psychiatric 
committee; it was based on my experience a rotation in the Nuclear Medicine 
Department at the Catholic University of Chile. Due to this work in 2010 I was 
invited as International guest speaker to the Psychiatry Congress at San Juan, 
Puerto Rico.
To broaden my knowledge in Psychiatry and gain clinical experience, I was 
accepted in the externship program in Psychiatry at the University of Barcelona 
in 2005. There I took part in a workshop on Bipolar Patients together with Drs. 
Vieta and and Dr. Scott.
The study of mood disorders has been my main focus of interest throughout my 
fellowship as well as in my subsequent practice; this is clear that most of my 
research projects and papers have been oriented to that specific field.
In fact ,  my ex team in Chile got an award for the best scientific paper presented 
at the 2009 Chilean Psychiatric Congress with “Clinical and genetic comparative 
study on Bordeline Personality Disorder and Bipolar II Patients”.
Two years months ago, by the means of the Chilean government awarded me a 
grand which will allow me to continue my postgraduate studies doing a PhD in 
Psychological Medicine and Psychiatry at King’s College, London.
The Institute of Psychiatry at King’s College of London has a tradition of 
excellence and is recognized around the world.( number one in citations in this 
field around the world )
This Phd in neurobiology of mood disorders has given me the opportunity to 
find answers to many of the questions I have had for years. My programme 
blends every aspect of Psychiatry, enabling a student to expand his/her vision 
of the human being and to explore the cutting edge in what regards the roots 
of psychiatric illnesses with the latest intellectual and scientific tools.
I have already started my new project utilises a novel method of assessment of 
long-term stress and its relationship to several affective and related disorders. 
I proposed to obtain hair cortisol samples from will be measured . These will 
be prospectively cross correlated with salivary cortisol measures to validate 
hair cortisol as an accurate measure of long-term activity of HPA activity. In 
doing so, I will also wish to clarify biological distinctions between subtypes of 
affective disorders.
This work will have a specific relevance to latin america as the intention is also to 
collaborate with his previous colleagues in Chile as well as other colleagues in Brazil.
SUMMARY PROJECT: 
HAIR CORTISOL AS A BIOMARKER FOR PSYCHIATRIC ILLNESSES
The hypothalamic–pituitary–adrenal axis (HPA) consists of a chain of 
stimulatory hormones and  feedback loops and is under control of the higher 
cerebral centres that determine their overall  activity (Papadopoulos and Cleare, 
2011). One of those hormones is cortisol which regulates a  wide range of bodily 
functions including metabolism, immunity, neuronal survival, neurogenesis 
(Dettenborn et al., 2011) and stress (Chrousos, 2009)  Acute stress has 
been associated with an activation of the HPA axis resulting in an increased 
release of cortisol from the adrenal glands (Selye, 1936). There are also some 
psychiatric illnesses  related to an abnormal response in terms of cortisol 
concentration but with some controversy  about the direction of that response. 
Mostly, that disagreement comes from the fact that different specimens were 
used to assess chronic  cortisol concentration. Until now, there have been 
many different matrices to assess levels of  cortisol such as, blood, urine, and 
saliva. However they are just useful to obtain a picture of the  level of cortisol 
in real time; in other words, a good measure to reflect acute concentration, but 
they are not adequate matrices to obtain a measure of chronic cortisol levels. 
Therefore, there has been a critical need for the establishment of a biomarker 
of cortisol that  accurately measures its intensity and course over time due 
to the association between abnormal  cortisol production and mental health 
problems. In this review, hair cortisol, a novel specimen,  will be presented. 
This one would have the ability to reflect chronic cortisol concentration, as a 
result obtaining a true relationship with stress events and related psychiatric 
conditions. This  new biomarker promises then to be a better tool to solve 
many questions related to HPA axis  disregulations observed in psychiatric 
diseases and may help to identify appropriate and successful  management 
strategies.  This article reviews and updates views of stress and stress-related 
disorders and their implications  of HPA axis and cortisol levels. In addition, the 
development, current status, advantages,  limitations and main findings in hair 
cortisol in relation to some psychiatric diseases such as Post  traumatic stress 
disorder (PTSD), Chronic fatigue syndrome (CFS), Mayor depressive disorder 
(MDD), Bipolar disorder (BD). 
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Vania Martínez is a Child and Adolescent Psychiatrist from the Universidad 
de Chile, currently working in the Faculty of Medicine of the Universidad de 
Chile in the Center of Reproductive Medicine and Comprehensive Development 
for Adolescents (CEMERA). She has earned the following degrees: Doctorate 
in Psychotherapy from the Pontificia Universidad Católica in Chile, Doctorate 
of Medicine from the University of Heidelberg in Germany (International 
Doctorate Program in Psychotherapy), Masters in Psychotherapy from the 
Pontificia Universidad Católica of Chile, and Masters in Clinical Psychology from 
the Universidad Diego Portales in Chile.  Additionally, she has a diploma in 
Family Therapy from the Chilean Institute of Family Therapy and is a member of 
the Chilean Society of Pediatrics, the Chilean Society of Child  and  Adolescent 
Psychiatry  and Neurology, and the Society for Psychotherapy Research.  Her 
investigations focus on adolescent depression, quality of life in adolescents, and 
adolescent sexuality.  
SUMMARY PROJECT: 
QUALITATIVE ASSESSMENT OF A SCHOOL-BASED INTERVENTION TO PREVENT 
ADOLESCENT DEPRESSION IN LOWINCOME COMMUNITIES OF SANTIAGO, 
CHILETHE STUDY CONSISTED OF A QUALITATIVE ASSESSMENT OF THE 
INTERVENTION “YO PIENSO, YO SIENTO, YO ACTÚO” (“I THINK, I FEEL, I DO”) 
This program  is  intended to prevent  depression  in  adolescents  and  is  based 
on  the cognitive-behavioral approach. The 11-session intervention was carried 
out in four classes, with 163 students, of primero medio (ninth grade) in two 
low-income public schools in Santiago, Chile. The objective of the study was to 
understand the dtudents´  perceptions of the program  and their suggestions 
for improvements, in order to gather input for future changes to the  workshop. 
The methodology included conducting focus groups in each class, focusing on 
the evaluation of the main components of the workshop. The principal results 
were that participants gave an overall positive assessment of the workshopand 
found group work methodology successful. They also noted the need for the 
use of more disciplinary control during the workshops and emphasized the 
importance of establishing rapport with the facilitators. The students were 
most interested in the sessions related to problem solving techniques. The 
workshop environment was found to generate positive communication and 
improve interpersonal relationships within the classes. In conclusion, the 
workshop was well accepted by the participants, and for future school-based 
programs, it is important to strengthen disciplinary management used during 
the sessions and ensure the quality of the relationship with the facilitators.
jaNNi NiclaSeN
POSITION TITLE:
Ph.D. fellow in Psychology, University 
of Copenhagen, Denmark
INSTITUTION AND  
LOCATION
DEGREE FIELD OF STUDY
University College London, UK B.Sc. Psychology
University of Copenhagen M.Sc. Psychology
Lund University, Sweden M.A. Asian studies
University of Copenhagen Ph.D. Psychology/ 
epidemiology
BIO SKETCH: 
My name is Janni Niclasen and I am a psychologist and Ph.D. fellow from the 
University of Copenhagen, Denmark. The title of my Ph.D. project is ‘Prenatal 
Exposure to Alcohol and Neurobehavioural Development in Childhood’. I am 
working with data from the large scale Danish National Birth Cohort (DNBC) 
and register data from Statistics Denmark. I have thus far submitted one article 
on the topic ‘Alcohol and neurobehavioural development’ and I have written 
one feature article for the newspaper. Apart from this work I am also very 
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interested in psychometrics. I have thus far published two articles looking at the 
psychometric properties of the Danish version of the Strengths and Difficulties 
Questionnaire (SDQ). As part of the 11-year DNBC follow-up I am in charge of 
a collection of teacher SDQ questionnaires. Thus far app. 13.000 questionnaires 
have been collected, but we expect approximately 25.000 questionnaires by 
the end of the data collection period. Before starting my Ph.D. I worked as a 
research assistant on a large-scale project where I neuropsychologically tested 
300 children. Apart from my research I have taught statistics for psychology 
students and I am currently supervising a Ph.D. projects at faculties of Health 
Science looking at fish oil intervention in breastfeeding period and behavioural 
and emotional development at age 13. I am also involved in other projects 
looking at the psychometric properties of different assessment tools and 
questionnaires. I am using the statistical programs SPSS, MPlus and SAS. After 
finishing my Ph.D. I will continue the work within the field of preventive mental 
health among children and adolescents and I will also continue the work within 
the field of psychometrics. I currently have funding for two years post doc. work.
SUMMARY PROJECT: 
Objective: To investigate possible associations between prenatal exposure to 
binge drinking and cumulated alcohol intake in pregnancy and behavioural and 
emotional development at age seven.
Method: Data from the Danish National Birth Cohort. Exposure variables: binge 
drinking and cumulated alcohol exposure from three interviews gathered at 
approximately weeks 16 and 30 of pregnancy and 6 months post-partum. 
Outcome measures: The Strengths and Difficulties Questionnaire (SDQ) used 
as continuous externalising and internalising scores and as above cut-off 
hyperactivity/inattention, conduct, emotional and peer problems scores. 
Inclusion criteria: information on alcohol exposure from three interviews, SDQ 
scores and being term-born (N=37,152). 
Results: controlling for relevant confounders and mediators small positive 
associations were observed between binge drinking and internalising and 
externalising scores (relative change in median: 1.01-1.07) and hyperactivity/
inattention, conduct, emotional and peer problem scores for boys (OR: 1.00-
1.28) and externalising scores (relative change in median: 1.02-1.05) and 
hyperactivity/inattention and emotional scores for girls (OR: 0.99-1.14). No 
associations with cumulated alcohol exposure were observed. 
Conclusions: large differences in background characteristics were observed 
between the cumulated alcohol exposure groups, leaving the interpretations with 
great uncertainty. The consequences of these large differences in background 
characteristics will be discussed. Exposure to binge drinking is associated with 
behavioural and emotional development measured at age seven.
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Ditte Lammers Vernal is a psychologist and Ph.D student at the Child- and 
Adolescent Psychiatry Department, Aalborg, Denmark. Her Ph.D. project is a 
register study comparing the outcome of early onset schizophrenia with the 
outcome of schizophrenia with adult onset. Variables such as hospital admissions, 
bed days, morbidity, living situation and employment will be analyzed.
Ditte Lammers graduated from Aarhus University in 2003 and has been 
working in Child- and adolescent psychiatry since 2004. She is studying Ph.D. 
part time and working clinically part time. In 2012 she was on a 6 months 
clinical research rotation at the Zucker Hillside Hospital New York where she 
participated in 3 clinical research studies under the guidance of Dr. Christoph 
Correll. 5 publications are under way as a result of the research rotation (2 first-
author, 3 co-authoring). Ditte Lammers is involved in writing national guidelines 
for assessment and treatment of psychoses and schizophrenia in children and 
adolescents. To date, she has authored or co-authored 2 publications.
SUMMARY PROJECT: 
Schizophrenia is known to be one of the most severe mental disorders. Early 
onset before age 18 is associated with a particular poor prognosis. Research on 
the subject is however biased by small samples sizes and high attrition rated. In 
this project we will look at the long-term outcome of early onset schizophrenia 
and compare it to the outcome of adult onset schizophrenia by use of the 
Danish registers. All patients diagnosed in 1994-2007 in Danish psychiatry will 
be included in the analyses, thus providing a large and representative sample. 
The Danish registers provide an excellent opportunity to study outcome in a 
large patient sample. Regardless of whether the patients continue medical 
treatment and/or remain in contact with psychiatry, the registers will allow for 
follow-up on several parameters.  Registers in Nordic countries are generally 
thought to provide a good basis for epidemiological studies. Also, very few 
patients with schizophrenia are diagnosed among private practitioners in 
Denmark so the total sample is expected to include close to 100% of diagnosed 
cases. Data on patients with this diagnosis can then be linked to other registers 
and thus we will have data on psychiatric outcome, suicide rates and morbidity 
and psychosocial outcomes in terms of living situation, education and social 
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benefits. The main hypothesis is that patients with early onset schizophrenia 
will have a worse outcome, both by psychiatric outcome data and psychosocial 
parameters. 
The project is not yet finalized. Baseline characteristics of the sample will be 
presented along with a more detailed description of the project.
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Menan Rabie is currently an Assistant Professor of Psychiatry, Institute of 
Psychiatry, Ain Shams University. Her area of interest in her research involves 
psychiatric disorders in adolescent age group, mood disorders and cognitive 
functions. She obtained her Bachelor degree in Medicine and Surgery from 
Ain Shams University in 1997 and Masters degree and the MD degree in 
Neuropsychiatry from Ain Shams University in 2001, and 2006 (respectively). 
She has also been a staff member of the Institute of Psychiatry, Ain Shams 
University since 2001- currently. She is also an associate Member of The 
International Federation of Psychiatric Epidemiology (IFPE), since May 2009- 
currently. She is also a Member of the editorial board of the journal of Middle 
East Current Psychiatry, since December 2010- currently. She has authored 
or co-authored 11 publications in refereed journals, one chapter in an online 
book and one book “Cognition & neurological soft signs, bipolar state or trait 
markers” 
SUMMARY PROJECT: 
EGYPTIAN YOUTH PSYCHIATRIC ASSESSMENT STUDY (EYPAS)
The epidemiology of psychiatric disorders in Egyptian adolescence Adolescents 
and young adults are usually reluctant to visit psychiatrists. While, most mental 
health problems diagnosed in adulthood begin in adolescence. Half of lifetime 
diagnosable mental health disorders start by age 14; this number increases to 
three fourths by age 24. 
This study will help in secondary and tertiary prevention of psychiatric disorders 
of the youth. Early detection of psychiatric disorders may help minimizing the 
direct and indirect family losses, improve the quality of life of the Egyptian 
youth and the Egyptian family and society. Youth with better mental health are 
physically healthier, demonstrate more socially positive behaviors and engage 
in fewer risky behaviors. Adolescents (11-17 years old) and young adults (18-25 
years old), of both genders, will be encouraged to share in the Egyptian Youth 
Psychiatric Assessment Study (EYPAS). 
The student will be asked to answer some ID questions age, gender, etc…) and 
some screening questions. 
Based on his answers, he will be then shuffled off to a psychiatrist, who subjects 
him to SCID-I for more accurate diagnosis. 
Based on the student’s assessment, and the diagnosis he is given, he is then 
sent off for treatment with an expert consultant. 
As the first Egyptian study to assess adolescent psychiatric disorders, it will be 
of high significance to the epidemiological data base. If interesting to authority 
figures, it will help to develop better services for this special population. A 
step in the prevention of psychiatric disorders may be achieved through the 
recommendations of this study. 
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Corinde Wiers is PhD Candidate at the Berlin School of Mind and Brain and 
Charité Medical School, Berlin, Germany, under the supervision of Prof. Dr. Felix 
Bermpohl, Prof. Dr. Dr. Henrik Walter.
She studied psychology and psychobiology at the University of Amsterdam 
and conducted a final Master’s project on umami taste bud receptors at the 
University of Brighton, UK. After an internship on the neurobiological bases of 
alcohol and cocaine addiction at the Amsterdam Medical Centre, she applied at 
the Berlin School of Mind and Brain graduate school with an independent project 
on the neural basis of implicit biases in alcohol-dependent patients in alcohol 
addiction and the neural effects of “bias modification training” in these patients.
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Areas of interest are cognitive, neurobiological, genetic and epigenetic bases 
of psychiatric disorders – with alcohol addiction in particular –, clinical and 
neural effects of behavioral treatments, how neuroimaging techniques can be 
of use for treatment in psychiatry and conceptual shifts in mental health due to 
neuroscientific research.
SUMMARY PROJECT:
ALCOHOL ADDICTION: THE SPIRIT IS WILLING TO REFRAIN BUT THE FLESH IS 
WEAK FOR SPIRITS
A paradox in addictive behaviors is the continuation of drug use despite strong 
explicit desires to quit (Stacy and Wiers 2010). One important factor for high 
rates of relapse might be the degree to which drug cues trigger a motivational 
reaction to use again, which happens largely outside conscious awareness. 
For example, it has been shown that alcohol-dependent patients have the 
automatic tendency to faster approach than avoid alcohol stimuli, the so-called 
approach bias (ApB), which has been associated with higher relapse rates 
(Field & Cox, 2008). Since relatively little is known about the brain processes 
underlying this automatic tendency, the goal of this study is to identify the 
neural mechanisms underlying the ApB to alcohol.
Recently detoxified and treatment-seeking alcohol-dependent patients (n 
=20) and healthy controls (n=17) conducted an Approach Avoidance task 
(AAT) in a 3 Tesla Magnetic Resonance Imaging (MRI) scanner, in which 
participants pushed and pulled pictures of alcohol and softdrink projected on 
a screen, towards and away from the body with a joystick. All pictures were 
moreover rated for valence and arousal.
As hypothesized, although there were no group difference in explicit rating 
of the pictures, alcohol-dependent patients revealed higher ApB for alcohol 
than for softdrink cues, whereas the reverse was found for control subjects. 
Furthermore, activity in reward-related areas (e.g. the ventromedial prefrontal 
cortex (vmPFC), and right nucleus accumbens (NAcc)) was larger in alcohol-
dependent patients compared to control subjects.
The data suggest that an overactive reward system is associated with the 
ApB to approach alcohol-related stimuli. The ApB has therapeutic potential: 
a behavioural Bias Modification Training (BMT) that selectively trains away 
ApB reduces relapse rates one year after training (Wiers et al, 2011) and, as 
preliminary results of our ongoing study suggest, also downregulates NAcc 
activity while watching alcohol cues.
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Lydia Pöhland was born in 1986. She completed her diploma in psychology at 
the Freie Universität, Berlin in 2011. Since 2008, she is working as a research 
assistant in the multidisciplinary imaging group “Emotional Neuroscience” at 
the Department of Psychiatry and Psychotherapy, Charité – Universitätsmedizin 
Berlin, Germany. Within this working group, Ms. Pöhland also prepared 
her diploma thesis with the topic “Emotional face processing in relatives of 
schizophrenia patients”. Currently, she is working on her PhD thesis with the 
working title “Psychobiological influences on emotion experience” Her research 
interest focuses on intermediate phenotypes, emotion processing and related 
risk factors for the development of mood disorders. 
SUMMARY PROJECT: 
The project “Brain structural anomalies in high risk subjects for Major 
Depressive Disorder (MDD)” focuses on potential intermediate phenotypes for 
MDD. Although a heritable contribution to risk for MDD has been established 
and neural alterations in patients have been identified through neuroimaging, 
it is unclear which brain abnormalities are related to genetic risk. Therefore, 
82 healthy first degree relatives of patients with MDD and 82 healthy controls 
underwent structural magnetic resonance imaging. Regional gray matter 
volumes were analysed via voxel-based morphometry (VBM). Whole-
brain analysis revealed significant gray matter volume increases in the right 
amygdala and the left thalamus in first-degree relatives of patients with MDD. 
Furthermore, relatives showed significantly increased gray matter volume in 
anatomical structures found relevant to MDD in previous literature, specifically 
in bilateral hippocampus and amygdala as well as left dorsolateral prefrontal 
cortex (DLPFC). Further, the DLPFC volume correlated positively with depressive 
symptoms in the healthy relatives. The observed volume increases in healthy 
relatives may represent a resilience factor, as a majority of studies describes 
decreases in amygdala and thalamus volume in patients with MDD. 
Data was collected within the multicenter study “MooDS” (Imaging genetics: 
Systematic Investigation of the Molecular Causes of Major Mood Disorders 
and Schizophrenia). Funding was provided by the German Federal Ministry of 
Education and Research. 
Participants were examined at three scanner sites in Germany: Zentralinstitut 
für Seelische Gesundheit Mannheim, Department of Psychiatry and 
Psychotherapy, Universitätsklinikum Bonn and the Department of Psychiatry 
and Psychotherapy, Charité - Universitätsmedizin Berlin.
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Assistant Professor, Department of 
Psychiatry, Kasturba Medical College, 
Manipal, Karnataka, India
INSTITUTION AND  
LOCATION
DEGREE FIELD OF STUDY
Gauhati Medical College & 
Hospital, Guwahati, Assam, India
MBBS Medicine
Central Institute of Psychiatry, 
Kanke, Ranchi, Jharkhand, India
DPM Psychiatry
Central Institute of Psychiatry, 
Kanke, Ranchi, Jharkhand, India
MD Psychiatry
BIO SKETCH:
Samir Kumar Praharaj is currently working as Assistant Professor at Department 
of Psychiatry, Kasturba Medical College, Manipal, India. He has studied Medicine 
from Gauhati Medical College & Hospital, Guwahati, India and post-graduate 
diploma and degree in Psychiatry from Central Institute of Psychiatry, Ranchi, 
India. For his work on transcranial magnetic stimulation, he has received the 
Samuel Gershon Junior Investigator Award in 2008. He has also worked on life 
events and disability in psychiatric disorders. Currently, he is studying the role 
of life events in alcoholic relapse. He has authored and co-authored several 
articles in indexed journals.
SUMMARY PROJECT:
Alcoholics experiencing psychosocial stress following treatment are more likely 
to relapse than those not experiencing such stress. In this pilot study, the role 
of life events was examined in 20 patients presenting with alcoholic relapse. 
The median number of life events in past one year was 3 (IQR 2.75), which 
was higher than 2 stressful life events in past one year that are considered as 
threshold for producing mental illness. The number of undesirable life events 
was higher than desirable events and the most common life events reported 
included financial loss and large loan. The severity of alcohol dependence 
negatively correlated with age of onset of problem drinking (rs = 0.6), and 
positively correlated with the degree of familial alcoholism (rs = 0.41). However, 
neither the number of life events nor the perceived stress was associated with 
either the severity of alcohol dependence or the degree of familial alcoholism. 
As the sample size was small in this pilot study, larger sample would provide 
further information regarding the nature and temporal relationship of the 
stressful life events in the relapse of patients with alcohol dependence.
roHit VerMa
POSITION TITLE:
• Licensed Psychiatrist, Medical Council 
of India, Delhi Medical Council.
• Senior Resident, Academic-Regular, 
Department of Psychiatry and Drug 
De-addiction, Post Graduate Institute 
of Medical Education and Research Dr  
 Ram Manohar Lohia Hospital New  
 Delhi India.
INSTITUTION AND  
LOCATION
DEGREE YEAR(S) FIELD OF 
STUDY
University of Rajasthan, 






All India Institute of Medical 




Department of Psychiatry 
and Drug De-addiction, 
Govind Ballabh Pant Hospital, 
Maulana Azad Medical 
College and associated group 




Department of Psychiatry 
and Drug De-addiction, Post 
Graduate Institute of Medical 
Education and Research Dr 





Department of Psychiatry 
and Drug De-addiction, Lady 
Hardinge Medical College 






Since childhood, due to a fertile family medical background, my interest in 
patient care was soaring. Aspiring to focus on the improperly understood 
discipline having deeply rooted anarchy issues with cultural penetration, 
stigmatized and challenging, I chose psychiatry as my profession of expertise. 
Having completed M.D. in Psychiatry from the country’s most prestigious 
medical institute (All India Institute of Medical Sciences), I did senior residency 
from other tertiary care institutes to understand the differences in terms of clinics 
and teaching, finding lacunae to improvise and further strengthen myself to 
deal effectively with the pertinent issues of the discipline. Clinical - Expertise in 
work, Experienced in conducting structured Lorazepam interviews (innovative 
work), Initiated use of Botulinum toxin as a measure to treat Clozapine-induced-
sialorrhoea, Providing Modified Electro-convulsive therapy, Special interest in 
Psychotherapy (Behavioral/Cognitive), Ability to successfully handle outpatient 
clinics, inpatient ward, emergency as well as liason duties and responsibilities. 
Worked as Trauma therapist for assessment and management of immigration 
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survivors from Libiya, 2011. Received good conduct and appreciated for work at 
all working places. Participated in Community work associated with Tobbacco 
Cessation clinics and mental health awareness National Trade fair at New Delhi.
Teaching - Have been teaching undergraduate/postgraduate/post-doctoral 
fellows/nursing students, taking lectures, seminars, conferences, didactic and 
bed side teaching. Promoted for teaching as Lecturer for Training Programme 
for Tobacco use Intervention for Police personnel. Invited as Guest Lecturer for 
teaching Clinical Interviewing to Post Graduate Fellows in Geriatric Medicine, 
Indira Gandhi National Open University and Nursing students at PGIMER Dr Ram 
Manohar Lohia Hospital, New Delhi. Research - Thoroughly involved in research 
work evident from a plethora of publications (original studies, reviews as well 
as case reports) in psychiatry and neurology field. Presented work at various 
national and international academic bodies and have been accordingly awarded 
prizes and grants initiating during postgraduate training itself. Acknowledged 
in leading newspaper for the work done in adolescent population for emerging 
inhalant addiction and upcoming drug abuse problems as an occupational 
hazard. Administrative - Ensuring quality and smooth conduct of clinical 
services; Liaison with professionals from related disciplines such as clinical 
psychologists, psychiatric social workers and psychiatric nurses; Liaison with 
other professionals such as neurologists; supervising the out-patient, in-
patient, emergency and casualty and other clinical services (ECT etc); being 
available on all days 24-hours for patient care.
SUMMARY PROJECT: 
HOME VISITING INTERVENTION BASED ON PRE-MARITAL COUNSELLING IN A 
COMMUNITY SETTING FOR PREVENTING MENTAL DISORDERS
Marriage is one of the most important events of life affecting social status as 
well as the psyche of an individual. It not only serves to satisfy the fundamental 
biological need of sexual gratification through a socially acceptable way but 
also helps the individual to achieve a higher level of personality maturation. In 
India, marriage is a onetime event in life, which is glorified and sanctified and is 
associated with much social approval. Indian society believes that easy marriage 
and divorce cheapen the institution of marriage and threaten the structure of 
the family. Moreover, a significant stigma still exists to consult regarding sexual 
health and also a general tendency to keep the sexual problems secretive as, in 
Indian culture, pre-marital enrolment in sexual activity or self stimulation is not 
very common and considered atrocious.
All these factors make marriage a significant stressful event in an individual’s 
life, females more than males. Stress may induce neuro-endocrinal changes 
particularly mediating disturbances in HPA axis which may secondarily lead to 
mental health problems particularly so in vulnerable people. Further marital 
disharmony may propagate the building up of ill health. The rough familial 
atmosphere coupled with high societal expectations particularly during and 
after pregnancy may lead to development of mental illness in mothers or 
child. There is evidence that marital status is significantly associated with first 
admission rates, age of onset, course and outcome of mental illnesses. Research 
has as of yet not focused on this aspect of preventing mental illness.
We propose a two year study aimed to prevent mental disorders by a home 
visiting intervention in community setting. The intervention will be based on 
gender sensitive pre-marital counselling focusing on adolescents and young 
adults addressing factors such as sexual and reproductive health, sexual 
education (concerning about sexual function, sexual feelings and intimacy), 
sexual communication, nutrition, domestic violence and, socio-economic 
issues. A training programme (behaviourally-based intervention) will be 
undertaken to increase coherent child-parent interaction, amplify parental 
skills, and improve child’s problem-solving behaviour and social functioning. 
A script based role playing would be supplemented as training exercise. The 
intervention will initially be individualised and later age-bound-group based to 
increase association and flow of information among the community members. 
Outcome parameters will be assessment of mental health of individuals on general 
health questionnaire on six monthly follow up for 2 years extendable for 5 years.
fiaMMeta coSci
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DEGREE YEAR(S) FIELD OF STUDY
University of Florence, 
Italy
Degree 1999 Medicine
University of Florence, 
Italy
Degree 2003 Psychiatry
University of Maastricht, 
The Netherlands
M.Sc. 2003 Psychiatry




Referee for 22 Journals. Member of the Referees Register of the Italian Ministry of 
Instruction, of University and Research. Peer Reviewer for the Medical Research 
Council. Referee for the evaluation of abstracts for poster for the European 
Health Psychology Society (EHPS) (International Programme Committee of the 
23rd Annual Conference, Pisa, 23-26 September 2009).
From 2012 Member of the Editorial-Scientific Committee of “Tabaccology”, 
Journal of Italian Society of Tabaccology (SITAB).
Ongoing grants for research: Global Research Awards for Nicotine Dependence 
(GRAND), Pfizer; Grant from the Italian Ministry of Research and Instruction; 
Grant from the University of Florence for one research fellowship.
Completed grants for research: Grant from the University of Florence for one 
research fellowship; Life Long Learning Programme Erasmus scholarship; Grant 
from the University of Florence for Young Researchers.
Publications: 31 papers published in International Journals; 9 papers published in 
National scientific journals; 5 book chapters; 1 monograph; 67 abstracts; 4 posters.
Other titles: European Certificate in Anxiety and Mood Disorders (2001); 
Specialist in Psychosomatics (2009); EPA Research Prize 2009 winner.
SUMMARY PROJECT:
The level of negative affectivity seems to influence the outcome in quitting 
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smoking. The pharmacological treatments currently administered to quit may 
modulate negative affectivity because of dopaminergic and noradrenergic 
activity (bupropion) or nicotinic receptor partial agonism (varenicline).
The present project was born in 2005 with the assessment of negative 
affectivity in smokers applying for three public smoking cessation clinics of the 
Tuscany (Italy) compared to smokers of the general population. The first group 
showed higher negative affectivity than controls (see Depression & Anxiety 
2008 26(9):824-830). On the basis of these findings, in 2009 the smoking 
cessation clinic located in Pisa and involved in the previous multicenter study, 
introduced the Hospital Anxiety Depression Scale (HADS) as a screening scale 
assessing negative affectivity in smokers at first visit. On the basis of the HADS 
score, a decisional algorithm was also applied to propose the treatment and 
evaluate the need of a psychiatric advice.
The introduction of an objective measure of negative affectivity and the 
algorithm is an important step toward a proper treatment of smokers. This 
procedure allows an adequate assessment and pharmacological treatment, 
decreases the risk of psychiatric side effects due to the pharmacological 
treatment, and may increase the rate of success in quitting and/or the duration 
of smoking abstinence. Thus, tertiary prevention is put in practice. It may also 
allow an early diagnosis of affective disorders, according to the secondary 
prevention principles. Finally, it can allow primary prevention because high 
negative affectivity can be the prodrome of a psychiatric disorder and its early 
assessment should be a target for early intervention.
To further strengthen this project, we want to study negative affectivity 
in smokers who receive a pharmacological treatment and evaluate if such 
treatment influences negative affectivity and if negative affectivity influences 
the possibility to quit. 
loreNzo lelli
POSITION TITLE:
4th year Resident Physician 
in Psychiatry. Psychiatric Unit 
-Department of Neuropsychiatric 
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My name is Lorenzo Lelli, I was born in Pistoia (Italy) on 13/02/1982. I 
Graduated in Medicine and Surgery at University of Florence (Italy) in 2008 
(Score: 110/110 et lode) with a Thesis on “Dexamethasone Suppression Test 
and psychiatric symptoms: a trans-diagnostic approach” with Prof. Carlo 
Faravelli as supervisor. I’m a 4th year resident in Psychiatry at University of 
Florence. I’m also attending a training in cognitive-behaviour psychotherapy 
in Florence and I’m a first year student of the International Master In Affective 
Neuroscience (Maastricht University). During my residency, I’m mainly focused 
on Eating Disorders; Stress, HPA-Axis and psychopathology; Bipolar Disorders 
and Anxiety Disorders, panic disorder especially.
As demonstrated by my publications and the argument of my thesis, my 
clinical and research experience is related to the psychopathological, clinical 
and treatments features of these disorders. I am enthusiastically involved in 
several clinical studies in the field of epidemiology of life events and psychiatric 
disorders, eating disorders, stress-childhood traumata-HPA-Axis and adult 
psychopathology.
I’d like to improve my knowledge about biological and neurological aspects of 
psychiatric disorders such as mood and anxiety ones. I’m also very interested in 
epidemiology, neuropsychopharmacology and neuroimaging.
To date, I have published 9 papers in refereed journals
SUMMARY PROJECT:
THE ROLE OF EARLY STRESSFUL LIFE EVENTS IN THE ETIOPATHOGENESIS OF 
MENTAL DISORDERS: ARE THEY RISK FACTORS?
Background: An excess of childhood trauma, both loss and abuse events, is 
reported to be associated with the development of several Mental Disorders 
such as mood disorders, anxiety disorders, post-traumatic stress disorder 
(PTSD), eating disorders, schizophrenia, personality disorders and substance 
abuse. Previous animal models seem to confirm the relationship between early 
stressful events and the development of distress symptoms. This relationship 
seems to be mediated by the Hypothalamic-Pituitary-Adrenal-Axis (HPA-
axis). Accordingly, functional abnormalities of the HPA axis have been widely 
reported in psychiatric disorders, including depression, bipolar disorder, anxiety 
disorders, eating disorders, schizophrenia, substance abuse, dissociative 
symptoms, dementia, and posttraumatic stress disorder.
Aim of the study: To investigate the relationships between early stressful life 
events, HPA Axis functioning and psychiatric symptoms from a trans-diagnostic 
point of view.
Methods: The research project plans to study a consecutive series of 200 
patients admitted to the in and out-patient Psychiatric unit of Florence Hospital 
and University School of Medicine. A group of 200 people will be drew from 
the general population living in the same catchment area, matched with the 
psychiatric case for age, gender and education. The protocol includes a complete 
clinical and anamnestic assessment involving a face-to-face interview and the 
administration of self-report questionnaires including the Florence Psychiatric 
Interview (FPI), the Childhood Experience of Care and Abuse Questionnaire 
(CECA.Q), the Mini-International Neuropsychiatric Interview (MINI Plus) and 
the Self-report Symptom Inventory-Revised (SCL-90R). Saliva samples will be 
collected for cortisol analysis 30 and 60 minutes after awakening and at 8.00 pm.
Expected results: To establish in our sample if an excess of childhood trauma is 
correlated to HPA Axis alterations and the development of Mental disorders and 
psychiatric symptoms. Better understanding such a relationships could help to 
build up more appropriate strategies for prevention in adolescents who had 
experiment childhood traumata.
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Tomohiro Shirasaka is currently a Research Fellow at Sapporo Medical University 
School of Medicine, Department of Neuropsychiatry. 
He obtained his Doctor of Medicine from Saitama Medical University in 2005 
and he received a Ph.D. in Neuropsychopharmacology from the Sapporo 
Medical University in 2012.
His Ph.D. research was translational research, using stem cell transplantation for 
fetal alcohol spectrum disorder. 
He has also been a board member of the Japan Young Psychiatrist Organization 
(JYPO) and worked as research fellow at the department of neuropsychiatry, 
Sapporo Medical University School of Medicine. To date, he has authored or 
co-authored eighteen publications in refereed journals.
SUMMARY PROJECT:
PROMISING THERAPY OF INTRAVENOUS NEURAL STEM CELL TRANSPLANTATION 
- A STRATEGY FOR FACILITATION OF NEURAL NETWORK AND BEHAVIORAL 
RECOVERY -
Recent clinical neuroimaging studies have revealed a possible relationship 
between morphological brain changes and the manifestation of psychiatric 
disorders such as depression, schizophrenia, and alcoholism. Although its 
biological mechanism is still unclear, the emerging evidence suggests that the 
alteration of neurogenesis is the key factor for the morphological brain changes 
of these psychiatric disorders.
In our previous work, we analyzed the mechanism of neural network disruption 
by ethanol using cultured cells, and found a suppressive effect of ethanol on 
neural stem cell (NSC) differentiation. While, we also demonstrated that 
antidepressants, mood stabilizers and atypical antipsychotics stimulate NSC 
differentiation which was inhibited by ethanol.
In the present work, we have demonstrated that the usefulness of intravenous 
transplantation of NSCs to fetal alcohol spectrum disorder (FASD) model rat for 
the purpose of reconstructing the impaired neural network and investigating 
the possibility of regenerative therapy for patients with neurobehavioral 
deficits of FASD.
We have shown the potential migration of transplanted NSCs into the brain by 
visualizing a fluorescent cell marker and radioisotope, as well as the possible 
recovery of behavioral abnormalities observed in FASD model rats, such as 
anxiety-like behaviors, memory/cognitive function, and social interaction. 
We further assessed the characteristics of transplanted cells in the brain and 
found that the GABAergic interneurons were increased in amygdale, DG, 
cingulated cortex areas in the model rat. In the amygdala and cingulate Cortex 
of model rats, number of parvalbumin positive cells was reduced and the NSC 
transplantation recovered these disturbances. Moreover, in the amygdala 
and cingulate cortex, intravenous NSC transplantation appears to regenerate 
expression of post-synaptic density protein 95 (PSD95) in FASD model rats.
These results indicate that intravenous NSC transplantation has the potential to 
become a therapeutic intervention for FASD patients.
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Lourdes Nieto is PhD Psychology from Universitat Autònoma de Barcelona 
(UAB), Department of Clinical Psychology and Health in 2012. Her PhD research 
was lack of insight in psychotic spectrum disorders. She obtained her Bachelor’s 
degree in Clinical Psychology from Universidad Nacional Autónoma de México 
(UNAM) in 2003and Master’s degree in Psychopatology of children, adolescents 
and adults in 2011. She has training in Cognitive Behavioral Rational Emotive 
Therapy from Institute of Rational Emotive Therapy (RET) of Barcelona, Spain. 
During the last five years she has worked in different research projects about 
psychosis. To date, she has authored or co-authored eight publications in 
international refereed journals. She has participated in international congress.
SUMMARY PROJECT:
Lack of insight is a common feature of psychosis. Patients do not accept 
psychiatric and/or psychology treatment because unawareness of disease. 
Different studies have found that caregivers of patients with psychosis often 
develop symptoms of anxiety and depression related to patient care. LEAP 
method (Listen-Emphatize-Agree-Partner) is a program designed for develop 
ability to listen in a reflexive empathy with the psychotic patients. Aim of this 
study is LEAP method to teach a group of caregivers of patients with first 
episode and initial psychosis and compare presence and severity of symptoms 
of anxiety and depression with a group of caregivers who have no knowledge 
of this method.
We proposed a pilot study with prospective design and aleatorized parallel 
groups. All subjects who meet the following criteria will be invited to participate 
in the study: 1) men and women between 18 and 65 years of age, 2) who are 
the primary caregivers of a family member suffering a first and initial psychotic 
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episode with lack of insight, and 3) living with the patients or sharing more 
than 25 % of time with them. First and initial psychotic episode are defined as 
patients with psychotic symptoms less than five years of evolution. Diagnosis 
of the patients was based on the DSM-IV criteria (APA, 2000). Exclusion 
criteria for the caregivers included any mental disorder, drugs and alcohol 
abuse, taking any psychotropic medication or participation in similar studies. 
Considering the prevalence of the patients, we proposed an initial sample size 
of 15 caregivers on every group. The assignation of the volunteers to every 
group will be aleatorized. We assumed a maximum of 30% of lost cases, them 
the last sample will be included of a minimum of 10 caregivers by group.
jeSSica a. de  
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Maastricht University Bachelor 2003-2006 Psychology
Maastricht University Master of 
Sciences
2006-2008 Neuroscience and  
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BIO SKETCH: 
Jessica A. de Wild- Hartmann, originally from Germany, received her Bachelor 
in Biological Psychology (2006) and her Master in Cognitive Neuroscience, 
Neuropsychology & Psychopathology (2008, cum laude) from Maastricht 
University, the Netherlands. During her studies, she engaged in several 
research-oriented activities, such as extracurricular research assistance at 
the Department of Neurocognition and a work placement at the Max Planck 
Institute for Cognitive and Brain Sciences in Leipzig, Germany. She completed 
her graduate internship (nine months) at the Surrey Sleep Research Center, 
University of Surrey (United Kingdom) under the supervision of Prof. Dr. Derk-
Jan Dijk. From 2009 to 2011, Jessica worked as a research officer in a large 
intervention study targeting emotional resilience in depression, a joined project 
of Maastricht University and GGzE (Dutch mental health care institution). In 2011, 
she was appointed a position as PhD candidate at the School for Mental Health 
and Neuroscience (MhENS) in cooperation with GGzE, studying the association 
between sleep and affect in depression, under the supervision of Prof. Dr. Jim 
van Os (Maastricht University, Department of Psychiatry and Neuropsychology). 
Jessica presented her work at various national and international conferences, 
such as the ECNP (European College of Neuropsychopharmacology) in Vienna 
and the ERSR (European Sleep and Research Society) in Paris, and received 
several awards, such as the travel award from the ECNP and the poster award 
of the Dutch Organization for Sleep-Wake Research (NSWO). Jessica is married 
and lives with her husband in ‘s- Hertogenbosch, the Netherlands. 
SUMMARY PROJECT: 
SLEEP- AND AFFECT REGULATION IN DAILY LIFE: ON THE PATHWAY TO DEPRESSION
1) Sleep and affect are closely intertwined. Poor sleep is found to be a risk factor 
for depression, while sleep disturbances such as insomnia are also considered a 
symptom of depression. Both aspects, affect as well as sleep, appear to be easily 
dysregulated: insomnia and depression have high prevalence rates and are 
associated with high societal costs. But what are the mechanisms connecting 
sleep and affect and how do they relate to depression? The project endeavours 
to address this question by zooming down to the day-today dynamics of sleep 
and affect by making use of the Experience Sampling Method (ESM). ESM is a 
structured diary technique offering a unique perspective: by assessing variables 
of interest prospectively, repeatedly and ambulatory, it is possible to investigate 
daily within-person associations and dynamics on a micro level. First, in a 
sample of 553 women, ESM is used to investigate how subjective sleep and 
momentary affect are associated in everyday life and how it is related to future 
depression. Second, it is investigated who is genetically particularly sensitive to 
the effects of sleep and why.
2) Depression is an invalidating disease affecting 10% of the world population. 
The demand for affordable treatment alternatives is high. In the project, it is 
investigated whether ESM can be used not only to monitor, but also to intervene 
on depression. Recent evidence indicates that the ability to experience positive 
affect in daily life is associated with vulnerability for and course of depression. 
In a randomized controlled trial(n=102), it is studied whether feedback on daily 
life affect and behaviors, derived from data collected with ESM, can be effective 
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Maastricht University M.D. Neuroscience
BIO SKETCH: 
I am a PhD candidate in the Neuroscience program at Maastricht University. I 
received my M.D. in 2007 in Iran, and afterwards, practiced medicine for two 
years in the Neonatal Intensive Care Unit. In 2010, I moved to the Netherlands 
and joined the School for Mental Health and Neuroscience, at Maastricht 
University. I was involved in a research project investigating the behavioral 
and molecular effects of electrical deep brain stimulation on animal models of 
stress and depression under the supervision of Prof. Dr. Yasin Temel. In 2011, I 
started my own PhD projects in the department of psychiatry and psychology 
under supervision of Prof. Dr. Jim van Os, Dr Bart Rutten, and Dr Gunter Kenis. 
My research interest focuses on the modulation of gene-environment 
interactions through DNA methylation in psychiatric disorders. In our research 
iNterNacioNal StUdeNtS of 
tHe y-MiNd adVaNced ScieNce ScHool
46
group, we conduct epidemiologic, clinical, genetic, and neurochemical 
approaches, to investigate the effects of the environment on psychiatric 
disorders. I recruit different populations of healthy subjects and subjects with 
clinical psychopathology. With these subjects, I employ gene-environmental 
interaction models with a focus on genes relevant for epigenetic mechanisms. 
Furthermore, I follow a translational approach by using laboratory animals 
exposed to the environmental pathogens akin to real life situations such as the 
social defeat model of stress and prenatal stress to enhance our understanding 
about the precise epigenetic mechanisms, which mediate environmental 
effects on psychiatric phenotypes. 
SUMMARY PROJECT: 
EPIGENETIC MECHANISMS AND GENE-ENVIRONMENT INTERACTIONS IN 
PSYCHIATRY
E. Pishva, G. Kenis, M. Drukker, W. Viechtbauer, J. Decoster, D. Collip, R. van 
Winkel, M. Wichers, N. Jacobs, C. Derom, V. Thewissen, T. Lataster, I. Myin-
Germeys , J. van Os, B.P.F Rutten
Department of Psychiatry and Neuropsychology, South Limburg Mental 
Health Research and Teaching Network, EURON, School for Mental Health and 
Neuroscience MHeNS Maastricht University, Maastricht, The Netherlands.
Recent human and animal studies suggest that epigenetic mechanisms mediate 
the influence of adverse environmental conditions on the development of 
psychiatric disorders. Polymorphisms in the epigenetic machinery genes might 
therefore play a crucial role in vulnerability to psychological phenotypes. To 
evaluate this hypothesis, we conducted several gene-environment interaction 
studies to investigate whether polymorphisms in 30 SNPs over 4 DNA methylation 
relevant genes (DNMT1, DNMT3A, DNMT3B, and MTHFR) moderate the effect 
of environmental conditions such as obstetric complications, low birth weight, 
childhood trauma and daily stressful events in adulthood on various psychiatric 
outcomes like affects, emotional reactivity, paranoia and psychosis reactivity. 
Momentary social stress, stressful events paranoia and emotional states in 
daily life were determined with experience sampling methodologies. A two-
stage association analysis using multilevel linear regression was employed. 
First, main effects and interactions were tested in 113 healthy individuals. In 
the second stage, significant associations (at p<0.05) were replicated in a 
sample of 380 female twins from a general population. In addition, significant 
effects in both the original and replication sample were tested in several clinical 
samples of patients with psychotic disorder (n=108), siblings of patients with 
psychotic disorder (n=96), and patients with residual symptoms of depression 
(n=125). Regression analyses revealed that the associations between different 
environmental risks over the life course and some mentioned psychiatric 
phenotypes are significantly different in healthy individuals with a certain 
genotype of the DNMT3a gene and the effects were consistently significant 
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Cayetano Heredia University, 
Lima-Peru
MD Medicine
Cayetano Heredia University, 
Lima-Peru
MSc MSc in Epidemiology
BIO SKETCH:
Dr Peña-Olano has been involved within Psychiatry since medical school. He 
gained experience in clinical rotations in both, at the national and international 
level. After his graduation, he obtained an award to study a Masters Program 
in Epidemiological Research at Cayetano Heredia University and John s´ Hopkins 
University agreement. As part of his training, he was involved in research 
projects at the National Institute of Mental Health “Honorio Delgado – Hideyo 
Noguchi” and Institute of Studies in Health, Sexuality and Human Development 
in Lima, Perú; which are still in process. 
Due to his commitment to Psychiatry and the alleviation of Mental Health 
disorders in the community, he recently was elected to work as a physician in a 
rehabilitation center for the mentally ill, as well he is writing his own proposal 
about the promotion of Mental Health using Social Media with all learned in 
his master’s program. His future plans include the application for a residency in 
Psychiatry in the upcoming year. 
SUMMARY PROJECT:
ASSOCIATION BETWEEN SLEEP QUALITY AND SUICIDE BEHAVIOR IN COASTAL 
ADULTS, PERU
Objective: Explore the association between Sleep Quality and Suicide Behavior 
in a sample of adults living in 5 coastal cities in Peru. 
Methods: We performed a secondary data analysis of the Epidemiological Study 
of Mental Health in the Peruvian Coast, in which a total of 7020 participants 
between 18 and 60 years old were enrolled by using Conglomerate Sampling 
Design. Data were collected using the Pittsburgh Scale for the evaluation of 
Sleep Quality and questionnaire regarding suicide behavior since desire for 
death to attempted suicide in the last month. We adjusted the association with 
other covariates as age, sex, socioeconomic status, education level, history of 
depression, history of suicide behavior and history of physical and sexual abuse. 
Analysis is being performed with the use of Stata Version 12, by using Survey 
Data Analysis (SVY) considering a 95% confidence interval (bootstrapping).
Expected Results: We expect to find a significant association between both 
variables. The results will establish the basis for the incorporation of new 
strategies in the prevention of suicide. 
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psychotherapy and clinical 
psychology department, 
Samara State Medical 
University Samara, Russia
Specialist 2004-2006 Psychiatry
Moscow Research Institute of 
Psychiatry, Moscow, Russia
Candidate 




Daria Smirnova is currently a Teacher and Research Assistant at Samara State 
Medical University, Department of Psychiatry, narcology, psychotherapy and 
clinical psychology. Her Ph.D. research is devoted to clinical psychopathology 
and verbal features of mild depressions and reactions of normal sadness as 
well as an attempt to elaborate linguistic markers of these mental states. She 
obtained her Medical Doctor degree from Samara State Medical University in 
2004 and Candidate of medical sciences (Psychiatry) degree from Moscow 
Research Institute of Psychiatry in 2010. She has also been a member of 
Study group within the project on Language and schizophrenia (Language 
disorder in bilingual Russian-Hebrew patients with Schizophrenia) in Ben-
Gurion University of the Negev, Beersheva Mental Health Center, Beersheva, 
Bar-Ilan University, Telaviv, Israel. To date, she has authored or co-authored 
three publications in refereed international journals and a number of papers in 
Russian professional editions. 
SUMMARY PROJECT:
DIFFICULTIES IN DIAGNOSIS OF MILD DEPRESSIONS ARE RELATED TO CLINICAL 
INTERPRETATION OF THOUGHT STRUCTURE AND CONTENT WITHIN DEPRESSIVE 
TRIAD
The precise study of verbal structure and semantics of speech in relationship to 
cognitive function  is oriented to clarify the diagnosis and clinical perception of 
mild depression and normal sadness phenomenon.  
124 patients and 77 healthy controls, including 35 with normal sadness 
reactions, were observed. Speech (superficial, deep levels, Russian language 
native speakers) was studied using standardized psycholinguistic procedures. 
Statistical data evaluation included descriptive methodics, nonparametric 
analysis, mathematic modeling (discriminate analysis). 
Three clinical groups were formed upon to psychopathological subtypes 
(anxious, asthenic-hypodynamic, melancholic mild depressions). Leading 
hypotymic affect correlated with content of affective component, semantics 
of associative component, pronounced component of depressive triad and 
direction of the prevailing timeline representation. Lexical-stylistic sublevel 
of speech demonstrated verbosity, narration dominated over reasoning, signs 
of oral speech, increased number of phraseologisms, tautologies, lexical and 
semantic repetitions, metaphors, comparisons, inversions, ellipsis. Lexical-
grammer sublevel contained more pronouns of all types with the prevalence 
of personal pronouns, imperfective verbs in preferential past tense. Syntax-
stylistic sublevel represented the prevalence of simple sentences (truncated, 
impersonal), inversive word order. Component analysis of speech demonstrated 
the qualitative distortion and reduction of semantic component. 
Disruptions in structure and semantics of speech related to the most clinically 
pronounced thought disorder were presented in melancholic depression. 
Superficial level of speech was damaged mostly in asthenic-hypodynamic 
depression. Speech was similar to healthy controls and demonstrated the 
highest among subgroups cognitive adaptability level in anxious subtype. 
Depressive states and normal sadness were significantly differentiated based 
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Araceli Núñez recently got her PhD at the University of Barcelona with the 
dissertation called: “Gender, Phenotypical differentiation and therapy response 
for Bulimia Nervosa”. She also obtained a Postgraduate Degree in Rational 
Emotive Behavior Therapy at 2011 and a Master degree as an Agent on Equal-
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Opportunity for Women in the Rural Environment at 2008. From 2008 to 2011 
she was a Marie Curie Research Fellow at the University of Minho (Portugal) 
and worked within the European project INTACT on the prevention of eating 
disorders (ED) among College students. She has broad experience on clinical 
work specifically in the area of ED, but also in other mental health problems. To 
date, she has authored or co-authored seven publications in refereed journals.
SUMMARY PROJECT:
Mental disorders are a serious problem, causing pain and social distress to 
those who are suffering from the pathology and their caregivers, and likewise 
cause great cost to our community. Cognitive-behavioural therapy has been 
supported as an effective treatment for a variety of mental disorders. Prevention 
programs with children can be quite beneficial in future behaviours, social 
interactions and academic results. The aim of this project will be to implement 
and evaluate the effectiveness of using “healthypersonal skills”-workshops 
with children as a prevention of symptomatology of four mental disorders: 
eating (EDs), depression (D), anxiety (ADs) and substance use disorders (SUDs). 
The main objective will be (1) to analyze the effectiveness of using “healthy 
personal skills” workshops with children as a prevention of EDs, SUDs, ADs and 
D symptomatology, when compared with a comparison group of children with 
no access to the workshops. The secondary objectives will be: (2) to develop 
the workshops “healthy personal skills”; (3) to describe the adherence to the 
program and to analyze the relation between adherence and outcome. (As 
adherence variables will be used: active participation on the workshops and 
realization of the workshop tasks and/or homework and as outcomes will be 
used  the results on the different assessments.) Participants will be children 
with ages between 10 and 13 years old and the duration of intervention will 
last 4 scholar years (20 workshops per year). Positive results showing “healthy 
personal skills”-workshops as an adequate tool to teach body acceptance, 
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University of Barcelona, Spain M.D. Medicine
University of Barcelona, Spain M.Sc. Master in Neurosciences
BIO SKETCH:
Iria Grande obtained her degree in Medicine and Surgery, specialized in 
Psychiatry at the Hospital Clínic, Barcelona and attained a Master’s Degree at 
the Neurosciences Master by the University of Barcelona. Dr. Grande currently 
works as a researcher at the Barcelona Bipolar Disorders Unit in the Hospital 
Clínic. She is involved in diverse research projects on functioning and different 
pharmacological treatments for the bipolar disorder. At the same time, she is 
investigating about possible peripheral biomarkers in the bipolar disorder and 
in the conceptualization of this disorder into a model of staging. In the study of 
these last two areas, she spent 6 months in the Bipolar Disorder Program and 
Laboratory of Molecular Psychiatry of Porto Alegre, Brazil directed by Professor 
Flávio Kapczinski. Dr. Grande has been speaker, moderator and has presented 
oral communications and posters in national and international congresses. 
She has published 18 articles and is reviewer in international journals. In 2011 
she received the international  Lilly Young Investigator Fellowship in Bipolar 
Disorder Award from the International Society of Bipolar Disorder (ISBD).
SUMMARY PROJECT:
LONGITUDINAL CHANGES IN SERUM BRAIN-DERIVED NEUROTROPHIC FACTOR 
DURING TREATMENT OF MOOD EPISODES IN MEDICATION-FREE PATIENTS WITH 
BIPOLAR DISORDER
Iria Grande1, Pedro VS Magalhães2, Laura Stertz2, Gabriel Fries2, Eduard Vieta1, 
Flávio Kapczinski2
1 Bipolar Disorders Unit,  Clinical Institute of Neurosciences,  Hospital Clínic, 
University of Barcelona, IDIBAPS, CIBERSAM, Barcelona, Spain.
2 Bipolar Disorder Program and Laboratory of Molecular Psychiatry, National 
Institute for Translational Medicine, INCT-TM Hospital de Clínicas de Porto 
Alegre, Federal University of Rio Grande do Sul, Porto Alegre, Brazil.
Synaptic plasticity and resilience are increasingly recognized as being part of 
a dimension of paramount importance in mood disorders. Neurotrophins are 
key regulators of pathways influencing neuronal survival, and a neurotrophic 
model of mood disorders has been actively investigated in the last decade. 
Brainderived neurotrophic factor (BDNF) has enjoyed particular prominence, 
mediating neural processes involved in synaptic efficacy and neuroplasticity 
and  has been put forward as a potential marker of treatment response in 
bipolar disorder (BD). In the present 16-week naturalistic, open-label clinical 
trial study, we prospectively investigate the associations of serum BDNF 
levels and the BDNF  VAL66METpolymorphism with clinical response. One 
hundred and twenty eight subjects were enrolled in this study. Sixty-four 
medication-free  bipolar patients in acute mood episode (19 manic, 16 mixed, 
29 depressed) according to SCID-I were matched for age, gender and ethnicity 
with 64 healthy controls. Patients had their mood and functional assessments 
(YMRS, HDRS-21, CGI and GAF) and serum samples obtained at baseline and 
weeks 2, 4, 8 and 16. Serum BDNF levels were measured with sandwich-ELISA, 
using a commercial kit (Millipore, Temecula, USA). The genotyping of the BDNF 
VAL66MET SNP polymorphism was performed using a 5’nuclease TaqMan allelic 
discrimination assay on the 7500 Real-Time PCR Systems (Applied Biosystems, 
Carlsbad, USA).  Mixed models were used to investigate longitudinal changes 
in serum BDNF.  We did not find  differences in serum BDNF levels or in the 
VAL66METpolymorphism between patients and controls.  The multivariable 
model showed lower BDNF levels in patients with the  VAL66MET genotype 
and higher BDNF levels for those achieving remission. These results  suggest 
that serum BDNF levels during the acute mood episode could be associated 
with treatment response in BD and further adds to the literature that BDNF 
levels may be a useful biomarker of treatment response in BD.
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I completed my Bachelor’s Degree in Psychology in 2006 at the Faculty of 
Psychology of the University Complutense of Madrid. Two years later I started 
to work at the Hospital Clinico San Carlos of Madrid where I have been working 
for 6 years as a Psychologist Researcher. I have been involved in more than 
7 European and national research projects since then and granted by the 
Ministry of Education, the Ministry of Health and other national and private 
bodies in order to continue my training and work. Some of my tasks in the 
hospital are the following: projects writing, scientific papers’ writing, clinical 
and neuropsychological assessment of patients, European projects’ updates, 
translation of scientific documents… and others.  
Simultaneously, I have my own private Psychology consultation from 2006 
(Compass Psicologia) where clinical consultation and training are offered. I 
am a tutor of the Master of the Spanish Association  of Cognitive-Behavioral 
Psychology and provide training in the private field. Currently I am a member 
of the CIBERSAM (Network of Mental Health Research in Spain) and I work with 
Borderline Personality Disordersand their impulsive behaviors and how those 
behaviors and symptoms may affect to the cognitive skills of the patients. I 
am currently attending an International Master in Affective Neuroscience in 
Florence and Holland. Furthermore, I am currently performing my  PhD at the 
Faculty of Medicine in the University Complutense of Madrid about the Feeling 
of Emptiness in Borderline Personality Disorders.  
I can speak fluently French, Italian and English besides the Spanish (my mother 
tongue) and I have the Simultaneous Interpretation Degree and the Higher 
Official Degree in French.  
SUMMARY PROJECT:
A STUDY OF THE EFECTIVENESS OF NEUROCOGNITIVE REHABILITATION IN 
BORDERLINE PERSONALITY DISORDER
Objectives: To investigate the efectiveness of a neurocognitive rehabilitation 
program in borderline personality disorder, a severe mental disorder with 
intense functional impairment. Effects in cognitive functioning as well as in 
clinical symptoms and in psicosocial functioning will be evaluated. 
Design: Six-month, multicentric randomized study (3 centers) with two branches 
of treatment, blinded for clinical raters. One branch of 21 group weekly sessions of 
neurocognitive rehabilitation program. The second branch of treatment as usual, 
including medication and nonspecific psychological support. 
Sample: Patients with Borderline Personality Disorder according to DSM-IV 
TR criteria, ranging from 18 to 45 years old, without schizophrenic or mood 
comorbid disorders, substance dependence disorder and IQ > 85. Medication is 
allowed according to clinical criteria. A sample of 70 patients (35 per branch) has 
been estimated for statistical significance. 
Ratings: Clinical variables: 1. Severity with specific CGI-BPD, 2. Overt Aggression 
Scale (OAS) for aggressive behaviors, 3. Barrat Impulsiveness Scale (BSI) for 
impulsive behaviors. Global functioning: 1. Personal and Social Performance 
Scale (PSP) for psicosocial functioning and 2. WHODAS-II for quality of life. 
Neuropsychological evaluation: Set of tests for detection of dysfunctions of 
memory, working memory, flexibility, inhibitory control and executive functions. 
Blinded clinical ratings at baseline, every month of treatment, at end-point and 
six month after discontinuation. 
Statistics: Multivariate ANOVA and Chi-square for distribution of continuous and 
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BIO SKETCH:
My name is Viktoria Johansson and I live in Stockholm, Sweden. I have been 
working as an MD in the field ofpsychiatry in Sweden since 2001. In 2007 I 
started as a data collector in a Swedish twin study at the Department ofMedical 
Epidemiology and Biostatistics, Karolinska Institutet (PI Prof. Christina Hultman), 
examining twin-pairs withbipolar disorder and schizophrenia. I then became 
interested in research and I was involved in a project looking at biomarkers 
of the CSF in twins with bipolar disorder and schizophrenia. Since 2010 I am 
working with my own PhD project with Professor Christina Hultman as my 
main supervisor and Mikael Landén and Lennart Wetterberg as cosupervisors. 
We have collected a unique material of CSF from twin pairs with schizophrenia 
and bipolar disorder where biomarker discovery is one of our aims. The project 
has led to two publications. I am also working with a register study looking at 
the comorbidity of multiple sclerosis and psychiatric disorders (bipolar disorder 
and schizophrenia). Studying the environmental and genetic relation between 
psychiatric disorders and multiple sclerosis may provide support for and develop 
the immuno-hypothesis of schizophrenia and bipolar disorder. Publications:
Johansson V, Nybom R, Wetterberg L, Hultman CM, Cannon TD, Johansson 
AG, Ekman CJ, Landén M. Microscopic particles in two fractions of fresh 
cerebrospinal fluid in twins with schizophrenia or bipolar disorder and in healthy 
controls. PLoS One. 2012;7(9):e45994. doi: 10.1371/journal.pone.0045994. Epub 
2012 Sep 25.
Mobarrez F, Nybom R, Johansson V, Hultman CM, Wallén H, Landén M, 
Wetterberg L. Microparticles and microscopic structures in three fractions of 
fresh cerebrospinal fluid in schizophrenia: Case report of twins. Schizophr Res. 
2012 Nov 19. pii: S0920-9964(12)00604-4. doi: 10.1016/j.schres.2012.10.030.
SUMMARY PROJECT:
Psychotic disorders represent major public health concerns as current treatments 
are limited and palliative, with significant side effect burden, poor adherence and 
lack of vulnerability markers. The main objective of my project is to 1) identify 
biological markers for schizophrenia and bipolar disorder in a clinical setting and 
to 2) study the pattern ofgenetics and comorbidity between schizophrenia, bipolar 
disorder and multiple sclerosis in an epidemiological setting.
1) We have examined micrometer-sized particles in cerebrospinal fluid (CSF) of 
twins and controls with schizophrenia, schizoaffective and bipolar disorder. We 
have found microscopic particles in the CSF of twins affected with schizophrenia 
and bipolar disorder. Also we have found that particles are more common in 
the non-affected co-twin1. Our next step is to analyze markers of microglia and 
inflammation (kynurenic acid and cytokines) in our sample and our goal is to 
identify diagnostic biomarkers as in the field of neurology.
2) In multiple sclerosis several biomarkers have been identified. By studying the 
presence of comorbidity between schizophrenia, bipolar disorder and multiple 
sclerosis as well as the genetic relationship by studying first degree relatives 
using the national health care registers of Sweden, we are able to decide the 
focus of a targeted biomarker discovery. Sweden has nation-wide registers of 
hospital treatment since 1973 and outpatient treatment from 2001 with high 
diagnostic validity. The total population in Sweden is about 9 million individuals 
and we have identified 25000 individuals with schizophrenia, 33000 individuals 
with Bipolar disorder and 17000 individuals with multiple sclerosis. We have 
preliminary results ready to be presented.
1 Johansson V, Nybom R, Wetterberg L, Hultman CM, Cannon TD, Johansson AG, 
Ekman CJ, Landén M. Microscopicparticles in two fractions of fresh cerebrospinal 
fluid in twins with schizophrenia or bipolar disorder and in healthy controls. PLoS 
One. 2012;7(9):e45994. doi: 10.1371/journal.pone.0045994. Epub 2012 Sep 25.
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Ayşe Burcu Ayaz is working as a medical doctor in Sakarya University Training 
and Research Hospital, Child and Adolescent Psychiatry Clinic. She had 
participated in Cognitive Behavioral Therapy and Play Therapy in her residency 
and her area of interest is social problems in children with ADHD. She has been 
a member of Turkish Association of Child and Adolescent Psychiatry. To date, 
she has authored or co-authored seven publications in refereed journals.
SUMMARY PROJECT:
OXYTOCIN RECEPTOR GENE POLYMORPHISMS IN ATTENTION-DEFICIT/ 
HYPERACTIVITY DISORDER
Oxytocin  (OXT) system is defined in many of the regulating systems that 
investigate behavioral models. It has been suggested that intranasal OXT 
administration increases social behaviors, and has theraupatic potential for 
the treatment of a number of psychological disorders (Guastella and MacLeod 
2012). There are studies reporting that genetic variations in OXTR gene may lead 
to susceptibility to autism. Wu et al. (2005) investigated 4 single nucleotide 
polymorphisms (SNP) in a Chinese sample diagnosed with autism and found 
a relation with rs2254298 and rs53576 SNP’s in intron 3. In a recent case 
control study, Liu et al. (2010) found evidence of a relation between autism 
spectrum disorders and rs2254298/rs2268491 in a Japanese sample. In a study, 
consistent with the studies of Wu et al. (2005), many haplotype transmissions 
were detected containing “A” allele of rs53576 (Wermter et al.2010). Although 
the relation between social dysfunctioning and autism is a much adressed 
issue, there are few studies investigating the potential relation between OXT 
system and ADHD. In a twin study, Ronald et al.  (2008) reported that the 
correlation of phenotypic temperamental characteristics in autism and ADHD 
may be explained by genetic factors at the rates of  %72 and  %96, respectively. 
In our study, we planned to investigate the relation between some TNPs in 
OXTR gene (rs53576, rs13316193,and rs 2268493) and social dysfunctioning in 
ADHD and compare them with those in healthy controls.  Children participating 
in the study will be diagnosed using Turkish version of Schedule for affective 
disorders and Schizophrenia for school age children-present and lifetime 
version   (K-SADS). The parents will be administered sociodemographic form, 
and Social Reciprocity Scale (SRC) for the evaluation of social reciprocity skill. 
1. Guastella AJ, MacLeod C. A critical review of the influence of oxytocin nasal 
spray on social cognition in humans: Evidence and future directions, Horm. 
Behav. (2012), doi:10.1016/j.yhbeh.2012.01.002
2. Liu X, Kawamura Y, Shimada T, Otowa T, Koishi S, Sugiyama T, et al. 
Association of the oxytocin receptor (OXTR) gene polymorphisms with autism 
spectrum disorder (ASD) in the Japanese population. J Hum Genet 2010, 
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doi:10.1038/jhg.2009.140.
3. Ronald A, Simonoff E, Kuntsi J, Asherson P, Plomin R. Evidence for overlapping 
genetic influences on autistic and ADHD behaviours in a community twin 
sample. J Child Psychol Psychiatry 2008;49:535–42.
4. Wermter AK, Kamp-Becker I, Hesse P, Schulte-Körne G, Strauch K, Remschmidt 
H. Evidence for the involvement of genetic variation  in the oxytocin receptor 
gene (OXTR) in the etiology of autistic disorders on high-functioning level. Am 
J Med Genet B Neuropsychiatr Genet 2010; 153B(2):629–39.
5. Wu S, Jia M, Ruan Y, Liu J, Guo Y, Shuang M, et al. Positive association of 
the oxytocin receptor gene (OXTR) with autism in the Chinese Han population. 
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BIO SKETCH:
Seheryeli Yılmaz is currently a 3rd year resident in Child and Adolescent 
Psychiatry Department in Marmara University, Faculty of Medicine. She got 
her medical degree in İstanbul University, Faculty of Medicine in 2008. She 
spent 6 months as a research fellow in Harvard University, McLean Hospital 
on first episode bipolar and schizophrenia patients. She has been a member 
of Turkish Medical Association and Turkish Psychiatric Association. To date, she 
has authored or co-authored six poster presentations.
SUMMARY PROJECT:
THE CHARACTERISTICS OF ADOLESCENT MOTHERS’ ATTACHMENT STYLE AND 
THEIR OFFSPRINGS’ DEVELOPMENT
Seheryeli YILMAZ1, Yankı YAZGAN2 
1.MD, Marmara University, Marmara University Faculty of Medicine, Child and 
Adolescent Psychiatry Department, Istanbul, Turkey 
2.MD, Professor, Marmara University, Marmara University Faculty of Medicine, 
Child and Adolescent Psychiatry Department, Istanbul, Turkey; Asst Prof (Adj), 
Yale Child Study Center, New Haven, CT
Teen pregnancy is an increasing issue of concern in society. It has negative 
outcomes both on mother and the infant. In Turkey, not many studies have 
been conducted regarding prevalence or psychosocial and developmental 
consequences of teen pregnancies on the mother’s and infant’s development. 
Knowledge about teen pregnancy frequency and the role of Turkish culture on 
negative outcomes of adolescent pregnancies is scarce among Turkish youth 
population. This project aims to detect and identify adolescent mothers in a 
university hospital’s catchment area, assess their mental health (in terms 
of the presence of a mental disorder and attachment styles), assess their 
children’s developmental level, and identify any possible relationship between 
these variables. The district has both semi-rural and urban sites, and attracts 
waves of internal immigrants from the other cities. Findings are intended to 
inform strategies for community-based programs to assist teenage mothers’ 
knowledge and competence in child development, so they can meet their 
children’s developmental needs (age appropriate), and provide the psychosocial 
base for a secure attachment and optimal parenting. The ultimate aim of 
this preventive approach is improving health and mental health outcomes 
for young women and their children; improving women’s use of community 
services, informal social support and health habits (Olds et al., 1986). This study 
will generate important information to develop a home based intervention to 
help the teenage mothers.
Nataliya zHabeNKo
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Postdoctoral student, State 
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Lugansk, Ukraine
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BIO SKETCH:
Nataliya Zhabenko, M.D., is a Ph.D student at the State Establishment “The 
Lugansk state medical university”, Ukraine. She received her MD in 2006, she 
completed her residency in psychiatry in 2008. She also completed a year of 
research addiction training in the United States, she has been a Fogarty Research 
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Fellow at the Substance Abuse Section at the University of Michigan (2010-
2011). Her research interests focus on psychiatric aspects of HIV, addictions and 
insomnia. Nataliya Zhabenko has authored and coauthored two peer-reviewed 
papers in the international journals, and greater then 15 publications in the 
national journals, 11 scientific presentations, invited presentations, and posters. 
SUMMARY PROJECT:
ATTITUDES TOWARD PEOPLE WITH HIV OR AIDS
AIDS is one of diseases that has been stigmatized since its development, 
stigmatization of people living with HIV is an important barrier to using HIV 
testing and treatment. Stigma and discrimination can occur at all levels of a 
person’s daily life and can be associated with different health-related problems. 
Ukraine is a country with one of the highest number of annual HIV infections. 
The goal of this study was to evaluate medical practitioners’ and nonmedical 
specialists’ attitude toward people with HIV/AIDS. Acceptance of people who 
have AIDS or are infected with HIV was assessed with the help of the “Attitudes 
toward people with HIV or AIDS”. Total scores range from 50 to 10, higher scores 
indicate high acceptance of persons with HIV/AIDS. A total of 180 individuals 
participated in the study. Younger participants reported higher acceptance of 
persons with HIV or AIDS (p<.05). Females and males did not differ in terms 
of attitudes toward people living with HIV/AIDS (p>.05). Medical practitioners 
showed greater total score, compare to nonmedical specialists (38.0 ± 6.0 
vs. 34.0 ± 5.5, respectively, p<.05). There was not a statistically significant 
difference at the level in total score for surgeons,  therapists, psychiatrists 
and students. In conclusion, young age and having medical education were 
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BIO SKETCH:
Matthew graduated from the University of Glasgow before moving to 
Cambridge to pursue an MPhil in Epidemiology. During his masters he 
started working on the 10/66 study with Prof Martin Prince at the Institute 
of Psychiatry, a collaboration that is still ongoing. He has recently submitted 
and defended his Doctoral thesis at Pembroke College, University of Cambridge, 
titled “An investigation of common mental disorders and health services 
in later life’ under the supervision of Prof. Carol Brayne and Dr. Tom Dening. 
He is currently based at the Institute of Public Health in Cambridge, but he 
collaborates with institutions in Africa, South America, Australia and Europe. 
Matthew is particularly interested in large epidemiological studies that look at 
mental health in older age, and he has been involved in several projects using 
large international cohorts of ageing  such as the UK MRC Cognitive Function 
and Ageing Studies (CFAS), the Australian Longitudinal Assessment of Ageing 
in Women (LAW) Study, the Longitudinal Aging Study Amsterdam (LASA), the 
Health in Men Study (HIMS) and the 10/66.
SUMMARY PROJECT:
Background: Studies that have investigated the relation between depression 
and the type, nature, extent and outcome of general hospital admissions 
have been limited by their retrospective designs and focus on specific clinical 
populations. We explored this relation prospectively in a large, community-
based sample of older men.
Methods: A cohort of 5411 men aged 69 years and older enrolled in the Health 
in Men Study was assessed at baseline for depressive symptoms, defined as a 
score of 7 or higher on the 15-item Geriatric Depression Scale. Participants were 
followed for 2 years for occurrence and number of hospital admissions, type of 
hospital admission, length of hospital stay and inpatient death as recorded in 
the Western Australian Data Linkage System.
Results: Of 339 men with depressive symptoms, 152 (44.8%) had at least 
1 emergency hospital admission, compared with 1164 of 5072 (22.9%) 
nondepressed men (p < 0.001). In multivariate analyses, the presence of 
depressive symptoms was a significant independent predictor of hospital 
admission (hazard ratio 1.67, 95% confidence interval [CI] 1.38–2.01), number 
of hospital admissions (incidence rate ratio [IRR] 1.22, 95% CI 1.07– 1.39) and 
total length of hospital stay (IRR 1.65, 95% CI 1.36–2.01).
Interpretation: Participants with depressive symptoms were at higher risk 
of hospital admission for non-psychiatric conditions and were more likely to 
have longer hospital stays and worse hospital outcomes, compared with non-
depressed participants. These results highlight the potential to target this high-
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BIO SKETCH:
My name is Peter Musiat and I am currently working as a postdoctoral researcher 
at the Institute of Psychiatry, King’s College London. After studying psychology 
in Dresden, Germany, I relocated to the UK to start my PhD at the Institute of 
Psychiatry. During this PhD at the Eating Disorders Section of the Institute, I 
developed and evaluated a trait-focused, web-based prevention programme 
for common mental disorders in students (supervision Prof. Ulrike Schmidt). The 
aim of this project was to develop a transdiagnostic intervention that focuses 
on shared risk factors of common mental disorders, such as depression, anxiety, 
substance abuse or eating disorders. The results will contribute to numerous 
papers, some of which have been published or are under review. During my 
time as a PhD student I have also worked clinically as an honorary therapist 
at the Maudsley Hospital Eating Disorders outpatient service and I currently 
lead weekly self-help group session for students with an eating disorder. Given 
my strong interest in e-mental health, self-help fand prevention, I started a 
postdoctoral research position at the Institute of Psychiatry aiming to promote 
and facilitate e-health research at King’s College London. 
SUMMARY PROJECT:
PREVENTION OF COMMON MENTAL HEALTH PROBLEMS IN UNIVERSITY 
STUDENTS; RCT OF A TRANSDIAGNOSTIC TRAIT-FOCUSED WEB-BASED 
PREVENTION PROGRAM
Objective: To evaluate the efficacy of a transdiagnostic trait-focused web-based 
intervention aimed at  preventing common mental disorders (depression, 
anxiety, substance misuse disorders and eating disorders)  in university 
students.  Method: Participating students recruited online (n = 1047, age: M 
=21.8, SD = 4.2) were categorized into  those at high or low risk of mental 
disorder based on their personality traits. Students were randomly  allocated 
to either a cognitive-behavioral trait-focused (n = 519) or an active control 
intervention (n = 528).  Both interventions were fully automated and delivered 
online. Outcomes were self-assessed at baseline as  well as at 6 weeks and 
12 weeks after the intervention. The primary outcomes were symptoms of 
depression  and anxiety, assessed on the Patient Health Questionnaire and 
Generalized Anxiety Disorder Scale. A range  of secondary outcome measures 
focused on alcohol and substance use, disordered eating, and other  outcomes. 
Results: Students at high risk were successfully identified using personality 
indicators and reported poorer  mental health than students at low risk. Mixed 
effects analyses (intention to treat) revealed that the traitfocused  intervention 
reduced depression and anxiety, particularly in students at high risk and 
these  improvements were clinically significant. In addition, self-esteem and 
psychological health were improved.  No changes were observed regarding the 
use of alcohol or disordered eating and attrition was high (62%).  Conclusions: 
This study provides preliminary support for the efficacy of a transdiagnostic web-
based  intervention for university students targeting underlying personality risk 
factors as an efficient way of  preventing common mental disorders.  
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BIO SKETCH:
For my undergraduate studies I completed a BSc (Hons) in Neuroscience at King’s 
College London (2005-2008). The course’s main focus was on the functioning 
of the human central nervous system in both normal physiological, and also 
pathophysiological, states investigated both at the cellular and systems level. 
In my final year I specialized in cognitive neuropsychology for which I produced 
a dissertation investigating the differential effects of Schizophrenia associated 
genotypes on neural activation in adolescents during the ‘GoNoGo’ paradigm. 
Subsequently, between 2009-2012, I undertook a PhD with Dr Andrea Mechelli 
at the Institute of Psychiatry, King’s College London, again focusing on the 
neuroimaging of psychosis. Specifically, the focus of my doctoral work was to 
investigate whether those who had experienced a first episode of psychosis, 
and those thought to be at increased risk of developing psychosis in the near 
future, could be differentiated from control subjects, and/or each other, at the 
level of the individual, using either genetic, neuroimaging, and/or cognitive 
data in conjunction with multivariate machine learning analysis, and whether 
the capacity for this differentiation might be enhanced through the integration 
of different data types.
SUMMARY PROJECT:
NUMEROUS STUDIES REPORT SIGNIFICANT BIOLOGICAL AND COGNITIVE 
ALTERATIONS IN CHRONIC SCHIZOPHRENIA (CHSZ) PATIENTS RELATIVE TO 
HEALTHY CONTROLS (HCS)
More recently, similar, albeit less severe, changes have been reported in 
subjects with a recent first episode of psychosis (FEP), and those at clinical 
high-risk, referred to as the at-risk mental state (ARMS). The clinical impact 
of such findings has been limited, however, driven in part by the univariate 
analyses employed by the majority of studies, which allow inference at the 
group level only. Support vector machine (SVM) is one alternative multivariate 
analysis, which, able to provide inference at individual level, has high potential 
for translation into a clinical setting. Here, we employed a multimodal approach 
comprising genetic, structural magnetic resonance imaging (sMRI), diffusion 
tensor imaging, functional MRI, and cognitive data, in order to investigate the 
capacity of each modality to distinguish FEP and ARMS subjects from HCs, and 
each other, both at the group, and the single-subject level, using standard 
univariate and multivariate SVM analyses respectively. Since the clinical 
potential of SVM is ultimately governed by its classification accuracy, we also 
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performed an empirical comparison of four integrative methods, proposed to 
enhance classification through data integration. Collectively, the results provide 
relative support to the notion that FEP and the ARMS may be characterised 
by genetic, neuroanatomical, neurofunctional and/or cognitive alterations 
similar to those previously observed in ChSz, albeit less severe. With respect 
to neuroanatomy, and neurofunction moreover, they suggest such changes 
may be both subtle, and spatially diffuse. The achievement of only modest 
classification accuracies, however, suggest that the modalities investigated 
here have only limited diagnostic power with respect to early-stage psychosis, 
though it remains that they may be able to provide useful information for 
predicting conversion to psychosis or treatment outcome, a prospect which 
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Rohan is a clinical psychologist with a range of both research and clinical 
experience. He has worked in several community health settings in Australia and 
Canada, in addition to a variety of rehabilitation agencies and as a psychologist 
within the Australian prison system. After completing his doctorate in clinical 
psychology in Australia in 2005, Rohan worked as a researcher at the Institute 
of Health Promotion Research in Vancouver in 2005-06, before joining St 
George’s University of London as a Research Fellow in 2006 and the Institute 
of Psychiatry in 2008. Rohan is currently working on two studies; the first 
is his current PhD study, which is a Medical Research Council-funded RCT 
investigating the impact of joint crisis plans (JCPs) on self-harm behavior in 
outpatients diagnosed with borderline personality disorder. The second study 
is investigating the prevalence of violence and victimisation amongst those in 
the community who suffer from mental health problems.
SUMMARY PROJECT:
JOINT CRISIS PLANS (JCPS) FOR PEOPLE WITH BORDERLINE PERSONALITY 
DISORDER WHO HAVE SELF-HARMED
Background: People with borderline personality disorder (BPD) frequently 
experience crises, resulting in episodes of self-harm. To date, no randomised 
controlled trials of crisis interventions for this population have been published. 
Aims: To examine the feasibility of recruiting and retaining a sample of adults 
with BPD to a pilot randomised controlled trial investigating the potential 
efficacy and cost-effectiveness of using a joint crisis plan to reduce self-harming 
behaviour. Methods: A randomised controlled trial of joint crisis plans for 
community-dwelling adults meeting DSM-IV  criteria for BPD was conducted. 
The primary outcome measure was the occurrence of self-harming  behaviour 
over the six-month period following randomisation. Secondary outcomes 
included depression, anxiety, engagement and satisfaction with services, 
quality of life, well-being and cost-effectiveness.  Results:  Eighty-eight adults 
out of the 133 referred were eligible, provided written informed consent and 
were randomised to receive a joint crisis plan in addition to treatment-as-usual 
(TAU; N = 46) or TAU alone (N=42). This represented approximately 75% 
of our target sample size and follow-up data were collected on 73 (83.0%) 
participants. Intention-to-treat analysis revealed no significant differences 
in the proportion of participants who reported self-harming (odds ratio: 1.9, 
95%CI: .9, 0.53 - 6.5; p=0.33) or the frequency of self-harming behaviour (rate 
ratio: 0.74, 95%CI: 0.4 - 1.63; p=0.46) between the two groups at follow-up. 
No significant differences were observed between the two groups on any of the 
secondary outcome measures or costs. Conclusions: Whilst is feasible to recruit 
and retain people with BPD to a trial of joint crisis plans and the intervention 
appears to have high face validity with this population, we found no evidence 
of clinical efficacy in this feasibility study.  
This trial was supported by a Medical Research Council (MRC) trial platform 
grant (ID: 85397) in the UK and conducted through the Institute of Psychiatry 
at King’s College London, United Kingdom
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BIO SKETCH:
Dr. Evans-Lacko is a Lecturer at King’s College London, Institute of Psychiatry 
(IoP) and also a Visiting Professor at Mackenzie University in Sao Paulo, Brazil. 
She has a particular interest in the role of health services and social support in 
the prevention and treatment of mental illness. Her future research plans are to 
advance innovative methods to improve access to and quality of mental health 
care for young people and cross-cultural applications of this. She also works 
on the evaluation of public health interventions such as England’s Time to 
Change anti-stigma campaign which aim to improve important changes at the 
population level. Prior to joining the IoP, she worked as a health care consultant 
for the National Institute of Mental Health (NIMH, USA). She has an M.H.S. in 
psychiatric epidemiology and PhD in Health Policy and Management, from the 
Johns Hopkins Bloomberg School of Public Health where she had a fellowship 
in child, adolescent and family health services and systems research. To date 
she has authored or co-authored more than 30 peer reviewed publications.
SUMMARY PROJECT:
IMPROVING ADOLESCENT ENGAGEMENT WITH MENTAL HEALTH CARE – 
LEARNING FROM PATTERNS OF FORMAL AND INFORMAL CARE
The aim of this research is to produce a body of evidence that illustrates how 
young people with mental health problems currently interact with both formal 
mental health services and informal social and familial support structures. 
Careful analysis of data gathered from a community cohort of young people 
will allow the formulation of relevant insights into mental health and social 
care delivery for this vulnerable group of individuals, which will be presented 
as a resource for future health and social care service design and policy making. 
Whilst standard analysis has allowed for snapshots of health service use, using 
innovative sequencing and cluster analysis methods we will characterise 
each individual participant’s experience of accessing formal mental health 
care and informal social support. This ground-breaking and interdisciplinary 
combination of research methodologies will broaden the yield of our data and 
provide a far greater depth of analysis.  For the proposed project, I will conduct 
analyses using quantitative survey data, medical records and qualitative 
interview data from an existing community cohort of young people. In addition 
to investigating predictors of care pattern variation and associated outcomes 
(e.g., mental health functioning, likelihood of serious psychiatric disorder 
during late adolescence and / or adulthood, emergency inpatient or forensic 
service use, substance abuse and school achievement), I will also perform 
economic evaluation of the impact of improving initial access or continuity 
of care. Longitudinal data on care patterns and mental health will allow for 
investigation of short and medium term impact. Simulation modeling of 
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I have been working at London’s leading research centre  – the NIHR  Biomedical 
Research Centre Nucleus - for the last three years as a CRIS system administrator. 
My interests have largely evolved around youth mental health in developing 
countries and under – served populations here in the United Kingdom. I have 
worked on  various research projects with the aim to contribute to the literature 
on mental health among youth and refugees. I undertook a Masters to obtain 
a formal qualification in Psychiatric Epidemiology and I am currently leading 
on a systematic review on youth suicides in Asia for which I was awarded 
the prestigious BRC Travel Fellowship in 2011 to present preliminary results 
a the International Association of Suicide Prevention in China. My interest in 
this particular project arose from secondary data analysis we conducted on a 
youth sample from Goa in India. This project offers a chance to explore the 
effects of an intervention for a group of people that are potentially restricted 
by society to not disclose traumatic and very stigmatizing experiences. We can 
better modify, improve or facilitate the access to services to such individuals 
depending on the results of this intervention.
Publications:
Fernandes A, Hayes RD, Patel V. Abuse and other correlates of common mental 
disorders in youth: a cross-sectional study in Goa, India. Social Psychiatry and 
Psychiatric Epidemiology, (Corresponding author Patel V, impact factor 2.97 in 
press 16 Oct 2012)
Fernandes A, Hayes RD, Patel V. Abuse and other correlates of common mental 
disorders in youth: a cross-sectional study in Goa, India. Social Psychiatry and 
Psychiatric Epidemiology, (Corresponding author Patel V, impact factor 2.97 in 
press 16 Oct 2012)
Hayes RD, Chang C-K, Fernandes AC, Begum, A, To D, Broadbent M, Hotopf M, 
Stewart R. Functional status and allcause mortality in serious mental illness 
PloS ONE 2012 (Corresponding author Hayes RD , Impact Factor:4.41, in press 
iNterNacioNal StUdeNtS of 
tHe y-MiNd adVaNced ScieNce ScHool
56
August 6, 2012)
Hayes RD,  Chang C-K,  Fernandes A, Begum, A, To D, Broadbent M, Hotopf 
M, Stewart R. Associations between symptoms and all-cause mortality in 
individuals with serious mental illness. Journal of Psychosomatic Research.2012, 
72(2), 114-119 (Corresponding author Hayes RD,impact factor 2.84)
Hayes RD, Chang C-K, Fernandes A, Broadbent M, Lee W, Hotopf M, Stewart R. 
Associations between substance use disorder sub-groups, life expectancy and 
all-cause mortality in a large British specialist mental healthcare service. Drug 
and Alcohol Dependence 2011, 118, 56– 61 (Corresponding author: Hayes RD, 
Impact Factor:3.37, Citations:2)
Chang C-K, Hayes RD, Perera G, Broadbent MTM, Fernandes AC, Lee WE, Hotopf 
M, and Stewart R. Life expectancy at birth for people with serious mental illness 
from a secondary mental health care case register in London, UK PloS ONE 2011 
6(5) (Corresponding author: Chang C-K, Impact Factor:4.41, Citations: 3)
Chang CK, Hayes RD, Broadbent M,  Fernandes A, Lee W, Hotopf M Stewart RAll-
cause Mortality among People with Serious Mental Illness (SMI), Substance Use 
Disorders, and Depressive Disorders in Southeast London: a cohort study. BMC 
Psychiatry volume 10, September 24, 2010. (Corresponding author: Chang CK, 
Impact Factor: 2.89, Citations:10)
SUMMARY PROJECT:
THE ACCEPTABILITY, FEASIBILITY AND EFFECTIVENESS OF AN ANONYMOUS 
TELEPHONE PSYCHOTHERAPY COUNSELING SERVICE FOR MALE VICTIMS OF 
PHYSICAL AND SEXUAL ABUSE IN THE COMMUNITY – A GENDER-SENSITIVE 
APPROACH TO HELPING MALE VICTIMS OF ABUSE
In recent times, with the spate of disclosed cases of male victims of abuse, it 
is acknowledged that there are not enough treatment options or interventions 
adapted towards helping male victims relative to female victims. The aim, 
hence, of this intervention is to determine the feasibility, acceptability and 
effectiveness of an anonymous telephone psychotherapy counseling service 
for male victims of physical and sexual abuse in the community using an 
exploratory randomized controlled trial. Set in the Indian capital state of Delhi, 
within metropolitan urban, rural and slum  community populations, two 
urban communities will be (as similar to each other as possible to account for 
confounding) would be randomly selected.  The telephone counseling service 
will be provided in one of the communities. Male individuals in community 
aged between 18 to 24 years old.  The intervention will consist of five trained 
psychotherapists, who have attended training in gender-specific therapy for 
abuse victims. They will be set up in a hotline centre available 9 to 5pm. For out 
of hours contact a voicemail service will set up to ask caller to leave a set date 
and time for therapists to contact them. The voicemail will inform caller that 
they are not obliged to answer the call when therapists do get in touch in the 
event they change their mind. In addition, no caller ID will be installed and the 
caller will be informed of this as well. Based on  and recommendations from Tsui 
et al  standard psychotherapy procedures will be used as counseling for those 
contacting the anonymous hotline.  The same households will be approached 
at follow up and only  Measure prevalence and depression and anxiety using 
the same questionnaire.  We hypothesise, compared to no intervention group, 
intervention group will have significantly improved outcomes on depression, 
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After training for three years in the Medical School of Hanover, I obtained a 
BA(Hons) in Psychology in Deree College, The American College of Greece. Next, 
I completed a MSc in Health Psychology in the University College of London 
(UCL), whereby I received a distinction for my work on personality clusters and 
the health related quality of life of patients with Non-Epileptic Attack Disorder. 
I joined Prof. Frangou’s Group in the section of Psychosis Studies in the Institute 
of Psychiatry, King’s College London in January 2010 and I am currently 
finalizing my PhD in the area of psychiatric epidemiology. Initial results of the 
PhD have been published in high impact peer-reviewed journals and I have 
been offered travel awards to present the results in key meetings including the 
Society of Biological Psychiatry (SOBP) meeting in 2012 in Philadelphia, PA, 
USA. Concurrently, I am the leading academic tutor for postgraduate students 
and I am involved as a research fellow in an international EU funded project. 
My main research interests include the pathogenesis and the developmental 
progression of bipolar disorder as well as the statistical modeling and advanced 
analytical techniques for longitudinal study designs. My current work involves 
the examination of the interplay of familial and non-familial risk factors with 
syndromal and subsyndromal manic symptomatology trajectories during 
childhood, adolescence and early adulthood.
SUMMARY PROJECT:
Much of the disability associated with Bipolar Disorder (BD) is linked to the 
early onset of the disorder. Therefore, it is important to identify individuals at 
high risk for BD as early as possible, as this may allow for early intervention and 
reduced burden. This presentation will focus on our recent study that aimed 
to examine the longitudinal relationship between parental reports of manic-
like symptomatology in childhood and manic disorder in early adulthood in a 
representative community sample of children and adolescents. 
We analyzed data from TRAILS (TRacking Adolescents’ Individual Lives 
Survey), a prospective population-based study of 2,230 Dutch adolescents. 
Measurements of mania-like behavioral disturbance at age 11 were based on 
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the Child Behavior Checklist- Mania Scale (CBCL-MS). Clinical assessments of 
mental disorders using the Composite International Diagnostic Interview (CIDI) 
were conducted at age 18 years. Forty-two cases meeting criteria for mania 
between ages 12 and 18 years were identified using the CIDI.   
A Latent Class Analysis (LCA) using the 19 items of the CBCL-MS as class indicators 
extracted three classes; a ‘low risk’ (n=856), a ‘moderate risk’ (n=838) and a 
‘high risk’ class (n=191) for BD.The risk for BD was 6.6-fold higher for children 
in the ‘high risk’ class (OR: 6.63, 95%CI 2.69-16.35) compared with the ‘low 
risk’ class. The high-risk class was also characterized by a confluence of familial 
and non-familial risk-factors. Age-11 subsyndromal mania-like behaviors 
predicted mania but not major depressive disorder, general anxiety disorder or 
substance abuse suggesting specificity of prediction to mania.  
These findings suggest a simple and reliable assessment of manic symptoms in 
childhood may provide means to identify children at ultra high risk to develop 
mania. As non-pathological phenotypic expression of manic-like behavior in 
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The goal of my research is to implement cognitive-behavioral treatment 
(CBT) and other evidence-based interventions for women’s mental health 
in resource-poor settings. I seek to do this through studying the following 
areas: 1) integrate CBT with primary and other medical care; 2) use of the 
internet and mobile technology to bolster effectiveness and improve patient 
adherence; and 3) investigate the role of poverty alleviation strategies.  The 
proposed research plan will allow me, as principal investigator, to target the 
first two goals.  My academic training and research experiences have given 
me an excellent background for this line of research.  I have significant global 
mental health experience. Under a Fulbright to Beijing, I worked with Dr. 
Michael R. Phillips in depression and suicide prevention in China’s rural areas 
and co-authored 3 papers from this work.  As an NIH/Fogarty International 
Clinical Research Scholar, I worked at a Cochrane Collaboration Center in 
Buenos Aires and published a systematic review on maternal health with my 
Argentine colleagues.  I also worked closely with Drs. Geoffrey Reed, Michael 
First, and Assen Jablensky at the WHO in Geneva on revisions for ICD-11.  At 
UCSF, I am examining how to use technology (e.g., Internet) to make mental 
health resources more accessible under Dr. Ricardo Muñoz. I recently launched 
a Chinese language, Internet-based mood and suicide screener to demonstrate 
proof-of-concept for this approach.
SUMMARY PROJECT:
This study will examine the use of a technology-enhanced cognitive-behavioral 
intervention “Mamás y Bebés” (eM&B) to prevent post-partum depression 
(PPD) in low-income, Spanish-speaking Latinas receiving their primary 
medical care at a large county hospital serving primarily underserved and 
uninsured populations. Eligible women will receive an evidence-based skills 
training aimed at stress management and half of the participants will be 
randomized to a eM&B to examine whether this improves application of skills 
and improvement in mood. We aim to 1) assess the feasibility of implementing 
a technologyenhanced CBT prevention (i.e., eM&B) in this population, 2) test 
whether the eM&B reduces depressive symptoms over time compared to 
regular cognitive-behavioral therapy (i.e., M&B) alone, and 3) for women who 
endorse symptoms of PTSD in both groups, test whether either intervention 
will improve symptoms of PTSD.  We expect that 1) participants in eM&B will 
report a significant reduction in depressive symptoms during the postpartum 
period when compared to participants in the usual M&B course, 2) participants 
with a high risk for developing a major depressive episode in the eM&B will 
report a lower rate of PPD during the follow-up period than participants with a 
high risk of MDE assigned to M&B, 3) for women who endorse PTSD symptoms, 
both eM&B and M&B will improve symptoms of PTSD from baseline to follow-
up in both groups.
lUcia MoNSerrat  
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BIO SKETCH:
I graduated with honors as a clinical psychologist from University of Buenos 
Aires (Argentina) in 2004. A year Later, I moved to the United Kingdom to study 
a MSc in Cognitive Neuropsychology at University College London. I worked on 
a research project examining the effects of top-down and bottom-up processes 
in auditory speech perception by applying an fMRI paradigm. Subsequently, 
I was appointed as a research assistant at the University of Bonn (Germany). 
There, I was involved a project about the correlation of functional language 
dominance and cortical structural measures in medial temporal lobe epilepsy. 
In 2008, I enrolled on a PhD program at Durham University (United Kingdom) 
and I completed my doctoral degree (PhD) in 2011. While working on my PhD 
thesis, I studied the neural underpinnings of emotional prosody processing in 
healthy controls as well as in the schizophrenia spectrum applying a diversity of 
techniques (fMRI, rTMS, behavioral measures, etc). This work led to five quality 
publications. After finishing my PhD, I moved to the USA for a postdoctoral 
fellowship in the Roskamp Lab. at the department of Psychiatry and 
Neuroscience of USF. Here I am continuing to learn about Transcranial Magnetic 
Stimulation and Deep Brain Stimulation, and their application as therapeutic 
tools in the treatment of substance abuse disorders. This research assesses the 
feasibility and effectiveness of targeting different nodes of the brain reward 
system to ameliorate cravings which has already led to a publication. 
I have presented my work in several international conferences, including three 
in which I was invited as a speaker. I am also an ad hoc reviewer for the journals 
Psychological Medicine, Schizophrenia Research and PlosOne, and an ad hoc 
grant reviewer for the Swiss National Science Foundation (SNSF).
SUMMARY PROJECT:
IMAGING DOPAMINERGIC PROJECTION ABNORMALITIES IN UNTREATED 
SCHIZOPHRENIA SUBJECTS AND UNAFFECTED FIRST DEGREE RELATIVES: 
TOWARDS CONSTRUCTING AN ENDOPHENOTYPE
Objective: Parkinsonism is present in ~30% of patients with never-treated 
schizophrenia and it predicts greater susceptibility to neuroleptic side effects. 
Parkinsonism in schizophrenia is a heritable trait independent of clinical state. 
The pathogenesis of parkinsonism is related to neuronal loss in dopaminergic 
circuits of the substantia nigra and ventral tegmental area. We have identified 
a population of patients with schizophrenia that are neuroleptic naïve and 
have shown that parkinsonism and its associated deficits have characteristics 
of an endophenotype in first degree relatives. We investigated white matter 
tracts of dopaminergic networks in schizophrenia patients and their unaffected 
relatives by using DTI. Design: 3 medication naïve schizophrenia patients (SZ), 
5 first degree relatives and 3 healthy matched controls underwent a diffusion 
weighted MRI scan. Left and right substantia nigra pars compacta and ventral 
tegmental area were traced manually and selected as ROIs. Fractional anisotropy 
(FA) and number of fibers for each ROI were calculated. Results: A discriminant 
analysis revealed that FA and number of fibers were able to classify 52% of 
the cases accurately. Moreover, there was a numerical difference by which 
schizophrenia subjects had increased FA and decreased fiber density in all ROIs 
in comparison to controls. First degree relatives FA and number of fiber values 
were in between patients and controls. Conclusion: This preliminary data 
illustrates the neural bases of motor dysfunction in schizophrenia, suggesting 
an endophenotype. Further data is currently being collected. 
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My research interest is to build foundational knowledge and a better 
understanding of causes of stress-related mental disorders by demonstrating 
involvement of HPA-axis genes in mood disorders. My program stems from 
my ongoing work on Fkbp5, and thus form the rationale of my “next logical 
steps” in translational research. My initial inquiry to determine the epigenetics 
of stress hormone action on HPA-axis genes led to the identification of an 
intronic region of Fkbp5 that undergoes substantial DNA methylation in 
response to glucocorticoids. By focusing on this crucial stress-response gene 
in rodent models, I made several discoveries that link together glucocorticoid 
exposure, physiological changes, persistence of DNA methylation change, and 
mood-related behavior. For instance, I have demonstrated that a single drop 
of blood can be used to determine degree of exposure of mouse brains to 
glucocorticoids, which has enormous translational potential given the strong 
association between glucocorticoid exposure and mood disorders. My next 
hypothesis then is to ask whether homologous regions in human brain tissues 
undergo stress-induced epigenetic changes and whether these regions are 
altered in stress-related neuropsychiatric illnesses. My research program utilizes 
cutting-edge techniques in epigenetics, along with innovative approaches in 
translational neuroscience, which were honed under the mentorship of the 
world-renowned epigeneticist Dr. Andy Feinberg, and given a psychiatric 
imperative under the guidance of Dr. Jimmy Potash (current chairman of 
psychiatry at the University of Iowa). In addition, the unique environment 
that exists at Hopkins has given me the opportunity to garner the support of 
powerful collaborators in psychiatry (Dr. Fernando Goes), neuroendocrinology 
(Dr. Gary Wand), large-scale epigenomics (Drs. Sarven Sabunciyan and 
Andy Feinberg), and bioinformatics (Dr. Peter Zandi). I am confident that my 
background and experience will be of great value to Y-Mind, and that I, in turn, 
will benefit greatly from the scientific community at Sao Paulo. 
SUMMARY PROJECT:
TISSUE-SPECIFIC ALTERATIONS IN DNA METHYLATION OF FKBP5 AS A 
DETERMINANT OF BLOOD-BRAIN CORRELATION OF GLUCOCORTICOID EXPOSURE 
IN MICE
iNterNacioNal StUdeNtS of 
tHe y-MiNd adVaNced ScieNce ScHool
59
Erin R. Ewald 1,2, Fayaz Seifuddin1,2, Xiaoju Yang 3, Gretha Boersma 1,2, Kellie 
L. Tamashiro 1,2, Peter Zandi1,2,4, James B. Potash 5, Timothy H. Moran 1,2, 
Gary S. Wand 2,3, Richard S. Lee1,2,*
1The Johns Hopkins Mood Disorders Center, 2Department of Psychiatry and 
Behavioral Sciences,
3Department of Medicine, Division of Endocrinology, of the School of Medicine, and
4Department of Mental Health of the Bloomberg School of Public Health, Johns 
Hopkins University, Baltimore, MD.
5Department of Psychiatry, University of Iowa Hospitals and Clinics, Iowa City, IA.
Several lines of evidence suggest that chronic exposure to high levels of 
iatrogenic or endogenous glucocorticoids (GCs) poses a significant risk 
factor for mood disorders. Therefore, it is important to be able to measure 
exposure to GCs, or GC burden, in order to assess risk for mood disorders and 
to administer patient-tailored steroid medications. However, calculating this 
burden is challenging, given that existing measures reflect GC exposure over 
a short duration and have not been proven to reliably quantify the burden 
over weeks or months. Indeed, this problem has hampered population-based 
studies attempting to identify a neuroendocrine link between GC exposure and 
metabolic and neurologic dysregulation. What we need are peripheral tissue 
biomarkers of GC exposure that can more accurately capture GC burden in 
the brain. Of great clinical relevance is the use of blood tissue as a potential 
biomarker and surrogate tissue for exposure-induced changes in the brain, 
since brain tissues in living humans are mostly inaccessible. In this project, we 
provide proof-of-concept and empirical evidence of blood-brain correlation 
of glucocorticoid exposure and investigate the role that tissue-specific DNA 
methylation plays in shaping this relationship. We utilize a mouse model of 
Cushing’ syndrome, in which adolescent male mice are given high doses of 
corticosterone for four weeks, and their blood and brain tissues are examined for 
DNA methylation changes. We focus on two bioinformatically and functionally 
characterized glucocorticoid-response elements in two intronic regions of the 
stress-response gene Fkbp5. Blood DNA methylation changes in intron 1 of 
Fkbp5show the strongest correlation to four-week mean plasma corticosterone 
levels (R2 = 0.78, P =9.7x10-9), whereas methylation changes in intron 5 in 
all four brain regions tested, i.e. amygdala, hippocampus, hypothalamus, and 
prefrontal cortex, show the strongest correlation (R2 ≥ 0.55, P ≤3.9 x 10-5). 
Consequently, additional analysis reveals that same CpG-to-CpG blood-brain 
comparisons are characterized by poor correlation between the CpGs and/
or absence of robust DNA methylation differences at those CpGs between 
treated and untreated animals. Taken together, our results demonstrate that 
GC-induced epigenetic changes in blood can be used as a surrogate for those 
of brain tissues, and that this relationship is determined by tissue-specific 
alterations in DNA methylation.
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2013 Department of Global 
Health and Population, 
with a focus on global 
mental health
BIO SKETCH:
Pamela Scorza is a Doctor of Science candidate in the Department of 
Global Health and Population at the Harvard School of Public Health. Her 
research focuses crosscultural mental health measurement and intervention 
development and assessment. In particular she has been working for the past 
several years on a project in rural Rwanda- the development and validation 
of local mental health screening tools for use with children and adolescents, 
leading to the development of a family strengthening intervention to 
prevent mental disorders and promote protective processes for children in 
families affected by HIV/AIDS.  In addition to this research, Pamela’s doctoral 
dissertation utilizes latent class analysis and latent transition analysis to explore 
cross-country differences in depression measurement in the World Mental 
Health Surveys and the implications for depression prevalence estimates 
across countries.  Pamela is also very interested in incorporating mindfulness 
techniques for treatment and prevention of depression and other psychosocial 
disorders. Before coming to Harvard, she earned an MPH from the University 
of Ghana, where she studied maternal depression in women in rural Ghana. 
She holds a BA in anthropology from New York University and has studied at 
Universidad San Francisco de Quito in Ecuador.
SUMMARY PROJECT:
ASSESSING INDIVIDUAL-LEVEL PROTECTIVE FACTORS AND THEIR SENSITIVITY 
TO A FAMILY-BASED INTERVENTION TO PREVENT MENTAL DISORDERS IN 
YOUTH IN RWANDA
The findings I will present are situated within a project that aims to develop and 
evaluatean intervention to prevent mental, emotional, and behavioral disorders 
in youth in families affected by HIV/AIDS in Rwanda.  Because the objective of 
the intervention is to promote sources of strength to prevent mental disorders, 
we sought to understand these sources of strength more deeply, and to 
assess whether these protective factors are uniquely important in Rwanda or 
whether they represent a more universal set of resilience factors. While there 
is widespread agreement that some mental disorders, such as depression, are 
quite similar across cultures, the extent to which protective factors are similar 
across cultures is not well known.  Instead of assuming cross-cultural similarity, 
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our research group conducted qualitative research to explore protective factors 
that were identified as being important locally for youth faced with HIV/AIDS, 
poverty, and other adversities. I will present the factor analytic structure 
and measurement of the individual-level protective factors in a sample of 
367 Rwandan youth.  We find that in Rwanda, protective factors important 
for resilient psychosocial outcomes at the individual level include:  a sense of 
survival, faith, engagement in social interaction, selfmotivation/self-efficacy, 
and sense of self-worth or self-esteem. The majority of research conducted 
on individual-level protective factors in Western settings has centered around 
factors like self-esteem and self-efficacy.  This analysis in a Rwandan context 
found that these factors were important, however, engagement in social 
interactions was the just asstrongly related to depression and functional 
impairment. I will these findings in the context of the family strengthening 
intervention in Rwanda, and I will discuss implications of these findings for 
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Mailman School of Public 
Health, Columbia University
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BIO SKETCH:
As a current graduate student pursuing a Master’s in Public Health (MPH) and 
Latin American Studies (MA) at Columbia University, my specialties range 
across international health policy and health implications of at-risk groups. 
Her main interests are particularly situated on issues of drug use, where she 
has increasingly sought to join and participate in debates detailing health and 
drug abuse within the public health community, and recently in the mental 
health field. As a career goal, she seeks to combine her  passion and interest 
for Latin America as well as public health in analyzing the impact of drug use 
policies on the international health framework. The intention is to contribute in 
the formation of empirically proven policies representative of the implications 
associated with drug consumption. At Columbia University, she has been 
involved with the New York State Psychiatric Institute- Brazil Mental Health 
group, lead by Drs. Milton Wainberg and Cristiane Duarte. Due to her experience 
on qualitative and ethnographic research, she is currently participating in the 
STYLE-B project being developed by NYSPI in Itaborai, Rio de Janeiro. Upon 
completing her dual masters degree in May 2013, she will join the U.S. Foreign 
Service to serve as a diplomat.  She plans to work under USAID (United States 
Agency for International Development) on public health projects across Latin 
America and some areas in Africa.
Kristina Rosales holds a Bachelors degree (BA) from the  University of Miami in 
International Studies and Political Science.
SUMMARY PROJECT:
Rio de Janeiro has been engaging in a much-touted security push before 
the 2014 World Cup and 2016 Olympics, setting up ‘peaceful’ police stations 
in once-trafficker controlled favelas. Crack has filtered in the city since 2005, 
presenting a tough challenge for authorities seeking to control drug trafficking 
and now increasing drug use. With the establishment of these pacifying 
police units, the municipal and state entities are seeking to combat this “crack 
problematic” in areas denominated as “cracolândias” or crack lands with the 
same public policy approach. On a different front, crack cocaine dependence 
represents a new challenge in the area of prevention for mental, emotional, 
and behavioral disorders (MEB). In general, substance abuse prevention has 
been pointed as an effective control methodology (due in part to the gateway 
drug theory), yet this has often not been the case in Brazil where a growing 
focus has been centered on environmental rather than individual pre-emptive 
efforts. Similar to the U.S. model of approaching crack cocaine abuse, Brazil has 
often sought to invest all resources on treatment efforts rather than preventive 
or harm reduction campaigns. Although there are some prevention programs 
at play, including those implemented by the CAPS-AD and the Clinicas de 
Saúde da Família, it remains an at-large policy challenge. Through compulsory 
treatment, as an example, Rio de Janeiro requires underage users to participate 
in involuntary rehabilitation programs, while adults are referred to Centers for 
Psychosocial assistance, which also treat mental health disorders. Although 
Brazil could improve its preventive efforts towards crack use by referring to 
past policies used to tackle HIV/AIDS within at-risk populations, it has chosen 
to at times treat users as a public security concern rather than vulnerable 
subjects to mental, emotional, and behavioral disorders. With a variety of 
successful prevention efforts available, among these, utilizing resources such 
as community health workers (CHW’s) for precautionary home visitations, 
Brazil could avidly seek to invest its resources in concrete preventive efforts 
to deter substance abuse in families and children at an early age (Olds, D. et 
al., 1997, 1998). Utilizing information acquired during a Fulbright research 
experience(Fulbright Fellow 2010-2011) examining the spread of crack along 
specific marginalized communities in Rio de Janeiro, this project presentation 
will focus on the changing scenes of the crack epidemic in Brazil as a growing 
but poorly addressed public and mental health concern.
*This project presentation will be developed with the assistance of Dr. Cristiane 
Duarte, Assistant Professor of Clinical Psychology at Columbia University and 
New Yorks State Psychiatric Institute.
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Dr. Hauser is a clinical psychologist with appointments as Assistant Professor 
at Hofstra University- North Shore Long Island Jewish (LIJ) School of Medicine 
and Assistant Investigator at The Feinstein Institute for Medical Research, North 
Shore-LIJ Health System. Her research has focused on the early identification 
and prevention of psychosis- and bipolar-spectrum disorders. Working at 
the Early Recognition and Prevention Center for Beginning Psychoses of the 
Charite University Medical Center in Berlin, Germany, she was involved in 
nationally funded multi-center studies (EPOS: European Prediction of Psychosis 
Study, and PREVENT: Secondary Prevention of Schizophrenia: a randomized 
controlled trial) as well as various other related research projects. Dr. Hauser’s 
major areas of research interest have included clinical features (e.g. mood 
swings, operationalized psychodynamic diagnostics) and biomarkers (sense 
of agency, auditory event-related P300, loudness dependence of auditory 
evoked activity) that may enhance early identification by contributing to the 
predictive validity of prior investigated clinical risk symptoms. Furthermore, 
she has investigated attitudes towards illness and treatment as well as the 
effects of psychoeducation in psychosis-risk and first episode patients and their 
relatives. Currently Dr. Hauser is spearheading a large longitudinal cohort study 
of 700 adolescents with various mood- and psychotic disorders, followed for 5 
years, in New York, USA. The study aims at further expanding our knowledge 
on predictors of bipolar and psychotic disorders as well as on the course of 
established mood and psychotic disorders.
SUMMARY PROJECT:
BIOMARKERS FOR THE EARLY DETECTION OF UNIPOLAR DEPRESSION VS. 
BIPOLAR DISORDER IN YOUTH
Background: Unipolar major depression (MDD) in adolescents can be mistaken 
for bipolar-I disorder (BP-I), as irritability is a common main clinical criterion 
for both disorders. Misdiagnosis can have serious adverse consequences, 
requiring reliable differentiating biomarkers. Biased emotional processing, high 
sensitivity to goal- and reward-related cues, and cyclothymic-hypersensitive 
temperament (CHT) are promising candidates that could help differentiate 
MDD from emerging BP-I during adolescence.
Hypotheses: 1. Compared to youth with BP-I and bipolar disorders not 
otherwise specified (BP-NOS), MDD youth will show significantly less
a) positive bias in an emotional processing task 
b) sensitivity to goal- and reward-related cues
c) CHT traits (trait difference). 
2. BP-NOS youth will not differ from BP-I youth in the emotional processing 
task (trait similarity).
Methods: Subjects: Inclusion criteria: (1) 13-18 years; (2) MDD, BP-NOS and 
BP-I diagnoses; (3) MDD youth with clearly operationalized current irritability, 
no lifetime history of mania symptoms, or family history of BP-I; (4) BP-NOS 
youth with clearly operationalized current irritability; (5) BP-I youth meeting 
full diagnostic criteria. Exclusion criteria: 1) IQ <70; 2) Pervasive developmental 
disorders, current substance dependence; psychosis-spectrum disorders; 3) 
History of medical condition known to affect the brain.
Assessments: Structured assessment of  diagnoses and symptoms; 
neuropsychological assessment of emotional processing; self-reports of 
sensitivity to goal- and-reward related cues and temperament.
Statistical plan: Comparisons between groups will be analyzed using linear 
regression with fixed covariates. One exploratory backward likelihood ratio 
regression including all three biomarkers will be performed.   
Design: Cross-sectional comparison of 90 irritable youth with MDD, BP-NOS, 
and BP-I (n=30 each), on three promising biomarkers.
Outcomes/Goals: Biomarkers, which can differentiate unipolar MDD youth 
from BP-spectrum youth who present with clinically significant irritability in 
the absence of full mania symptoms, are urgently needed to enhance clinical 
decision making and to employ evidence based and guideline consistent 
treatments in help-seeking youth.
reNata PellegriNo
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I have been working on several biomedical research projects, specifically 
focused on the genetic risks of mental health and sleep disorders. I am 
dedicated to Sleep deprivation projects involving gene expression, DNA 
sequencing and cellular and functional studies in Humans and mice. Also, I am 
responsible for the CGH-arrays projects at CHOP which mainly investigate the 
rare Copy Number Variation in Autism and ADHD. She connected Upenn to her 
Federal University in São Paulo (UNIFESP) to develop and research the Genetics 
Sleep Apnea in different populations (Sleep Apnea Consortium). 
Lab skills: Microarrays, Sanger sequencing, qPCR (Taqman SNP, Gene expression 
and genotyping). Copy Number Variation, CGH-arrays, Transcriptome library 
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preparations (Next Generation sequencing), Cell culture and transfection, 
plasmid construction. 
Bioinformatics: microarrays experimental design, Pathways analysis, GO 
analysis. (Partek, Ingenuity, Dchip, DAVID, R).
SpecialtiesMicroarrays technology, Molecular Biology, Human genetics, Molecular 
Biology, Bioinformatics.Current: effects of sleep deprivation in Humans and Mice.
SUMMARY PROJECT:
ANALYSIS OF CNV IN AUTISM AND ADHD COHORTS
The purpose of the project is to perform higher-resolution genotyping by aCGH 
on subjects with autism and ADHD to determine the prevalence of CNVs in 
genes within the metabotropic glutamate receptor (mGluR) network. Recently, 
CAG – center for applied genoomics has found that genes in this network 
were enriched for CNVs in patients withADHD and autism unpublished. The 
analysis was based on genotyping on Illumina SNP arrays (550-610K), and 
the CNV analyses revealed that ~10% of individuals with ADHD and ~2-3% 
of individuals with autism have CNVs within genes in the mGluR network. 
However, the resolution of the analyses was limited by the spacing of the probes 
in these SNP arrays (~4-6kb between probes), and potentially important CNVs 
that were missed due to lack of sensitivity of the arrays. Thus, we designed 
a custom array for comparative genomic hybridization (CGH) with dense 
coverage(~300-400bp between probes) within genes in the mGluR network 
as well other genes implicated in ADHD and other mental disorders. The ADHD 
and autism cohort within CHOP that was used in the previous analyses will be 
systematically screened again with the custom CGH array for mGluR network 
mutations. Importantly, those subjects with these mGluR network mutations 
could represent a distinct subset that where the etiology of their disorder arises 







DEGREE YEAR(S) FIELD OF STUDY
St. Olaf College BA 05/2008 Psychology/ Statistics
Emory University MPH 05/2012 Global Epidemiology
BIO SKETCH:
Brad Wagenaar is currently a PhD student in the University of Washington’s 
Department of Epidemiology within the School of Public Health. He completed 
his Master’s training in Global Epidemiology at the Rollins School of Public 
Health in Atlanta, Georgia in May 2012. He is a returned Peace Corps volunteer 
(08-10) from Cameroon who has provided epidemiologic and biostatistical 
consulting on projects ranging from alcohol tax research in the United States, to 
HIV/AIDS prevention among MSM in the US and Africa, epidemic cholera in the 
Far North region of Cameroon, time-series analyses of vaccine exemptions in 
California, and, most recently, work on depression, suicide, and other common 
mental disorders in the Central Plateau of Haiti. In 2012, Mr. Wagenaar was 
awarded the Eugene J. Gangarosa Award by Emory University for taking 
creative approaches to solving public health problems and for showing promise 
for service in the international arena. He has published 6 peer-reviewed 
publications to date and has 4 other publications currently under review. Mr. 
Wagenaar is particularly interested in working on health systems research and 
implementation science in French-speaking Africa.
SUMMARY PROJECT:
Objective: This study had three aims focused on depression and suicide in Haiti: 
(1) to epidemiologically quantify depression symptomatology, suicidal ideation, 
and associated factors; (2) to describe patterns, determinants, and costs of 
seeking care for psychiatric distress; and (3) to describe causal pathways and 
attitudes towards suicidal behavior. 
Methods: For aims one and two, a cross-sectional, zone-stratified household 
survey of 408 adults was conducted. Multivariable regression models were 
built using depression symptomatology, suicidal ideation, or anticipated care 
seeking as outcomes. For aim three, 24 semi-structured in-depth interviews 
were conducted and analyzed using interpretive phenomenological analysis. 
Results: The mean BDI score was 20.4 (95% CI: 19.3-21.5), and 6.13% (N=25) 
of participants endorsed current suicidal ideation. Factors associated with BDI 
scores were: age, female gender, suicidal ideation, death in family, and prior life-
threatening illness. Thirty-two percent of respondents endorsed God as their 
first choice for care if suffering from mental distress, with 28% of respondents 
endorsing clinics/hospitals. Forty-seven percent of respondents chose providers 
based on anticipated efficacy. Suicidal individuals were 7.6 times (CI: 1.4, 42.0) 
as likely to prefer community-based providers over hospitals/clinics. Median 
service costs were US$1 for hospitals/clinics, US$6 for herbal healers, and 
US$120 for Vodou priests. Compared to community members, health providers 
were less likely to consider suicide a “common” and important issue. Many suicide 
stories illuminated common causes as strained love relationships, public shame, 
and extreme poverty. Religious engagement appears to be a protective factor and 
a potential resource/target for future prevention programs. 
Conclusion: A large proportion of Haiti’s Central Plateau may be experiencing 
high levels of depression symptomatology and/or current suicidal ideation. 
Isolated clinical interventions may have limited impact because of less frequent 
use. Educational programs for health workers on suicide awareness, lay 
understanding of suicide causation and treatment, and local idioms of distress 
would be essential.
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University of Limoges, France PhD Public Health
BIO SKETCH:
Maëlenn Guerchet is currently a post-doctoral researcher at the University of 
Limoges (France), in the Tropical Neuroepidemiology Unit (Inserm U1094). Her 
PhD researches involved the estimation of prevalence of dementia in three-
french speaking African countries, and the study of the associated factors. She 
obtained her Bachelor’s degree in Biological Sciences from Nantes’ University in 
2005 and her Master’s degree in Epidemiology and Biostatistics from the Institute 
of Epidemiology, Development and Public Health (Bordeaux University) in 2007.
She has participated to several field studies in West and Central Africa. She 
teaches methodology and practical sides of epidemiological studies to MSc 
students, and did statistical tutorials for medical students.
To date, she has communicated at several national and international conferences, 
and authored or co-authored nine publications in peer-reviewed journals
SUMMARY PROJECT:
DEMENTIA IN THREE FRENCH-SPEAKING AFRICAN COUNTRIES: RESULTS AND 
PERSPECTIVES
Dementia and related syndromes are of major public  health concern because 
of the ageing of global population. If researches on dementia in low-income 
countries have increased during the last years, few have been carried out 
in Africa compared to developed countries.   During the last years, several 
door-to-door surveys were carried out in rural and urban areas of three 
West and Central African French-speaking countries (Benin, Central African 
Republic (CAR) and Republic of Congo). Participants aged  ≥65 years old were 
interviewed. Secondly, a neurologist clinically assessed subjects who had a 
poor performance at cognitive tests. The DSMIV and NINCDS-ADRDA criteria 
were required for dementia and Alzheimer’s disease diagnoses. Two years 
later after the initial study, a follow-up was done in Central Africa aiming at 
retrieving all subjects with dementia or cognitive impairment and controls 
free-of-dementia.  
The prevalence of dementia was low in Djidja, the rural area of Benin (2.6%) 
and in Cotonou, urban Benin (3.7%), whereas it was higher in Central African 
cities (8.1% in Bangui and 6.7% in Brazzaville). Age and current depressive 
symptoms were the two factors most significantly associated with dementia 
in these populations. Other factors such as female gender, hypertension, a BMI 
<18.5 kg/m², and the lack of a primary education were significantly associated 
with dementia. Death of one parent during childhood and recent moving were 
also associated with dementia.  
Prevalence of dementia seems to vary between different regions of Africa, and 
between urban and rural areas. Beyond the usual risk factors for dementia, our 
studies highlight the role of psychosocial risk factors in low-income countries. 
These results add to the few available figures from developing countries.  
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Born on July 21, 1980 in Fortaleza, Ceará. First and second grades held at 
Military College of Fortaleza (1990-1998). Undergraduate Medicine, Federal 
University of Ceara (1999-2004). Residency in Psychiatry at the Hospital de 
Clinicas de Porto Alegre, HCPA. (2005-2008). Analytic Psychotherapy Specialist 
at Hospital de Clinicas de Porto Alegre (2008-2009). Master of Medical Science 
from Universidade Federal do Rio Grande do Sul, UFRGS (2007-2009). Doctor of 
Psychiatry, Federal University of Rio Grande do Sul, UFRGS (2009-2012). Post 
Doctorate in Physiology & Pharmacology, Federal University of Ceará (2012) 
is currently Professor of Graduate School of Medicine Christus, Chief Resident 
Physician, Hospital Mental Health Messejana (HSMM) Outpatient Preceptor 
First Psychotic Episode - HSMM Developers Lab Psychiatric Molelular HCPA and 
Researcher of Neuropharmacology Laboratory, Federal University of Ceará.
SUMMARY PROJECT:
Omega-3 has shown efficacy to prevent schizophrenia conversion in ultra-high 
risk population. We evaluated the efficacy of omega-3 in preventing neonatal 
neuroinflammation induced by Poly-IC in an animal model of schizophrenia 
and its effect on brain-derived neurotrophic factor (BDNF). Omega-3 or 
vehicle was administered in Wistar male rats, both groups at the 30th day of 
life for 15 days. Each group was split in two to receive along the following 
7 days POLY_IC or saline. Locomotor and exploratory activities, memory test 
and social interaction between pairs were evaluated at the 52nd day of life. 
Prefrontal-cortex, hippocampus and striatum tissues were extracted right 
after behavioral tasks for mRNA BDNF expression analysis.  Administration 
of omega-3 in neonatal rats could prevent positive, negative and cognitive 
symptoms in a inflammatory animal model of schizophrenia. Whether these 
findings are consequence of BDNF increase it is unclear.
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Hospital das Clínicas da 
Faculdade de Medicina de 
Ribeirão Preto – USP
Mental Health 
System
Hospital das Clínicas da 
Faculdade de Medicina de 
Ribeirão Preto – USP
PhD Mental Health 
System
BIO SKETCH:
Régis Eric Maia Barros has currently a MD and Ph.D degree at Universidade de Sao 
Paulo (USP), Departamento de Neurociências e Ciências do Comportamento. His 
Master’s degree and Ph.D. research involves analysis of mental health networks 
besides to study psychiatric admissions and readmissions. He obtained his 
Bachelor’s degree in Medicine from UNIFESP in 2002, medical specializations 
(Psychiatry and Psychotherapy) in 2002 to 2005, Master’s degree in Mental 
Health Networks from USP in 2008 and Ph.D in psychiatric admission and 
readmissions from USP in 2013. He is an active researcher in his department 
and contributes to publications on public health. He has also worked in the 
Coordination of Health Presidency of Brazil as a psychiatric doctor. To date, he 
has authored of more than 30 publications (articles and literary chronicles).  
SUMMARY PROJECT:
Background: Little is known about the impact of length of stay as a predictor 
of psychiatric readmissions in low- and middle-income countries.  Aims: Verify 
the occurrence of features changes in patients during their first admission 
and analyzing the factors associated with psychiatric readmissions. Verify 
the relationship between length of stay and readmission.  Method: Socio-
demographic and clinical data of all patients admitted in the 2000-2007 period 
were analyzed using survival curves and logistic regression.  Results: During the 
study period, 6,261 individuals were admitted for the fist time showing increases 
in the proportion of patients with some socio-demographic (professionally 
inactive, elderly and young adults) and clinical (brief hospitalizations, 
diagnoses of depressive or personality disorders) characteristics. The psychiatric 
readmissions were related to age, longer admissions, affective and psychotic 
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disorders.  Conclusions: Psychiatric readmissions using as references the first 
admissions have as risk factors: young age, longer length of stay and diagnosis 
of severe mental disorder.
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Child/ Adolescent  
Psychiatry
Universidade Federal do 
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PhD student Psychiatry
BIO SKETCH:
The proposed research aims at evaluating a psychosocial intervention with 
depressed mothers in  relation to their child s´ behavioral problems in a 
Brazilian sample. As a child and adolescent  psychiatrist with a particular 
interest in early interventions and prevention of mental health  problems, 
I have the motivation, enthusiasm and expertise to conduct this project as a 
principal  investigator. I graduated in medicine in 2005 in an internationally 
recognized medical school in  Brazil (Universidade Federal do Rio Grande do 
Sul) and completed my residency training in  psychiatry in 2008 and in child 
and adolescent psychiatry in 2009 in the same institution. In  2010 I completed 
a substance addiction specialization course in the Universidade Federal de São 
Paulo. After finishing my residency training I idealized and implemented for 
the first time the  child psychiatry outpatient clinic in the tertiary hospital I 
work in and started teaching in both  the Psychiatry Residency Program and 
the Medical School of Universidade de Brasilia. Currently I  am member of the 
scientific board of the Associação Brasileira de Neurologia, Psiquiatria Infantil 
e  Profissões Afins  (Brazilian Association of Neurology, Child Psychiatry and 
Allied Professions)-   Distrito Federal. I have a strong interest in Research and 
Academic Career. In the last years my involvement with research resulted in 
3 published articles, 9 book chapters and several abstracts  and posters in 
conferences. I was member of the technical review board of the translation 
into  portuguese of the Encyclopedia on Early Child Development (Canada). I 
am currently a reviewer  for Revista Brasileira de Psicoterapia and Trends in 
Psychiatry and Psychotherapy. The  participation in the São Paulo  School of 
Advanced Science for Prevention of Mental  Disorders will be an important step 
in the process of conception and implementation of a  preventive program in the 
field of child mental health in Brasília-DF. 
SUMMARY PROJECT:
A PREVENTION PROGRAM FOR MENTAL  HEALTH PROBLEMS IN CHILDREN OF 
DEPRESSED MOTHERS IN A BRAZILIAN  SAMPLE- A PILOT STUDY
Child and adolescent mental health (CAMH) problems are highly prevalent 
(10-20%) around the globe. There is an urgent need for preventive studies 
and interventions for mental health problems in Brazil. Several factors are 
associated with poor developmental and mental health outcomes in childhood 
including maternal depression. Perinatal depression negatively affects the 
mother s´ capacity to interact with her child. Interventions targeted at improving 
mother-infant interactions among depressed mothers may be of potential 
benefit in preventing behavioral problems in childhood. The pilot study design 
is a longitudinal controlled trial involving a primary care unit (Family Health 
Program) in Brasilia, with pregnant women attending antenatal health care. 
Women will be screened for depressive symptoms. Those assessed as having 
depressive symptoms will be invited to the referral to the psychoeducational 
intervention in addition of standard maternity care. The intervention group 
will be compared to the standard care group. The intervention will consist of 
4 weekly prenatal psychoeducational group sessions and 4 weekly postnatal 
group sessions delivered by mental health providers. In order to standardize 
the intervention, all professionals involved with delivery of psychoeducational 
sessions will receive specific and uniform training. The topics covered in the 
sessions will include coping with depressive symptoms as well as parenting 
skills, with emphasis on infant s´ competencies and mother-infant interaction. 
The sessions´  format will take into consideration previous evidence on number 
of sessions as well as topics supported by the literature (National Postnatal 
Depression Program, 2005; Scott, 2010; Wendlandcarro et al., 1999).The 
intervention is expected to prevent behavioral problems in children of depressed 
mothers, as well as reduce maternal depressive symptoms and improve mother-
infant interaction. As the pilot study succeeds, we intend to expand it to other 
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BIO SKETCH:
Physiotherapist, graduated  at Universidade Vila Velha  – UVV in 2005, has 
postgraduate in hospital physiotherapy  at Escola Superior de Ciências da Santa 
Casa de Misericórdia de Vitória – EMESCAM in 2007. The main professional 
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activity is in public service, the last one was in Centro de Reabilitação Física 
do Estado do Espírito Santo  – CREFES, between 2010  and 2012. Currently 
has scholarship from Coordenação de Aperfeiçoamento de Pessoal de Nível 
Superior  – CAPES to conduct master’s degree in collective health, area 
psychiatric epidemiology in Universidade Federal do Espírito Santo  – UFES. 
The study focuses on the association between chronic pain, depression and 
childhood adversity.
SUMMARY PROJECT:
THE ROLE OF CHILDHOOD ADVERSITY THE ASSOCIATION OF IN CHRONIC PAIN AND 
DEPRESSION: RESULTS FROM THE SÃO PAULO MEGACITY MENTAL HEALTH  SURVEY
Chronic pain and depression are clinical conditions that have, each one of 
them, high prevalence rates in the general population and are associated 
with numerous etiological determinants. Chronic pain may be present in 
adulthood affecting daily activities of individuals and, may not be related to 
organic causes, but to psychological stressors or psychiatric disorders. On the 
other hand, depression may express as pain syndromes. Thus, chronic pain and 
depression may be mutually reinforcing: pain can contribute to the onset of 
depression through a trajectory of losses and impairments; and depression 
can be expressed as various types of clinical pain. Moreover, several clinical 
conditions and risky behaviors in adulthood are associated with traumatic 
childhood experiences, such as loss of emotional bonds, maltreatment, 
neglect, physical and sexual abuse. The memory and impact of these adverse 
events in childhood, as well as neuroendocrine alterations, can increase the 
vulnerability to mental disorders and chronic diseases in adulthood.The aims 
of this  study are to evaluate the effect of depression and childhood adversity 
in the occurrence of chronic pain and the effect of chronic pain and childhood 
adversity in determining later onset of depression in a sample of the general 
adult population resident in the São Paulo Metropolitan Area.The present 
study will analyze the data related to chronic pain, depression and adversity in 
childhood collected in São Paulo Megacity Mental Health Survey. The São Paulo 
Megacity Mental Health Survey is a population-based cross-sectional survey of 
psychiatric morbidity, assessing a probabilistic sample of household residents 
in the São Paulo Metropolitan Area, aged 18 years and over. Respondents 
were selected from a stratified multistage clustered area probability sample 
of households, covering all 39 municipalities, without replacement.A total of 
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Mariane França graduated in Social Service from Federal University of Espírito 
Santo (UFES) in 2005. She took Multi professional Residency at Nossa Senhora 
da Glória Children’s Hospital (2004-2005) and  also took Latu Sensu Post-
graduation course in Public Health focused on Family Health Program (2005-
2006). In 2006 she  worked  for the  Counseling and Testing Center and STD/
AIDS Specialized Service inGuarapari/ES. She participated in the creation and 
implementation of the Technical Forum of Espírito Santo STD/AIDS. In 2007 
Mariane also worked for Espírito Santos’s Agriculture and Forestry Protection 
Instituteworking in the Human Resources and Life and Health Quality 
areas. Since 2007 she has been working as Social  Worker for Petrobras  in 
Project Management and programs concerning to Ocuppational Health: 
Social Attendances, Assistance to Crisis and Post Crises Program, Chemical 
Dependency Program, employees absenteeism follow-up, among other 
activities. She has participated in the University Extension Projects at  UFSC and 
UNIFESP related to alcohol, tabacco and other drugs use, abuse and dependence 
(2008-2010). Also she took Work Psychodynamic and Psychopathology and 
Employee’s Health courses. Today she has been taking masters in Public Health 
at UFES in the area of Psychiatric Epidemiology. Her study assesses the indirect 
costs of mental disorders in the workforce on individual and societal levels. This 
study is part of São Paulo Megacity Mental Health Survey, the World Health 
Organization and Harvard University iniciative.
SUMMARY PROJECT:
THE INDIRECT COSTS OF MENTAL DISORDERS: INDIVIDUAL AND SOCIETAL 
BURDEN IN THE WORKFORCE
The indirect costs of mental disorders in the workforce impose major individual 
and societal burdens. Although most studies identified strong correlations 
between occurrence of mental disorders with absenteeism and presenteeism, 
their impact on individual productivity has not been fully explored. In Brazil, 
systematic information representing the impact of mental disorders in 
individual and social costs in population-based samples has not been reported. 
The objective of this study is to estimate the indirect costs of mental disorders in 
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the workforce both on individual and on societal levels. At the individual level, 
data from the  São Paulo  Megacity Mental Health Survey, a population-based 
cross-sectional study of psychiatric morbidity in the São Paulo Metropolitan 
Area will be analyzed. On the societal level, secondary data from the National 
Social Security Institute (INSS) will be analyzed, assessing the global financial 
burden resulting from mental disorders in Brazilian employees.  Logistic 
regression multivariate models are used to analysis the associations between 
mental disorders with total and partial disability, presenteeism, absenteeism, 
work performance, productivity, efficiency and income, controlling for socio-
demographic variables (age, sex, education and marital status). Results on the 
individual level will be projected to obtain population level estimated costs in 
Brazil, identifying the overall financial burden of mental disorders to society. 
Preliminary results of the data on societal level from 2008 to 2011 indicate a 
gradual increase of the number of sickness benefit concessions due to mental 
disorders. An increase on the number of contributors making use of the benefits 
also happened. The financial costs of mental disorders keep ongrowing, 
representing a considerable share of the gross domestic product (GDP) and of 
the INSS. The mood disorders stand for the major burden, followed by anxiety 
disorders and alcohol and other drugs. These results will help to contribute 
to evidence a tangible portion of the cost associated with mental disorders, 
emphasizing the need to integrate the various indicators of individual and 
social cost for better understanding of the impact of these disorders on society.
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Master Student in the Post-Graduation Program of Psychology in the 
Universidade Federal de Minas Gerais (UFMGBrazil) in the “Human 
Development” area, with “Cognition and Language” line of work. Has  bachelor 
degree in Psychology (2011)  from Universidade Federal de Minas Gerais 
with a part-time period at the University of Leeds (United Kingdom). Also 
has Graduated in Technical Chemistry (2005) in Centro Federal de Educação 
Tecnológica de Minas Gerais (CEFET-MG-Brazil).  Had work experience in 
United States.  Works mainly with the following topics: Dyslexia, Cognitive 
Assessment, Neuroscience and Forensic Psychology.
SUMMARY PROJECT:
Approximately 10% of the population presents poor Reading and Writing 
abilities, memory and organization, facing difficulties in the written language. 
The minority of these cases of reading failure can be attributed to a cognitive 
impairment, which can have a general or specific cause. The first one results 
from a poor general ability and the second from a specific condition called 
Developmental Dyslexia. This reading disorder in most cases has a phonological 
deficit as the main cause underlying the observed slow and inaccurate word 
recognition (Decoding). Although this deficit seems to persist throughout 
the person’s whole life, it can be minimized with the appropriate teaching, 
which involves training in phoneme awareness, letter knowledge, explicit 
and systematic instruction in phonics. The earlier this intervention takes 
place, the easier it is to improve the reading functions and also to alter the 
low self-esteem and behavioral problems often found in those with reading 
difficulties. In Brazil, there is a lack of reliable and valid instruments to asses 
properly the reading processes, especially the ones that measure the Reading 
comprehension, Phonological Awareness and the ones to be used by the 
teacher. For this matter, we are building four instruments to access the Reading 
abilities of young children. One of them is EACOL, which was developed to guide 
the teacher’s judgment of the reading abilities of school children. The Second 
is an adaptation and validation to the Brazilian Portuguese of the instrument 
TIL (Test of Reading Age), which evaluates the Phonological Decoding and 
the Reading Comprehension. The other two tests are tasks that analyses the 
Visual/Lexical Route and the  Phonological Route.  By these means, we expect 
to approach children with Reading Disorder, being able to make an early 
intervention to minimize the harm caused by the negligence .
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I am psychiatry interesting in immunology and neurotrophins biomarkers 
related to neuropsychiatric disorders, specially in mood disorder. My research 
career started in 2006 at IPSEMG (Instituto de Previdencia dos Servidores 
do Estado de Minas Gerais) Brazil. I am interesting in research the role of 
proinflammatory cytokines in the biological effects of stress, mood alterations 
and in the pathogenesis of  neuropsychiatric disorders and in the molecular 
mechanism of drugs (antipsychotics and mood stabilizers).  
Selected Peer-reviewed Publications (Selected from 15 peer-reviewed 
publications)
Barbosa IG, Rocha NP, Huguet RB, Ferreira RA, Salgado JV, Carvalho LA, Pariante 
CM, Teixeira AL. Executive dysfunction in euthymic bipolar disorder patients 
and its association with plasma biomarkers. J Affect Disord. 2012 Mar; 137(1-
3):151-5.  
Barbosa IG, Rocha NP, Miranda AS, Magalhães PV, Huguet RB, Souza LP, 
Kapczinski F, Teixeira AL. Increased levels of adipokines in bipolar disorder. J 
Psychiatr Res. 2012 Mar; 46(3):389-93. 
Barbosa IG, Huguet RB, Neves FS, Reis HJ, Bauer ME, Janka Z, Palotás A, Teixeira 
AL. Impaired nerve growth factor homeostasis in patients with bipolar disorder. 
World J Biol Psychiatry. World J Biol Psychiatry. 2011 Apr;12(3):228-32. 
Barbosa IG, Huguet RB, Amaral VA, Souza LP, Neves FS, Bauer ME, Teixeira 
AL. Increased plasma levels of soluble TNF receptor I in patients with bipolar 
disorder. Eur Arch Psychiatry Clin Neurosci.  2011 Mar;261(2):139-43. 
Teixeira AL, Barbosa IG, Diniz BS, Kummer A. Circulating levels of brain-derived 
neurotrophic factor: correlation with mood, cognition and motor function. 
Biomarkers in Medicine. 2010; 4: 871 - 87.
SUMMARY PROJECT:
Background and relevance for the field:  Bipolar disorder (BD) is a psychiatric 
prevalent syndrome, characterized by chronic course and high morbidity. 
Evidence in the literature suggests that disturbance at immunologic mechanism 
play an important role in the pathophysiology of BD. It has been suggested 
that the immunologic and pro-inflammatory parameters stimulated the same 
second-messenger pathways than the mood stabilizers drugs.  Main Objectives: 
Therefore, this project aims to investigate aspects inflammatory and immune 
mechanisms of second-messengers in BD. Methodology: A cross-sectional 
observational study will be conducted including BD patients from the sector 
psychiatry at the Instituto de Previdência dos Servidores do Estado de Minas 
Gerais (IPSEMG) and controls. BD patients will be evaluated to characterized 
clinical and psychiatric aspects of illness. Peripheral blood and hair will be 
collected of subjects in order to evaluate immunologic and pro-inflammatory 
parameters. The blood will be processed for evaluation of immunologic and 
pro-inflammatory parameters in the plasma, peripheral blood mononuclear 
cells (PBMC) and collection tubes the PAXgene for genetic analysis. In plasma 
will be analyzed cytokines, chemokines, adipokines and neurotrophic factors 
by enzyme immunoassay (ELISA). Frozen PBMC are subjected to analysis by 
flow cytometry to evaluate of cell subpopulations and second-messengers 
parameters. PBMCs will be stimulated with specific stimuli, antiCD3/CD28, 
lipopolysaccharides (LPS), and mood stabilizers drugs. The inflammatory gene 
expression analysis will be performed following the PAXgene techniques. In 
hair samples of patients analysis will be performed cortisol levels in patients. 
Comparisons will be made between control subjects and BD patients according 
clinical and psychiatric parameters and the laboratory parameters. Expected 
results: We expect to find contribute to clarify the pathophysiology mechanism 
in BD illness.
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BIO SKETCH:
Mário César Rezende Andrade is from Brazil, where he is a Ph.D. student in 
Psychiatry and Psychological Medicine at Universidade Federal de São Paulo 
(UNIFESP). He is also a clinical psychologist in private practice, working with 
cognitive-behavioral therapy. His academic background includes participation 
in research activities into the mental health field since his undergraduate course 
in Psychology, with the following subjects: patient-reported outcome measures 
in mental health services and treatments, abnormal psychology, validation 
and adaptation of measures in mental health, addiction andpsychosocial 
interventions in mental health. He has also two postgraduate courses: one of 
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them in University Teaching, at Gama Filho University (UGF), and the other in 
Cognitive-Behavioural Therapy inMental Health, at the Institute of Psychiatry, 
University of São Paulo (USP). In his M.Sc. research project, he investigated 
the relationship between symptomatic changes and perceived improvement 
among patients with severe and persistent mental disorders treated in Brazilian 
mental health community services. During the M.Sc., he was also a graduate 
research trainee at a McGill University’s mental health affiliated hospital in 
Montreal (Canada), the Douglas Mental Health University Institute. In his Ph.D. 
study, he aims to assess the association between the needs of care in patients 
with schizophrenic disorders and variables of severity, disease history and use 
of community mental health services.
SUMMARY PROJECT:
STUDY OF NEEDS IN PATIENTS WITH SCHIZOPHRENIA SPECTRUM DISORDERS 
TREATED IN COMMUNITY MENTAL HEALTH SERVICES: THE INFLUENCE OF 
HISTORY AND SEVERITY OF ILLNESS AND SERVICE UTILIZATION
Introduction: The needs for care among psychiatric patients with severe 
disorders have been used in planning and monitoring of mental health services. 
However, the influence of the service utilization, clinical history and severity of 
the illness on patients’ needs has not been studied. The study of the influence of 
such variables would permit the development of new  strategies of prevention 
and treatment in mental health services. Objective: To assess the association 
between needs of care in patients with schizophrenic disorders and variables 
of symptom severity, clinical history of illness and utilization of community 
mental health services. Methodology: This study consists of the analysis of 401 
interviews from a cross-sectional survey with a random sample of patients 
with schizophrenic disorders treated in the Psychosocial Care Centers in the 
city of Santos throughout the year of 2005. The needs assessment was made 
by the Camberwell Assessment of Needs (CAN), the severity  of symptoms by 
the Positive and Negative Symptoms Scale (PANSS) and the clinical history 
of patient’s illness by the Chart Life Rating Form (CLRF). A questionnaire 
with information about service utilization was used to collect such data. The 
associations will be analyzed using two models of multiple regression analysis, 
with the number of total needs and unmet needs as dependent variables. 
Expected Results: It is expected an inverse association of the variables of service 
utilization with the number of unmet needs and the total number of needs, 
controlling the variables of history and severity of illness.
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BIO SKETCH:
Master in Public Health at Institute of Social Medicine (2012), postgraduated 
(lato sensu) in Medical Psychology (2009) and Hospital Psychology (2006), 
graduated in Social Communications  (1992) and Psychology (2003). During 
master s´ course studied psychosocial interventions for mental health in primary 
care and subsequently joined the Laboratory of Interdisciplinary Research in 
Primary Health Care from Rio de Janeiro State University (LIPAPS/UERJ) as a 
researcher.  From 2008 to 2010,  took part in  joint initiatives between UERJ and 
Rio de Janeiro s´ Municipal  Health Secretariat (SMS)  for establishing integration 
of Mental Health into Primary Care (called  “Estratégia de Saúde da Família” in 
Brazil). Also worked as teacher and supervisor in the training course offered 
for both mental health and primary care teams. Since 2009, has ministered 
disciplines at different UERJ courses: Medical Sciences graduation (medical 
psychology), Medical Psychology postgraduation (brief psychotherapy, body 
psychotherapy, psychology and neurosciences, psychosocial interventions for 
primary care) and Nursing post-graduation (mental health for primary care). In 
2012, was hired to teach Public Health Politics at the Brazilian largest technical 
educational initiative (PROFORMAR). This program is developed by Joaquim 
Venâncio Polytechnical Health School (from FIOCRUZ) as per the Ministry of 
Health request and it aims to qualify 30.000 vigilance health agents for future 
integration into primary care. Interested  in the following research areas: 
human and health sciences, public health; mental health, primary care; training 
in mental health; health promotion,  psychology; psychosocial  interventions; 
doctor-patient relationship; somatization; cultural, social and subjective 
implications  of new psychiatric and biomedical technology development. 
Besides researching and teaching,  handles a small private psychology practice. 
At last, before  working in the health sector,  has developed  an executive 
career working at multinational  companies with Marketing, Communications, 
Planning, Sales and Training.
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SUMMARY PROJECT:
PSYCHOSOCIAL INTERVENTIONS FOR COMMON MENTAL DISORDERS IN 
PRIMARY HEALTH CARE
Alice Menezes, Rio de Janeiro State University, Institute of Social Medicine 
(UERJ-IMS)
Master s´ dissertation, funding CNPQ
BACKGROUND: Common mental disorders (CMD), especially anxiety and 
depression, are highly prevalent. In Primary Health Care (PHC), represented 
in Brazil by Family Health Strategy (Estratégia de Saúde da Família), these 
conditions are not well detected or treated. This results in burden for 
patients, their families and communities, as well as social and economic 
losses. Integrating mental health care into primary care can diminish this 
situation.  OBJECTIVE: Identify and analyze psychosocial interventions  for 
mental suffering and CMD  currently adopted in Brazilian and international 
PHC. METHOD: Brazilian and international literature review through LILACS 
and MEDLINE bibliographic databases. Articles were classified according to 
its pertinenceand only high pertinent ones were selected. RESULTS: Identified 
interventions were gathered as follows:  in the first group were allocated 
those with traditional arrangements where a qualified professional performs 
the treatment face-to-face. In the second, were included those with different 
arrangements where contact with the professional is reduced and his role is 
more of a facilitator than that of a leader (example:  interventions conducted 
by lay people, self-help, electronic platforms offering treatment packages via 
internet).  Internationally, interventions were brief and structured, including 
a manual. Theoretically, Interpersonal Therapy, Cognitive-behavioral Therapy 
and Problem Solving Therapy anchored most interventions. In Brazil, group 
interventions and Community Therapy (a locally developed model) stood 
out. CONCLUSIONS: CMD gain more visibility as PHC gains more ground and 
establishes itself closer to the population. In foreign countries, the integration 
of mental healthcare in PHC is in consolidation and  structured psychosocial 
interventions are used, while in Brazil the tie between PHC and Family Health 
Strategy is recent and there are no standard procedures defined. The prevalence 






DEGREE FIELD OF STUDY
Center for Health  
Sciences, Federal 
University of Rio de 
Janeiro, Brazil
Graduation Phonoaudiology
Institute for Studies in 
Public Health,  
Federal University of Rio 
de Janeiro, Brazil
Master Public Health (MA)
Institute for Studies in 
Public Health,  
Federal University of Rio 
de Janeiro, Brazil
PhD Student Public Health
BIO SKETCH:
Daianna Lima Thiengo is currently a doctoral student at the Institute of Public 
Health Research at the Federal University of Rio de Janeiro. Currently his 
doctoral research aims to assess the stigma of mental illness in Brazil, aiming 
to implement a more appropriate service. Furthermore, this project is part of 
a larger project aiming to improve the development of research and training 
in the area of Mental Health in Latin America. She has obtained a bachelor’s 
degree in speech pathology at UFRJ in 2009 and master’s in public health at 
UFRJ in 2011. Currently she is the author of three publications and co-authored 
a chapter in the book.
SUMMARY PROJECT:
ASSESSING CULTURE SPECIFIC MENTAL ILLNESS STIGMA IN BRAZIL: ENHANCING 
SERVICE  IMPLEMENTATION
The research component is designed to address a key gap in the services 
offered by mental health clinics.These clinics are the primary location for 
outpatient treatment of patients with severe mental disorders in urban areas 
of Latin America, and they offer some important and basic care, such as clinical 
pharmacology. Generally these clinics also have a greatlimitation because 
they have minimal or no resources and training to provide community-based 
services, ie services provided off-site clinic in homes or elsewhere in the 
community. In most urban areas, also have weak linkages to primary health 
care and are not easily accessible to most of the population.It is important 
to generate sustained progress for health care in the community for people 
with severe mental disorders. This care takes into account the need to deal 
with discrimination, unemployment, extreme poverty, reduced access to 
health services and vulnerability to violence and abuse. A key component of 
this program is the ability to provide community-based services for people 
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with severe mental illnesses in their homes and elsewhere within their 
communities. Therefore, this project aims to develop Research and Training 
in the area of  Mental Health in Latin America. Therefore, over a period of 
five years, researchers from three sites (UFRJ = Federal University of Brazil 
at Rio de Janeiro. UCH = University of Chile at Santiago. CUGMP = Columbia 
University Global Mental Health Program) worked together to design the pilot 
an intervention that will introduce community-based services and will be 
viable for widespread use in North and South America. The userlevel service 
provides support for a better life community and promotes social integration, 
and system level strengthens the connections between mental health and 
primary care clinics. The model of care will be provided for 9 months, from 
the moment of  critical psychiatric patient in a mental health clinic. During this 
period, workers establish relationships that shape the continued use of the 
services and increase the potential for recovery over time thereafter. Mental 
Health Workers and peer support workers on the basis of mental health clinics 
and supervised by mental health professionals, sensitize the community and 
provided support to engage users, family members, primary care physicians, 
colleagues and other community members in recovery process.
jUliaNa doS SaNtoS Vaz
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BIO SKETCH:
I am a research Dietitian, Master in Endocrinology, PhD in Nutritional Science, 
and current a Postdoc Fellow in Nutritional Epidemiology at the Federal 
University of Rio de Janeiro. My research background includes experience in 
clinical trials and cohort studies in the field of dietary interventions, fatty acids 
metabolism, type 2 diabetes and mental health. During my doctoral training, I 
joined a research group in Nutritional Epidemiology at the University of Rio de 
Janeiro. In this group, we developed a cohort study to investigate nutritional 
aspects associated with common mental disorders in pregnancy and the 
postpartum. This study also presented a parallel group of high risk women 
who received fish oil capsules to test the possible effect of omega-3 on the 
prevention of postpartum depression. In my third year of PhD, I did 9 months 
of research training at the Laboratory of Nutritional Neuroscience at NIAAA – 
NIH. Later, I did 2 months research visit at the University of Bristol – UK, to 
investigate aspects of fish consumption and dietary patterns associated with 
higher anxiety in pregnancy, using the dataset of a British cohort study (Avon 
Longitudinal Study of Parents and Children - ALSPAC).
SUMMARY PROJECT:
DIETARY PATTERNS, N-3 FATTY ACIDS INTAKE FROM SEAFOOD AND HIGH 
LEVELS OF  ANXIETY SYMPTOMS DURING PREGNANCY: FINDINGS FROM THE 
AVON LONGITUDINAL STUDY OF PARENTS AND CHILDREN
Background: Little is known about relationships between dietary patterns, 
n-3 polyunsaturated fatty acids (PUFA) intake and excessive anxiety during 
pregnancy.
Objective: To examine whether dietary patterns and n-3 PUFA intake from 
seafood are associated with high levels of anxiety during pregnancy.
Design: Pregnant women enrolled from1991-1992 in  ALSPAC (n = 9,530). 
Dietary patterns were established from food frequency questionnaire using 
principal component analysis. Total intake of n-3 PUFA (grams/week) from 
seafood was also examined. Symptoms of anxiety were measured at 32 weeks 
of gestation with the Crown-Crisp Experiential Index; scores  ≥ 9 corresponded 
to the 85th percentile  was defined as high anxiety symptoms. Multivariate 
logistic regression models were used to estimate the OR and 95% CI, adjusted 
by socioeconomic and lifestyle variables.
Results: Multivariate results showed that women in the highest tertile of the 
health-conscious (OR 0.77; 0.65-0.93) and the traditional (OR 0.84; 0.73-0.97) 
pattern scores were less likely to report high anxiety symptoms. Women in the 
highest tertile of the vegetarian pattern score (OR 1.25; 1.08-1.44) were more 
likely to have high anxiety symptoms, as well as those with no n-3 PUFA intake 
from seafood (OR 1.53; 1.25-1.87) when compared with those with intake of 
>1.5 grams/week.
Conclusions: Women among the highest tertile of the health-conscious and the 
traditional dietary patterns were less likely to report high anxiety symptoms, 
while those with high scores on a vegetarian pattern or with intakes of n-3 
PUFA from seafood <1.5 grams/week were more likely to report high anxiety 
symptoms in pregnancy.
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I graduated in Psychology in 1999. I did a Master in Women’s Studies in the 
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subject area of the Humanities and Social Sciences at the University of Paris 8. 
I did a Diploma in Medical Psychology at the University of the State of Rio de 
Janeiro - UERJ and Psycho- oncology in National Câncer Institute ( Instituto 
Nacional do Câncer- INCa). I started to join the team of supervisors and 
preceptors Teaching Care Unit of Mental Health and Medical Psychology -UERJ 
in 2006.Act as coach of courses offered to teams of Strategy Family Health 
along with mental health teams in Rio de Janeiro in 2010 and 2011.I acted as a 
teacher in courses for management in psychosocial care in Primary Care Health. 
The students  was doctors, dentists, nurses, psychologists, psychiatrists  and 
health community agents.Since  early 2012, I joined the team of Community 
of Practice in Primary care Health, portal funded by the Brazilian Ministry of 
Health. (www.atencaobasica.org.br), and today I continue working as PAHO 
(Pan American health organization) consulting.Currently working on research 
related to Primary Care ( PC). For this reason, I went from the beginning of 
development and implementation teams work in collaboration between 
mental health and the PC of Rio de Janeiro, which is known in Brazil as “support 
matrix”. These investigations are in Interdisciplinary Research Laboratory in 
Primary Care Health – UERJ and it is my doctorate study theme .I work also 
on the organization of Mental Health Services  at the Polyclinic Piquet Carneiro 
/ UERJ. My functions are organize the network, planning the health services 
and human resources.In addition, I act in telehealth program for mental health 
network and organize conferences of mental health and primary care
SUMMARY PROJECT:
In Brazil   “matrix support” teams are the chosen model for integration of 
mental health in primary care in the National Health System(SUS). Their 
implementation  and management are  a challenge, with several difficulties 
being found. The objectives are to map and study the integrated actions of MH 
in PC in the city of  Rio de Janeiro from the perspective of the service managers. 
Our Hypothesis are that Matrix Support work in favor of integration of MH in PC. 
The design is a cross sectional study of qualitative and quantitative character.
The Methodology is a semi-structured interview realized with 18 managers 
(100% ) of the units in the sanitary district of Rio de Janeiro (Area Programática 
2.2) . From 18 managers, 12 from PC (Family Health Strategy-FHS = 8 and 
General Ambulatory Services= 4) and 6 from MH (Psychosocial CentersCAPS=2 
and Specialized Ambulatory Services = 4). The instrument maps the structural 
and relational dimensions of services (physical infrastructure, human resources, 
access, gateway, intervention, service integration, family focus, integration with 
the community, continuing education), with closed questions in a Likert scale 
and one open question on the advantages and disadvantages of integration 
of these actions. We have found that the structural features were well 
known but technical matters relating to therapeutic interventions performed 
were unknown. It was consensus that the PC matrix support model enabled 
advances in mental health care. On the other hand, there are several difficulties 
with human resources management due different types of work contracts, and 
also a lack of knowledge on available therapeutic techniques. Matrix support work 
has helped the advance of integrated care. In general, managers in Primary Care 
did not recognize their group  activities as an effective MH intervention, although 
these interventions are frequently used in MH clinical tools and networks.
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BIO SKETCH:
Graduated as a Medical Doctor in 2004, from the  Universidade Federal do Rio 
de Janeiro (UFRJ), and enrolled in Medical Residency in the same University 
from 2005 through 2008, specializing in adult and geriatric Psychiatry. Since 
2008, has been a student at the  Post-Graduation  Program  of Psychiatry and 
Mental Health at UFRJ. In 2010 obtained the MSc degree with the project title 
“Bibliometric tools applied to Psychiatry”. Since 2010 has been developing 
the PhD project entitled  “Conditional Risk for posttraumatic stress disorder 
(PTSD): systematic review, metaanalysis and epidemiological study”. Currently 
working as a psychiatrist and residency preceptor at the Institute of Psychiatry 
at Universidade Federal do Rio de Janeiroand is an active researcher from the 
Laboratório Integrado de Pesquisa sobre o Estresse (LINPES) at UFRJ.
SUMMARY PROJECT:
CONDITIONAL RISK FOR POSTTRAUMATIC STRESS DISORDER (PTSD): 
SYSTEMATIC REVIEW, METAANALYSIS AND EPIDEMIOLOGICAL STUDY.
Background: PTSD is a prevalent and disabling psychiatric disorder that can 
occur after experiencing a traumatic event (TE). The risk of developing PTSD 
after being exposed to a TE, i.e., the conditional risk for PTSD, is influenced 
by a number of aspects, such as the type of TE. Objectives: The objectives 
of our study are: 1) to summarize data on trauma exposure and conditional 
risk of PTSD in the general population through a systematic review; 2) to 
analyze the conditional risk for PTSD secondary to each type of TE and study’s 
geographic location through a metaanalysis; and 3) to report findings on the 
conditional risk for PTSD from an epidemiological survey performed in Brazil. 
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Methods (objectives 1 and 2): Studies were selected through literature search 
in electronic databases, review of the reference list of the selected articles and 
contact with researchers in PTSD. Preliminary results: a total of 21 studies were 
included. The conditional risk for PTSD varied from 0 to 15% (women 0-24%, 
men 0-10,6%). Sexual trauma and childhood sexual abuse were TEs with 
higher conditional risks in the majority of the selected studies (0 to 44,4%, 
women 0-49%, men 0-77%). Conclusion/expected outcomes: We project that 
our results will point out differences in the conditional risks for PTSD regarding 
type of TE and study’s geographic location. We believe that our research may 
aid in primary and secondary prevention of PTSD by identifying individuals and 
populations at risk and defining types of traumatic events most likely to be 
index traumas for the development of PTSD. The results may also aid the design 
of future preventive public mental health policies.
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BIO SKETCH:
The goal of my research project is to investigate the effect of chronic and acute 
treatment with lithium in the aversive memory, anxiety and depression in rats. 
I have been working on this project since I was anundergraduate student. I 
graduated in Biomedicine and chose this field because I’ve always intended to 
be a researcher. I’ve been involved in undergraduate research activities since the 
first university term in the Memory Studies Laboratory at UFRN, where I have a 
five-year background, with specific training and expertise in key research areas 
for the execution of this project. During undergraduate studies I participated 
in other projects, mostly in one focusing in episodic memory, which yielded 
two papers. Nowadays, I am in the middle of the master’s degree and I am 
coordinating my own project under the supervision of my advisor.
Recent Publications
Barbosa, FF; Pontes, IM; Ribeiro, S;  Ribeiro, AM; Silva, RH.  Differential roles 
of the dorsal hippocampal regions in the acquisition of spatial and temporal 
aspects of episodic-like memory. Behavioural Brain Research, v. 232, p. 269-
277, 2012.
Barbosa, FF; Pontes, IM; Ribeiro, AM; Silva, RH. Extending possible applications 
of an episodiclike memory task in rats. Behavioural Brain Research, v. 215, p. 
326-331, 2010.
SUMMARY PROJECT:
Lithium is the main treatment for bipolar disorder, and shows antidepressant-
like effect inanimal  models of depression. In addition,  several  studies have 
shown the neuroprotective, antiapoptotic and neurogenic  effects of lithium. 
Electrophysiological  studies  reveal that chronic lithium treatment increases 
long-term potentiation (LTP) in the hippocampus, which is the major 
neurophysiological basis for learning and memory. However, the possible 
association between the effects of lithium on mood and memory remains to 
be investigated.  The relationship between memory and negative emotions 
has been investigated and studies have shown that fear/anxiety isa necessary 
step to memory formation. This relationship between memory and anxiety 
has beensimultaneously investigated in rodents tested in the plus-maze 
discriminative avoidance task (PMDAT). In this  task, the animals are conditioned 
to choose between two enclosed arms (an aversive and a non-aversive arm) 
while avoiding the open arms of the apparatus. The aim of the present study  is 
to investigate the effects of  acute and  chronic lithium treatment on aversive 
memory, anxiety and depression in rats tested in the PMDAT and forced swim 
test (FST). In addition, evaluation of BDNF levels in the hippocampus and 
amygdala will be conducted.Three-month-old male rats submitted to PMDAT 
and FST will be previously treated with lithium carbonate (50, 100 or 200 mg/
kg) or saline acute (1 hour before the training in the PMDAT and 1 hour before 
the test in the FST) or chronically (21 days). Immunohistochemistry will be held 
to quantify BDNF.
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João Paulo Maia de Oliveira is currently a PhD student at Universidade de Sao 
Paulo (USP), Department of Neuroscience and Behavioral Sciences. His Ph.D. 
research involves psychopharmacology and prevention treatment studies in 
schizophrenia. He obtained his degree in medicine from UFRN in 2004 and 
Master’s degree in Psychopharmacology from USP in 2010. To date, he has 
authored or co-authored eight publications in refereed journals.
SUMMARY PROJECT:
In this project, we present preliminary results of experiments involving an 
animal model of schizophrenia, which consists of acute injection of ketamine 
(NMDA antagonist) in sub anesthetic doses and analysis of hyperlocomotion and 
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stereotyped behavior in rats. In this experiment, groups of animals were tested 
in the open field (locomotor activity) with subsequent injections of ketamine, 
or sodium nitroprusside (SNP, 2mg/kg and 4 mg / kg, a nitric oxide donor) plus 
a further injection of ketamine at different times (12 hours, 24 hours, 48  hours 
and 7 days). The results showed that the behavior hiperlocomotor induced by 
sub-anesthetic doses of ketamine was attenuated when animals are pretreated 
with NPS compared to control animals. Our data suggests that drugs which 
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BIO SKETCH:
Arthur Caye had always shown great interest in research and Psychiatry, and 
started working with his current supervisor, Luis Augusto Rohde, since his 
first year of Medical training. Since then he has been involved in many of the 
ADHD Outpatient Program projects coordinated by Rohde. He is co-author of 
the rticle Evidence-based information on the clinical use of neurofeedback for 
ADHD, recently published on Neurotherapeutics. He has also been working in 
a randomized clinical trial evaluating Neurofeedback as an early intervention 
for ADHD, and in his own project regarding inter-parental agreement on ADHD 
rating scores.
SUMMARY PROJECT:
IDENTIFYING HIGH-RISK INDIVIDUALS FOR ADOLESCENT PSYCHOPATHOLOGY: 
INTEGRATING EPIDEMIOLOGIC AND NEUROBIOLOGICAL EVIDENCE FOR A 
COMPOSED RISK SCORE
Mental disorders are a leading cause of impairment and mortality among 
adolescents. Depression and ADHD are two of the main diagnosis made in this 
age group. During adolescence, the prevalence of depression rises from 5 to 
20%, while ADHD prevalence has a strong declining pattern.  Early intervention 
strategies are being developed for these disorders, but these approaches are 
currently limited by the lack of knowledge on which subjects to target. Our 
objective is to identify risk factors for the incidence of depression and the 
persistence of ADHD during adolescence already determined by previous 
research and integrate these findings within a longitudinal prospective study 
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BIO SKETCH:
As an intern since 2009 at Molecular Psychiatry Laboratory I have been involved 
in psychiatry research from basics to clinical science. Now, as a PhD student, 
I participated over the last year, in all stages of development work resulting 
in the article Effects of omega-3 dietary supplement in prevention of positive, 
negative and cognitive Symptoms: A study in adolescent rats with ketamine-
induced schizophrenia model (C.S. Gama et al., 2012). The exciting results of this 
trial and the literature evidence provided a rationale for testing the effects of 
N-Acetylcisteine (NAC) for prevention of psychosis in ultra-high risk population 
for schizophrenia. This is a highly novel project and has the potential to advance 
our knowledge substantially. I am full-time committed to the NAC project.
SUMMARY PROJECT:
EFFECTS OF TREATMENT WITH N-ACETYL CYSTEINE IN AN ANIMAL MODEL OF 
SCHIZOPHRENIA INDUCED BY KETAMINE
Schizophrenia is a heterogeneous disease extremely  debilitating, considered 
one of the most morbid psychiatric disorders. Schizophrenia is characterized 
by multifactorial, involving genetic, neurodevelopmental and environmental 
vulnerabilities. Early diagnosis and prevention has been one of the targets to 
improve long-term outcomes. Currently there are a growing number of studies 
exploring the use of NAC in the treatment of psychiatric illness, with evidence 
of potential benefit of the drug in a number of disorders, many of which have 
limited treatment today and with unsatisfactory results. A large-scale study 
investigating NAC as an adjunctive therapy for schizophrenia was conducted 
(Berk M et al. 2008), where 1000mg of NAC were taken in two doses / day in 
addition to the existing medication  over 6 months. Improvements were seen in 
negative symptoms. Moreover, improvements in overall function and abnormal 
movements, particularly akathisia, have also been reported. Wistar rats will be 
administered for 15 days, a dose of N-acetyl cysteine (NAC), as a preventive 
treatment. After, for seven days, saline or ketamine will be administered, for 
the development or otherwise of schizophrenia-like behavior in these animals. 
With the model induced behavioral tests will be conducted to evaluate 
positive symptoms (open field), negative symptoms (social interaction) and 
cognitive symptoms (avoidance). Then the predictive testing the animals will 
be euthanized and structures prefrontal cortex, striatum and hippocampus are 
dissected for subsequent biochemical analyzes (oxidative stress,  mitochondrial 
parameters, inflammatory markers and neurotrophins)
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BIO SKETCH:
Christian Kieling is a child and adolescent psychiatrist from Porto Alegre, Brazil. 
He concluded his undergraduate studies in Communications and his medical 
training both at the Federal University of Rio Grande do Sul (UFRGS), where he 
also earned MSc and PhD degrees in Psychiatry. He is currently holding a post-
doctoral position at UFRGS, conducting research on depression and attention-
deficit/hyperactivity disorder among adolescents. He also serves as faculty 
member at the Graduate Program in Psychiatry at UFRGS and is responsible 
for courses to medical and MSc/PhD students. He has published more than 40 
items in peer-reviewed journals, including the Lancet, the American Journal 
of Psychiatry and Biological Psychiatry. He worked as associate editor for the 
Revista Brasileira de Psiquiatria, as consultant to the Publications Committee of 
the World Psychiatric Association, as well as ad hoc reviewer for journals such 
as the American Journal of Psychiatry, the British Journal of Psychiatry and the 
Journal of the American Academy of Child and Adolescent Psychiatry.
SUMMARY PROJECT:
ASSESSING THE OCCURRENCE OF ADOLESCENT DEPRESSION AND THE 
PERSISTENCE OF ATTENTION-DEFICIT/HYPERACTIVITY DISORDER USING 
COMPOSITE RISK SCORES
Mental disorders are among the leading cause of impairment and mortality 
among adolescents worldwide. Depression and attention-deficit/hyperactivity 
(ADHD) disorder are two of the most important diagnostic categories in this 
age group. During adolescence, the cumulative risk for depression rises from 
5% to 20%, whereas symptoms of ADHD exhibit a pattern of decline in some, 
but not in all individuals. Early intervention strategies are being developed 
for these disorders, but these approaches are currently limited by the lack 
of knowledge on which subjects to target. This project aims to develop a 
composite risk index for the occurrence of depression and the persistence of 
ADHD during adolescence using data from the Pelotas 1993 Birth Cohort Study 
(5,249 individuals followed up to the age of 18 years, with a retention rate 
of 81.4%). In a second phase of this study, we plan to assess neurobiological 
markers associated with at-risk states to further understand the mechanisms 
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BIO SKETCH:
Giovanni Abrahão Salum is currently a post-doctoral research fellow at the 
Federal University of Rio Grande do Sul. He finished medical school in 2009 
at the same university and graduated summa cum laude in 2012 at the Post-
graduate Program in Medical Sciences – Psychiatry (CAPES 7). His doctorate 
also included a sandwich period at the Emotion and Development Branch, 
National Institutes of Mental Health (NIMH). He is part of the Anxiety Disorders 
Program, the Outpatient Attention Deficit/Hyperactivity Program from the 
Hospital de Clínicas de Porto Alegre and the National Institute of Developmental 
Psychiatry for Children and Adolescent.  
He has 34 papers published, 113 citations and a H-index of 7 (SCOPUS). He was 
a member of the editorial board of the Revista Brasileira de Psiquiatria (junior 
Editor; 2008-2012) and is a scientific referee for several journals in psychiatry. 
His work focuses on studying clinical and biological aspects of pediatric anxiety 
disorders and attention deficits/hyperactivity disorder. In the last years he 
is specifically interested in measures of pathophysiology and also in brain 
imaging and genetics.  
SUMMARY PROJECT:
CAN COGNITIVE NEUROSCIENCE INFORM RISK FOR ATTENTION DEFICIT 
HYPERACTIVITY DISORDER?
Background: Prevention has recently become a hot topic in psychiatry 
research. Despite that, we still don’t know exactly who is at risk for developing 
psychiatric disorders early in life. Therefore it is difficult to elaborate indicated 
strategies for children at risk for psychiatric disorders. The objective of this 
project is to look for neurocognitive measures that are associated specifically 
with Attention Deficit Hyperactivity Disorder (ADHD) and to test current 
theories about ADHD pathophysiology. To study mental processes that are 
associated with mental disorders has found to be a key ingredient to advance 
research in prevention and early intervention. Increased intra-subject variability 
in reaction times (RT) is one of the most replicable behavioural correlates of 
Attention Deficit/Hyperactivity Disorder (ADHD) literature. However, the 
exact neuropsychological significance and the diagnostic specificity of such 
effects remain unclear. Here we investigate two questions: (1) Are patterns 
of ADHD-related RT variability affected by time on task effects - consistent 
with heightened sensitivity to the effects of fatigue in this group? (2) Is such 
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variability characterized by patterns of low frequency periodic fluctuations, 
suggestive of spontaneous occasional lapses in attention? In each case we also 
examine the extent to which such effects are specific to ADHD. Methods: A total 
of 667 subjects (6-12 years old) from a non-referred sample were classified 
into non-overlapping groups consisting of typically developing children (TDC; 
n=377), and children with fear disorders (n=91), distress disorders (n=56), 
ADHD (n=103), and oppositional defiant disorder/conduct disorder (ODD/CD; 
n=40). We used a simple 2-Choice Reaction Time to obtain within session 
RT series data. Analyses were performed on both time (functional analysis of 
variance) and frequency (spectral analysis and 1/f modeling) domains. Results: 
Higher RT variability was specifically associated with ADHD. However, neither 
time on task nor periodic oscillations were able to explain ADHD-related RT 
findings. Interestingly, ODD/CD presented a different variability of RT pattern 
than TDC in specific frequency bands. Conclusions: RT variability in ADHD 
does not appear to be related to either time on task effects or low frequency 
oscillations linked to attention lapses. In contrast periodicity may characterize RT 
variability in ODD/CD. RT variability may be an interesting neurocognitive marker 
to look for children at risk for ADHD. Further prospective studies are needed.
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Attending to the 2 nd  year of Psychiatry Residency in São Pedro Psychiatric 
Hospital, Porto Alegre, RS. PhD  student in Health Sciences - Neurosciences at 
the University of Southern Santa Catarina (UNESC). Graduated in Medicine, class 
of 2010, at the University of Southern Santa Catarina (UNESC). Master’s Degree 
(2010) in Health Sciences - Pathophysiology at the University of Southern Santa 
Catarina UNESC). Graduated in Pharmacy, class of 2004, at the Universidade 
Comunitária de Chapecó (UNOCHAPECÓ). 
Publications in the area of sepsis, novel pharmacologic approaches in septic 
encephalopathy and behavior. 
Erythropoietin reverts cognitive impairment and alters the oxidative 
parameters and energetic metabolism in sepsis animal model. J Neural Transm. 
2012 Nov;119(11):1267-74. 
Alterations in Inflammatory Mediators,Oxidative Stress Parameters and 
Energetic Metabolism in the Brain of Sepsis Survivor Rats. Neurochemical 
Research, v. 36, p. 304-311, 2011. 
Oxidative mechanisms of brain dysfunction during sepsis. Neurochemical 
Research, v. 35, p. 1-12, 2010.
Effects of N-Acetylcysteine/Deferoxamine, Taurine and RC-3095 on Respiratory 
Chain Complexes and Creatine Kinase Activities in Rat Brain After Sepsis. 
Neurochemical Research, v. 35, p. 515-521, 2010. 
Low dose dexamethasone reverses depressive-like parameters and memory 
impairment in rats submitted to sepsis. Neuroscience Letters (Print), v. 473, p. 
126-130, 2010.
Treatment with cannabidiol reverses oxidative stress parameters, cognitive 
impairment and mortality in rats submitted to sepsis by cecal ligation and 
puncture. brain research, v. 12, p. 128-138, 2010. 
Depressive-Like Parameters in Sepsis Survivor Rats. Neurotoxicity Research, v. 
17, p. 279-286, 2009. 
Oxidative variables and antioxidant enzymes activities in the mdx mouse brain. 
Neurochemistry International, v. 55, p. 802-805, 2009.
SUMMARY PROJECT:
Psychiatry symptoms and disorders are present in many medical conditions and 
its presence generally worsens the overall outcome and may turn a simple and 
effective treatment into a major challenge. In this context, muscular dystrophy 
(MD) patients may also present psychiatric disorders, negatively impacting 
on the dystrophy treatment and cause intense suffering. MDs are among the 
most known severe diseases that affect skeletal muscles and, recently, the 
brain. They present a constant degeneration-regeneration cycle which may, 
in time, not fully recover. Clinically the patients with MD present both motor 
and cognitive impairment, reducing patients’ mobility and functionality and 
increasing family burden and dependence. Since it is a chronic disease and 
produces a strong impact on both patients and their families, it may also 
produce psychiatry symptoms such as anxiety and depression. Dystrophic 
patients present low levels of BNDF which might be even lower in the presence 
of psychiatric symptoms. This study aims to draw a profile of psychiatric 
disorders and symptoms in patients affected by muscular dystrophy as well as 
their family members or caregivers and correlate with the BDNF levels. In order 
to accomplish our objectives, the patients and their families or caregivers with 
be  submitted to the Mini-International Neuropsychiatric Interview (M.I.N.I.) as 
well as clinical psychiatric evaluation by an experienced clinician. Blood will  be 
drawn by a nurse technician to assess BDNF levels.
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I am psychiatrist, with specialization in childhood and adolescence psychiatry 
on Hospital de Clinicas de Porto Alegre; and master and PhD in Epidemiology 
on Federal University of Rio Grande do Sul (UFRGS). During my master and 
PhD I worked in project “Mental Health and violence from ECCAGE – the Study 
of Food Intake and Eating Behavior in Pregnancy in Brazil” and I have some 
publications with this project:
Nunes, M.A.A.; Ferri, C.P ; Manzolli, P, et al . Nutrition, mental health and 
violence: from pregnancy to postpartum Cohort of women attending primary 
care units in Southern Brazil - ECCAGE study. BMC Psychiatry , 2010.
Manzolli, P.; Nunes, M.A.A.; et al. Violence and depressive symptoms during 
pregnancy: a primary care study in Brazil. Social Psychiatry and Psychiatric 
Epidemiology 2010.
Drehmer, M.; Camey, S.; Manzolli, P.; et al Socioeconomic, demographic and 
nutritional factors associated with maternal weight gain in general practices in 
Southern Brazil. Cadernos de Saúde Pública, 2010.
Manzolli, P.; Nunes, M.A.A.; Schmidt, M.I.; Ferri,CP. . Abuse Against Women, 
Depression, and Infant Morbidity. American Journal of Preventive Medicine, 
2012.
I´ m teacher of psychiatry in Universidade Federal de Pelotas since 2011 and 
currently, I´ m a postdoctoral student in Universidade Federal de São Paulo, 
working on project “Estudo Epidemiológico da Saúde Mental
SUMMARY PROJECT:
MENTAL HEALTH OF MOTHERS OF SCHOOL-AGE CHILDREN WITH DISABILITIES 
IN FOUR SCHOOLS OF DIFFERENT GEOGRAPHICAL AREAS IN BRAZIL
Objective: The present study investigated the mental health status of mothers 
of children with disabilities in four schools of different geographical areas in 
Brazil. Method: A cross sectional study was conducted in schools of four 
regions of Brazil, with a total sample of 1562 children aged 6 to 16 years. All 
children aged 6 to 9 years (n=890) entered the present study. Disability was 
assessed by a ten-question screening questionnaire and maternal mental 
health problems were identified by a total score greater than 7 in the Self-
Report Questionnaire (SRQ-20). Data were analyzed using Poisson Regression. 
Results: 37% of children were screened positive for disability (22% had one 
positive question and 15% had two or more positive questions in the applied 
scale). The prevalence rate of maternal common mental disorders was 
significantly higher among children with disability (30% and 40% respectively 
for children with one positive and two or more positive questions for disability) 
compared to healthy children (21%). Children presenting one positive question 
for disability were 1.26 (95% CI 0.97-1.63) more likely to have a mother with 
common mental disorders than healthy children, while the adjusted odds 
ratio for children presenting two or more positive questions was 1.91 (95% 
CI 1.48-2.44).  Conclusion: The cross-sectional design of the study precludes 
any conclusion about the direction of the association though it is important 
to include treatment of maternal common mental disorders when planning 
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Raffael Massuda is currently a PhD research fellow at the Federal University 
of Rio Grande do Sul (UFRGS). He finished medical school in 2007 at Federal 
University of Parana (UFPR) and Psychiatry Residency in 2010 at Federal 
University of Rio Grande do Sul (UFPR).He has 09 papers published. His work 
focuses on studying schizophrenia and bipolar disorder. In the last years he 
is specifically interested in neuroimaging, endophenotypes, and staging in 
psychiatry disorders. Nowadays he is a member of the Molecular Psychiatry 
Laboratory at Hospital de Clinicas de Porto Alegre. 
SUMMARY PROJECT:
VERBAL MEMORY DEFICIT IN SIBLINGS OF PATIENTS WITH SCHIZOPHRENIA.
Background: Verbal Memory (VM), Working Memory (WM), and Executive 
Function (EF) have been largely study in patients with schizophrenia (SZ) and 
proposed as endophenotypes of the disease. Patients in all stages of the disease 
have exhibited reduced VM, EF and WM capacity. Stroop Test has been used 
to access EF; Hopkins Verbal Learning Test (HVLT) to access VM and Wechsler 
Adult Intelligence Scale (WAIS-III) to access WM (Letter-Number Sequencing 
and Digit Span). The aim of this study was to test VM, WM and EF in healthy 
siblings of patients with SZ (SB) to compare it with matched healthy controls.
Methods: Forty-five SB (24 females, ages mean 39.6 ± 1.8 and mean of years 
of education 12.08 ± 3.6) were compared with forty-five healthy controls 
(23 females, ages mean 38.7 ± 1.3 and mean of years of education 12.02 ± 
3.0). Results: SB performed worse than controls in VM test (p<0.01, r=0.3 
on the delayed recall test and p<0.05, r=0.2 to total recall test). However 
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no differences have been found in executive function (Stroop Interference) 
(p = 0.88) or WM (p = 0.19 to LetterNumber Sequencing and p=0.61 to 
Digit Span).Conclusion: We haven’t found differences in working memory or 
executive function when SB were compared with healthy controls, however 
we found a significantly difference in VM with a small effect size. Our results 
support the hypothesis that impairment in verbal learning could be considered 
an intermediary phenotype of SZ. More studies are necessary to identify if 
impairment in VM is a risk factor to develop psychiatry disorders.
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Thiago Botter Maio Rocha is a child and adolescent psychiatrist from Porto 
Alegre, Brazil. He concluded his medical training at the Federal University 
of Rio Grande do Sul (UFRGS), where he also has just been admitted to the 
Post-Graduate Program for MSc degree in Psychiatry. He has done both his 
Psychiatry and Child and Adolescent Psychiatry training at the Hospital de 
Clinicas de Porto Alegre (HCPA) Medical Residency Program.
SUMMARY PROJECT:
Mental disorders are the leading causes of morbidity and mortality among 
adolescents, affecting the quality of life of individuals not only in this period 
but throughout adulthood. This project aims to examine factors associated 
with changes in the course of two major psychiatric diagnoses in adolescence. 
During adolescence, the prevalence of depressive disorders increases from 
about 5% to 20%. The attention deficit / hyperactivity disorder (ADHD), 
which affects more than 5% of children, reaches remission in many, but not 
all affected individuals in adolescence. Thus, our goal is to identify predictors 
of incidence of depression and persistence of ADHD in the period between 11 
and 18 years old. In a first phase, we will identify individual risk factors for 
outcomes above, from the literature review and study of 1993 Pelotas Birth 
Cohort, which includes more than four thousand participants followed until age 
18. From these findings, we will develop a composite score of risk for incidence 
of depression and persistence of ADHD in adolescence. The identification 
of modifiable risk factors and the development of risk scores predictors of 
incidence and chronicity may assist in defining public policies for reducing the 
burden of disease in adolescence and in subsequent ages.
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Medical doctor graduate at Medical School of São José do Rio Preto (2004). 
Residency in Psychiatry at the Faculty of Medicine of Ribeirão Preto- University 
of São Paulo -FMRP / USP (2005-2007), and specialization in Psychotherapy 
(2008).Member of Brazilian Psychiatry Association since 2008.Currently 
have been  developing assistance, teaching and research  activities in  Day 
Hospital FMRP/USP.Master student in Mental Health Postgraduate Program at 
Department of Neurosciencesand Behavior Science, FMRP / USP. Research field 
in borderline personality disorder, bipolar disorder and early life stress.
Academic achievements and publications:
MAZER, A. K.; DOMINGOS, N.A.M. Avaliação Psicossocial de Pacientes 
Pediátricos com Câncer (Psychosocial Assessment of Pediatric Patients with 
Cancer).  HB Científica (FUNFARME). , v.10, p.10 - , 2003.
PAZ, D.A.; MAZER, A. K. . Diagnóstico Diferencial em Paciente com Sintomas 
de Humor e Sintomas Psicóticos (Differential Diagnosis in Patients with Mood 
Symptoms and Psychotic Symptoms). 2010. (Poster presentation/Congress)
MAZER, A. K. ; PINTO, J.P. ; CHAVES, C. ; MORAIS, S.L. ; HALLAK, J.E.C. . 
Agressividade e Síndrome de Cornélia de Lange: relato de caso e revisão da 
literatura(Aggressiveness and Cornelia de Lange syndrome: case report and 
literature review). 2007. (Poster presentation/Symposium)
PINTO, J.P.; MORAIS, S.L.; MAZER, A. K. Difícil diagnóstico de quadro de intensa 
agressividade em paciente mantido sob contenção física contínua por 2 anos 
(Difficult diagnostic  in patient with intense aggression and maintained on 
physical restraint continued for 2 years). 2007. (Oral presentation/Congress)
SUMMARY PROJECT:
Bipolar Disorder (BD) and Borderline Personality Disorder (BPD) have common 
clinical features that difficulties the differential diagnosis. Factors involved in 
its development  and neurobiology, as early stress and psychoneuroendocrine 
markers, may represent indicators that differentiates them.
Assessment of early life stress and HPA axis associated with diagnosis of BD and 
BPD, in 26 subjects results in positive correlations between specific types of 
early stress and hormonal dosage in this preliminary sample. Thus, it indicates 
a possible distinguishing factor between the disorders studied by the analysis 
of parameters related to stress and early functioning of the HPA axis.
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Ary Gadelha obtained his Bachelor’s degree in Medicine at Universidade 
Federal do Ceará (UFC) in 2004, finished the Psychiatry Residency in 2007, 
and is currently a PhD student at Universidade Federal de Sao Paulo (UNIFESP), 
Department of Psychiatry. He is a member of the Interdisciplinary Laboratory 
of Clinical Neurosciences (Linc) at the Department of Psychiatry of UNIFESP 
and the scientific coordinator of the Schizophrenia Program (PROESQ) of 
UNIFESP. He is also the general coordinator of PRISMA, which is an outpatient 
clinic to individuals at-risk for psychotic disorders. Todate, he has authored 
or co-authored thirteen publications in refereed journals. The main interest 
of his Ph.D. research involves the characterization of the measurements of 
endopeptidases activity in schizophrenia and first episode psychosis.
SUMMARY PROJECT:
Several different evidences point toward the involvement of the DISC1 protein 
and its ligands such as the nuclear distribution element-like (Ndel1) in 
schizophrenia (SCZ). The interaction with the SCZ vulnerability marker DISC1 
regulates Ndel1 enzymatic activity. This led us to determine and compare 
the plasma Ndel1 enzyme activity of 92 SCZ patients and 97 health controls 
(HCs). A 32% lower mean value for Ndel1 activity was observed in SCZ 
patients compared to HCs (t = 4.47; p < 0.001). The AUC for receiver operating 
characteristic (ROC) curve was 0.703. Treatment-resistant (TR) SCZ patients 
presented a significant lower Ndel1 activity compared to non-TR patients (t 
= 2.25; p = 0.027). A lower enzymatic activity was significantly associated 
with both non-TR (p = 0.002; B = 1.19; OR = 3.29, CI 95% 1.57-6.88) and TR 
patients (p < 0.001; B = 2.27; OR = 9.64; CI 95% 4.12-22.54). The confounding 
effects of treatment with antipsychotic drug (clozapine or olanzapine), nicotine 
dependence, and body mass index revealed no significant correlation with the 
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measured Ndel1 enzyme activity. This is the first study showing that Ndel1 
enzyme activity is different among SCZ patients and HCs, with significant lower 
plasma Ndel1 activity for TR patients compared to non-TR. Our findings further 
support the investigation of the Ndel1 enzyme activity as a promising approach 
for the understanding of DISC1 and Ndel1 pathway, and of the neuropeptides 







DEGREE FIELD OF STUDY
UNIFESP MSc Schizophrenia Disease
UNIFESP PhD Central Nervous System
BIO SKETCH:
Camila Miyagui Yonamine is currently a Postdoc student at Universidade 
Federal de Sao Paulo (UNIFESP), Department of Pharmacology. Her Posdoctoral 
research involves the study of oligopeptidases in Schizophrenia. She obtained 
her Bachelor’s degree in Biologist from MACKENZIE in 2004 and Master’s degree 
in Nuclear Technology Application from IPEN (Nuclear and Energy Research 
Institute) in 2007. She has also been a member of the Interdisciplinary Lab of 
Clinical Neurosciences at the Department of Psychiatry of UNIFESP. To date, 
she has authored one national and three international publications and co-




Camila M. Yonamine, Ary G.A.A. Neto, Vitor Oliveira, Rodrigo A. Bressan, Mirian 
A.F. Hayashi
Schizophrenia (SCZ) is a severe chronic mental disease. The angiotensin 
I-converting enzyme (ACE) is mainly known due to its ability to convert Ang 
I into Ang II, which has hypertensive activity, but this oligopeptidase exhibits 
broad substrate specificity. ACE catalyzes the degradation of bradykinin (BK), 
neurotensin (NT), substance P, enkephalins, and other peptides. Interestingly, 
NT is a neuropeptide implicated in the pathophysiology of SCZ. Moreover, NT 
receptor agonists have been recently suggested to be potential antipsychotics. 
It is important to mention that ACE is widely distributed in many tissues, 
including the CNS, and changes in the levels of ACE have been found in 
the brain of SCZ patients. Although statistically not significantly, elevated 
cerebrospinal fluid (CSF) has been reported in neuroleptic-treated chronic 
patients. Thus, our primary objective in this project is to compare the plasma 
ECA enzyme activity levels of SCZ patients and healthy controls (HCs). Herein, 
88 SCZ patients were compared to 102 healthy controls (HCs) regarding ACE 
specific enzymatic activity in plasma. Subjects with hypertension and/or using 
antihypertensive drugs were excluded. A significantly lower mean value for ACE 
activity in SCZ patients compared to HCs (F=0.16, p< 0.001) was observed. 
Individuals with ACE enzymatic activity above the median increased almost 
4 times the risk for SCZ (p < 0.001; OR= 3.9, CI 95% 2.13-7.12). The area 
under the receive operating characteristic (ROC) curve was 0.70, suggesting 
a moderate prediction accuracy. Further studies are needed to improve our 
understanding on the biological underpinnings of the observed difference. This 
knowledge might contribute to find new biomarkers with potential clinical use 
in supporting diagnosis and/or drug-choice. Financial support from FAPESP, 
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I am currently a third-year PhD candidate at the Psychiatric Institute of the 
University of São Paulo. My research focuses on rare variation in the genome 
of obsessivecompulsive disorder patients (using array and whole exome 
sequencing). These variations are envolved with neurodevelopmental genes 
that can help us understand the risk factors for developing mental disorder. In 
the period from October 2011 until June 2012 I did an Exchange program of PhD 
at Yale University, Laboratory of Matthew W. State, M.D., Ph.D. Department 
of Psychiatry Yale University School of Medicine, learning analysis of copy 
number variation and rare single nucleotide variation. Is a research collaborator 
of INPD (National Institute of Development Psychiatry) and) and PROTOC (OCD 
Research Group at the University of São Paulo). To date, I have published eight 
scientific articles in refereed journals.
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SUMMARY PROJECT:
WHOLE-EXOME SEQUENCING IDENTIFIES DE NOVO POINT MUTATIONS IN 
OBSESSIVE COMPULSIVE DISORDER
Carolina Cappi; Helena Brentani; Stephan J. Sanders; Michael T.Murtha; Juliana Diniz; 
Michael Walker; Leandro Lima; Renato Puga; Viviani Neri; Roseli Shavitt; Michael 
Bloch; Matthew W. State; Euripedes Constantino Miguel, Thomas V. Fernandez
Whole exome sequencing for rare and de novo variants has become an essential 
approach for gene discovery in psychiatric disease. However, the overall 
contribution of rare and de novo single nucleotide variants SNVs to obsessive-
compulsive disorder (OCD) remains to be characterized. We conducted a family-
based study of 20 OCD sporadic trios (affected proband and their unaffected 
parents) to determine the frequency of spontaneous (de novo) mutation and 
to identify novel risk regions and relevant molecular pathways in OCD. Since 
a large amount of data generated, we consider those with greatest impact 
on protein function, missense, nonsense, and canonical splice site variants, 
using the RefSeq hg19 reference genome. We found 13 de novo variations. 
We confirmed, via PCR, 11de novo SNVs in 18 OCD trios that passing quality 
control. Using an in-house script algorithm, we generated a protein–protein 
interaction (PPI) network of the genes harboring de novo SNVs. Subsequently, 
a pathway analysis was conducted using the genes of this network in Ingenuity 
Pathway Analysis (IPA, Ingenuity Systems, www.ingenuity.com). This analysis 
found an enrichment of genes involved in immunological systems. We then 
used GeneMANIA to extend the list with functionally similar genes based on 
genomic and proteomic data. Pathway enrichment using this extended gene 
list confirmed the involvement of immunological systems. We conducted an 
pathway analysis, using IPA, of inherited rare variants, annotated using data 
from the 1000 Genomes Project and NHLBI GO Exome Sequencing Project. 
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BIO SKETCH:
Celina Andrade Pereira is currently a Master Degree student at Universidade de 
Sao Paulo (USP), Department of Psychiatry. Her master degree project involves 
a teleeducation program to train elementary teachers in child psychiatry. She 
obtained her Bachelor’s degree in Psychology from Pontifícia Universidade 
Católica de Sao Paulo (PUC-SP) in 1998 and two post-graduations latu sensu 
in drug addiction prevention in 2001 and 2006, both at the Department 
of Psychiatry of UNIFESP. To date, she is finishing, as the first author, three 
scientific articles in refereed journals. She wrote and translated two books and 
a chapter in a book.
SUMMARY PROJECT:
MENTAL HEALTH TRAINING FOR ELEMENTARY SCHOOL TEACHERS AND ITS 
IMPACT ON SCHOOL ATMOSPHERE – AN INPD PROJECT
MAIN OBJECTIVES: To develop and test the efficacy of a computer-based training 
to elementary school teachers of the most common mental health problems. 
Outcomes: (a)early identification of the most common mental health problems 
among children and adolescents, (b)teacher’s acquirement of manage skills to 
better deal with behavior problems and (c)teacher’s acquisition of important 
knowledge to refer students to treatment when necessary.
METHODOLOGY: The content used in the educational intervention is based 
on a) Similar telemedicine tools already developed in other countries and 
consulting to specialized professionals in child and adolescent psychiatry and 
child education. The partnership with the Department of Telemedicine, Faculty 





c. Educational videos 
d. Strengths and Difficulties Questionnaire Tutorial
e. Internet forum
f. Web-Conference
This research includes two steps: a pilot project and a RCT intervention.
a. Pilot project, without control group – 7 sessions, one per week, during a 
pedagogical school meeting to access the educational environment. 39 teachers 
without a control group composed the sample. The main objective of this pilot 
was to verify the feasibility of the training and to test the teleeducation tools 
used during the training.
b. RCT – Randomized Clinical Trial. Nine schools were randomized in 3 groups 
of different interventions: a teleeducation group; a group that received only a 
written material and a DVD about mental health and a 3rd group that was a 
waiting list group.
All teachers participating project were asked to answer questionnaires before 
and after the intervention. The outcomes evaluated were: knowledge about 
child mental health symptoms and how to deal with children with related 
behavioral problems, attitudes and beliefs towards mental health issues. The 
same outcomes that were
analyzed in the pilot project were analyzed for the RCT
RESULTS: Comparisons between pretest and posttest revealed: a discreet 
reduction towards stigma, and a light increase of mental health knowledge, 
how to proceed in face of a student with a mental disorder. Attitudes regarding 
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mental health subjects had a significant increase.
CONCLUSIONS: It’s important to implement clinical trials with a larger sample 
to better evaluate the effectiveness of the training and be able to generalize it’s 
results. Once evaluated, we can expand this model to a national scale.
clarice SaNdi MadrUga
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Research Associate at UNIAD/UNIFESP
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Clarice has recently awarded a PhD degree in Psychiatry and Medical 
Psychology by the Federal University of São Paulo. Was a Research Associate 
with at the Health Service and Population Research at the Institute of Psychiatry 
of the Kings College in London from 2008 to 2010 and is currently a Research 
Associate at UNIAD at UNIFESP where she coordinates the Second Brazilian 
National Alcohol Survey. Her field of interest is epidemiology of addictions, 
where she has authored five publications in peer- reviewed journals. 
SUMMARY PROJECT
ILLEGAL SUBSTANCE USE IN BRAZIL – THE SECOND BRAZILIAN NATIONAL 
ALCOHOL AND DRUG SURVEY (BNADS)
Clarice S Madruga, Ilana Pinsky, Raul Caetano, Ronaldo Laranjeira
Introduction: Brazil is undergoing a broad public debate as its drugs 
constitution is due to be reviewed. The knowledge of nationally representative 
consumption rates of illegal drugs should provide the necessary foundation to 
the debate allowing evidence-based decisions. Method: The Second Brazilian 
National Alcohol and Drugs Survey developed by the National Institute of 
Policies on Alcohol and Drugs (INPAD) and the Federal University of Sao Paulo, 
investigated the consumption of all psychotropic drugs and its associations. 
Dependence was assessed among cannabis and cocaine users using the Severity 
of Dependence Scale. The survey used probability multistage cluster sample 
design to select 4607 participants aged 14 and older from 149 municipalities 
across the country, achieving a total response rate of 77%. Results: Over 6% of 
the adult population have tried cannabis at least once in their lives, 3% reported 
having used it in the last year. Over half of the users (62%) tried cannabis for 
the first time before they were aged 18. Dependence rate was 37% among all 
users - 0.6% in the general population. Cocaine experimentation was reported 
by over 4% of the adult population, whilst 2% used it in the last year. Intra- 
nasal cocaine rates were 4% lifetime use and 2% last year use among adults; 
smoked cocaine (crack/merla/oxi) was tried by 1.4% of the adult population, 
1% reported having used it in the last year. Over 45% of the users have tried 
cocaine before they were 18 years old. Dependence was identified in nearly 
half of the current users (48%), injected cocaine was reported by 14% of the 
users. Prevalence of lifetime and last year use of all other illegal drugs combined 
was 4% and 1.6% respectively. Conclusion: Brazil is the second largest cocaine 
market in the world with regard to the sheer number of users. The knowledge 
of population-based studies must guide necessary changes in the health and 
legal systems and underlie policy makers’ decisions. 
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Clarissa Dantas is a full-time Assistant Professor at the University of Campinas, 
UNICAMP, Psychiatry Department, Medical School, Campinas, São Paulo, 
Brazil, since September, 2012. She finished Psychiatry residency at UNICAMP 
in February, 2003. Later that year she was hired as Assistant Psychiatrist at the 
Psychological and Psychiatric Service for Students at UNICAMP (SAPPE), where 
she worked until 2009 not only as a clinical psychiatrist, but also researching 
on university students’ mental health. Simultaneously,she had been working in 
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psychiatric hospitals and community mental health services with patients with 
severe mental disorders. She obtained her Master of Science degree at UNICAMP, 
in 2006, having studied insight and psychosis, and her PhD, in March, 2011, 
with a thesis on the psychopathology of negative symptoms of schizophrenia. 
In 2009 she became assistant psychiatrist at the Psychiatry Department of the 
Medical School, UNICAMP, and then Substitute Professor in August, 2011. She 
has been participating in research groups within the Psychiatry Department 
and in collaboration with groups from other departments and institutions. 
To date, she has authored and co-authored more than fifteen papers on 
university students’ mental health, insight in psychosis, negative symptoms 
and cognition in schizophrenia, and psychopathology in general, published in 
refereed journals.
SUMMARY PROJECT:
Anomalous self-experiences in university students who seek help at a campus 
mental health service: evaluation during the academic year of 2013. Early 
detection of psychotic syndromes may have a positive impact in their in 
their course and outcome. Recently, a growing body of research has focused 
on early diagnosis and intervention. Within this context, putative genetic, 
neuroimaging and psychopathological markers have been investigated 
in an attempt to identify strong predictors of the transition to psychosis. 
Subtle not-yet psychotic disturbances of subjectivity, called anomalous self- 
experience – which comprise an unstable sense of self-presence and first 
person perspective, a lack of basic sense of self-identity, disturbances of the 
tacit fluidity of the field of awareness, hyper-reflexivity, and perplexity, i.e. a 
pervasive difficulty in grasping the familiar and taken for granted meanings – 
have been proposed as psychopathological markers. Considering that psychotic 
experiences and most of mental illnesses have their onset during adolescence 
and young adulthood, many individuals will experience their first psychiatric 
episode during college. The aim of this study is to investigate the occurrence 
of anomalous self-experience among students that spontaneously seek help 
at the Psychological and Psychiatric Service for Students of the State University 
of Campinas (SAPPE/UNICAMP) during the academic year of 2013. Clinical and 
socio-demographic data will be collected and the Brazilian versions of the 
Examination of Anomalous Self-Experience (EASE), M.I.N.I. Plus, HAM-D and 
HAM-A will be adopted. This study is expected to characterize the occurrence 
of anomalous self-experience within this population by determining its 
prevalence and investigating its correlation to socio- demographic, clinical and 
other psychopathological variables. 
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Graduation in Medicine at Lutheran University of Brazil in 2006 and 
Specialization in Psychiatry in 2010. Master in Mental Health in Program of 
Postgraduate of USP-Ribeirao Preto (2012). Currently making PhD in Mental 
Health in Program of Postgraduate of USP-Ribeirao Preto. Has experience in 
the clinical care of adults in psychiatry and neurology. Currently is assistant 
psychiatrist of outpatient psychiatric clinic of the Clinics Hospital of Ribeirao 
Preto of the University of Sao Paulo. Addition to developing the function of 
supervisor of service residency in psychiatry in outpatient clinic of Mood 
Disorders at the Clinics Hospital of Ribeirao Preto of the University of Sao Paulo. 
Moreover, develops activities of teaching and academic training, with emphasis 
on Mental Health, Psychiatry and Neurosciences. Published until the present 
time: 9 original research articles and reviews and 3 book chapters. Currently is 
reviewer of the journal Psychology & Neuroscience. Has participations in national 
conferences as a speaker as well as more than 80 participations in international 
congresses and national in form of poster. Their studies relate to the diagnosis and 
treatment of Affective Disorders, Depressive and Bipolar and its relationship with 
the Early Life Stress and the Hypothalamic-Pituitary-Adrenal.
SUMMARY PROJECT:
We aim to evaluate the changes of the HPA axis and in the function of 
glucocorticoid and mineralocorticoid receptors in depressed patients with or 
without early life stress (ELS). We search also evaluate the relationship between 
the clinical course of depression, the HPA axis measures and prediction of 
treatment response. METHODS: Will be selected a sample of 100 subjects 
composed by two main groups: a) patients with current depressive episode; 
b) healthy control group. From this initial sample will be two  subanalysis. 
Firstly,  60 patients with current depressive episode will be divided into two 
groups according to the ELS through the Childhood Trauma Questionnaire. For 
the second subanalysis, the 60 patients with current depressive episode will 
be divided into: respondersand non-responders to treatment. Patients will be 
assessed by the Mini International Neuropsychiatric Interview for diagnosis 
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of depression. To assess the severity of depression will be used the Hamilton 
Depression Rating Scale and the  Montgomery-Asberg Depression Rating 
Scale score. Endocrine evaluation will be placebo-controlled,  single-blind 
for patients and controls, non-randomized. The effects of Fludrocortisone, 
Prednisolone, Dexamethasone and Espironolactone will be assessedthrough 
the salivary and plasma cortisol, adrenocorticotropic hormone (ACTH), 
dehydroepiandrosterone (DHEA), vasopressin (AVP), plasma renin activity 
(PRA),  aldosterone andprolactin. The salivary cortisol will be collected at 22:00 
after taking the medication or placebo and a new collect will be performed 24 
hours after. Saliva samples will be collected on waking, 30 and 60 min after 
waking. New plasma and saliva samples will be collected between 8:00 and 
8:30 min in the following days after the challenges to measure the salivary 
and plasma cortisol, ACTH, DHEA, AVP, PRA, aldosterone and prolactin. Patients 
will be evaluated at two  times: in admission in the study (current depressive 
episode - HAM-D> 17) and 60-90 days after.
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BIO SKETCH:
Cristiano Noto got his Bachelor’s degree in Medicine from Universidade Federal 
de Sao Paulo (UNIFESP) in 2006 and did the Psychiatry Residency at the same 
University (2008-2011). His Master’s degree was obtained from UNIFESP in 2012 
with a research on biomarkers in Schizophrenia. In 2012 he went to The Zucker 
Hillside Hospital, NY (USA) as a Visiting Scientist. Currently he is a PhD student 
at UNIFESP, Department of Psychiatry. His research involves Schizophrenia, 
First-episode Psychosis, Inflamation and Biomarkers.. He is also coordinator 
of the First-episode Psychosis Research Unit at Faculdade de Ciências Médicas 
da Santa Casa de São Paulo (FCMSCSP). He has published scientific articles as 
author and coauthor in refereed journals and organized a book that summarizes 
the advances in the multidisciplinary treatment of schizophrenia.
SUMMARY PROJECT:
Introduction: Recent studies on schizophrenia have suggested a model in 
which environmental risk factors and genetic vulnerability work together 
for the development of the disease. Biological markers such as Brain Derived 
Neurotrophic Factor (BDNF) and inflammatory cytokines are involved in the 
expression of many neurological and psychiatric disorders, but their role in 
schizophrenia are still unclear. Objective: This study analyzed serum biomarkers 
in patients with schizophrenia and in a group of healthy volunteers to investigate 
a possible association between levels of biological markers with specific clinical 
characteristics, such as depressive symptoms or treatment resistance. Methods: 
60 patients with schizophrenia and 120 controls were included and underwent 
psychiatric interviews and blood withdrawn for determination of peripheral levels 
of BDNF and inflammatory cytokines. Results: A positive correlation was found 
between BDNF and depressive symptoms among patients with schizophrenia. It 
was also observed elevated levels of TNF receptors in patients with specific clinical 
characteristics. Conclusion: The results support the involvement of neurotrophins 
and inflammatory abnormalities in the physiopathology of schizophrenia and its 
possible role as a marker of disease severity.
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Daniel Fatori is currently a PhD student at the University of São Paulo Medical 
School (FMUSP), Department of Psychiatry. His main field of research presently 
is child and adolescent mental health economics. He obtained his Bachelor’s 
degree in Psychology from Mackenzie Presbyterian University (UPM) in 2008 
and Master’s degree in Developmental Disorders from UPM in 2010. He is a 
collaborator in the Institute of Developmental Psychiatry (INPD) among 
many other research projects. Other areas of interest: child and adolescent 
psychopathology, mental health services, global mental health, epidemiology 
and statistics. To date, he has authored or co-authored several publications in 
refereed journals, including one article in The Lancet.
SUMMARY PROJECT:
BACKGROUND: Children and adolescent mental disorders (CAMD) are prevalent 
worldwide and are also known to cause enormous economic costs to  society as 
a whole.  Data regarding the cost of mental disorders in childhood are useful for 
planning the health system. However, there are no costof-illness studies in the 
field of children mental health in Brazil. OBJECTIVES: To estimate and compare 
the costs of (a) children diagnosed with mental disorders, (b) children with 
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symptoms but no diagnosis of mental disorder, and (c) children with no mental 
disorder or symptoms. METHODS: 2512 children aged 6-12 years in schools of 
Porto Alegre and Sao Paulo was selected through a survey of 9937 children. 
Two techniques were used for sample selection: random selection of children 
enrolled in schools and selection of children at high risk for developing mental 
disorders (psychiatric family history). Instruments: assessment of mental 
disorders in childhood: Development and Well Being Assesment (DAWBA); 
survey of sociodemographic profile, use of health services and other variables, 
we used a comprehensive questionnaire developed specifically for the study 
by researchers experienced in the field of epidemiology. Variables associated 
with cost-of-illness that will be analyzed: treatment for mental disorders, 
care for school problems, social service/shelter/child protection agency/court 
or prosecution, expulsion and suspension from school/truancy/school failure, 
government benefits, accidents, unemployment of parents. 
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Daniel Lucas da Conceição Costa is currently a PhD student at Universidade 
de São Paulo (USP), Department of Psychiatry. He is conducting a clinical trial 
entitled “Serotonin reuptake inhibitor augmentation with NAcetylcisteine in 
resistant obsessive-compulsive disorder: a double-blind, randomized and 
controlled study”.
Selected Publications
1. Assunção MC, Lucas da Conceição Costa D, Mathis MA, Gedanke Shavitt R, 
Arzeno Ferrão Y, Rosário MC, Constantino Miguel E, Rodrigues Torres A (2012) 
Social phobia in obsessive-compulsive disorder: Prevalence and correlates. J 
Affect Disord
2. Conceição Costa DL, Chagas Assunção M, Arzeno Ferrão Y, Archetti Conrado 
L, Hajaj Gonzalez C, Franklin Fontenelle L,Fossaluza V, Constantino Miguel E, 
Rodrigues Torres A, Gedanke Shavitt R (2012) Body dysmorphic disorder in 
patients with obsessive-compulsive disorder: Prevalence and clinical correlates. 
Depress Anxiety
3. Diniz JB, Miguel EC, Oliveira AR, Reimer AE, Brandão ML, Mathis MA, 
Batistuzzo MC, Costa DL, Hoexter MQ (2012)Outlining new frontiers for the 
comprehension of obsessive-compulsive disorder: A review of its relationship 
with fear and anxiety. Rev Bras Psiquiatr 34 Suppl 1:81-91
SUMMARY PROJECT:
SEROTONIN REUPTAKE INHIBITOR AUGMENTATION WITH N-ACETYLCISTEINE IN 
RESISTANT OBSESSIVECOMPULSIVE DISORDER: A DOUBLE-BLIND, RANDOMIZED 
AND CONTROLLED STUDY
Obsessive-compulsive disorder (OCD) is a debilitating psychiatric condition with 
a lifetime prevalence of 2-3%. The efficacy of both cognitive-behavior therapy 
(CBT) and serotonin reuptake inhibitors (SRI) for obsessive-compulsive disorder 
(OCD) treatment has been well established in controlled studies. Although 
most patients benefit from those treatments, up to 60% may not respond to 
a first trial with any of these options in effectiveness studies. Riluzole is an 
anti-glutamatergic agent that has been associated with improvement of OCD 
symptoms in an open label study of SRI augmentation. From this positive result, 
it has been hypothesized that other agents acting on the glutamatergic system 
could enhance the effect of the SRI in treatment-resistant OCD patients. The 
main objective of this randomized, double-blind, placebo-controlled study is 
to determine if N-Acetylcysteine (NAC), an anti-glutamatergic drug, is effective 
as an augmentation agent in treatment-resistant OCD subjects. The primary 
outcome is the reduction of the initial scores of the Yale-Brown Obsessive 
Compulsive Scale (Y-BOCS). Forty OCD patients will compose the sample 
and will be treated as outpatients. Half of them will receive SRI augmentation 
with NAC and the other half will receive placebo in association with the IRS in 
use. The study hypothesis is that treatment with NAC is effective in reducing 
OCD symptoms, as measured by the Yale-Brown Obsessive Compulsive Scale 
(Y-BOCS) after 16 weeks of follow-up. 
elSoN de MiraNda 
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Brazil UNIFESP
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Elson Asevedo is a psychiatrist working at the Program for Recognition and 
Intervention for Individuals in At-risk Mental States (PRISMA), at Federal 
University of São Paulo (UNIFESP). He is a member of the International 
Society for Bipolar Disorders, Brazilian Psychiatric Association and Paulista 
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Medical Association. Dr. Asevedo obtained his degree in Medicine at Federal 
University of Triângulo Mineiro, Minas Gerais, Brazil and continued his study 
in the Psychiatry Residency Program of UNIFESP, where he continues both  as 
a MSc student and psychiatrist. To date, he has authored or co-authored five 
publications in refereed journals.
SUMMARY PROJECT:
OBJECTIVE: TO COMPARE SERUM LEVELS OF BDNF, OXIDATIVE MARKERS AND 
CHEMOKINES BETWEEN PATIENTS WITH SZ  AND HEALTHY CONTROLS, AND 
INVESTIGATE THE IMPACT OF THESE BIOMARKERS IN COGNITIVE PERFORMANCE. 
Methods:  Thirty individuals with SZ according to DSM-IV and  chronically 
medicated from the Schizophrenia Program at UNIFESP, and  27 healthy controls 
were included. The following biomarkers’ blood levels were determined:  BDNF, 
TBARS, protein carbonyl content  (PCC)  and  the  chemokines IP-10/CXCL-10, 
IL-8/CXCL-8, CCL-11, CCL-24/Eotaxin-2,  CCL-2/MCP-1, MIP-1/CCL-3.  Selected 
neuropsychological tasks were administered to assess verbal learning, verbal 
fluency, working memory,set shifting, inhibition  and complex executive 
function tasks.
Results: Compared with the healthy control group, individuals with SZ presented 
significantly higher levels of BDNF and the chemokine CCL-11, and lower levels 
of TBARS and the chemokine IP-10/CXCL-10. Compared with healthy controls, 
individuals with SZ exhibited deficits in verbal learning (Hopkins test). When 
we examined only the SZ group, BDNF levels were positively correlated with 
semantic generation tasks (Spearman correlation test; r = 0.38, p = 0.044), 
which is a timing measure. Working memory ability, as evaluated by keep 
track task, was negatively correlated with PCC (Spearman correlation test; r = 
- 0.45, p = 0.014). Regarding chemokines, CCL-11 was negatively correlated to 
performance in working memory test (Spearman correlation test; r = - 0.40, p 
= 0.034), and positively correlated with cognitive flexibility task (r = 0.51, p = 
0.007). IL-8/ CXCL-8 was positively correlated with verbal fluency (Spearman 
correlation test; r = 0.38, p = 0.048). CCL-24/Eotaxin-2 was positively 
correlated with semantic generation ability (r = 0.42, p = 0.024) and letter 
memory task (Spearman correlation test; r = 0.38, p = 0.049). 
Conclusions:  Our results indicate that cognitive performance in SZ is associated 
with mediators of neuroplasticity that can be measured peripherally.
eMileNe reiSdorfer
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Mental Health in Primary 
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BIO SKETCH:
Emilene Reisdorfer is a Registered Nurse with an interest in Primary Healthcare 
and Mental Health.Psychiatric Nursing PhD student at the University of São 
Paulo at Ribeirão Preto College of Nursing, with internship at Faculty of Nursing 
of the University of Alberta. Graduated in Nursing from the University of Santa 
Maria, specialized in Management of Basic Health Units in the National School 
of Public Health Sergio Arouca and Master in Public Health, Federal University 
of Santa Catarina, with an emphasis on Mental Health. Her particular focus 
includes the situations of individuals, their families and work situations with 
addictions and/or mental illnesses, especially in Primary Healthcare settings. 
Her doctoral research is ongoing, and focus on describing the pattern of alcohol 
use and uncover its meaning as it relates to the professional practice of primary 
health care professionals. Her other research projects often involve workplace 
stressors and mental health, as well as addictions in the workplace. Emilene 
received scholarship during her doctoral and masters program of study from 
the Brazilian Federal Agency for Support and Evaluation of Graduate Education. 
Emilene’s experiential background includes nursing education and clinical 
practice in the areas of Family Health Strategy, population and community 
health; pre-hospital  care.
SUMMARY PROJECT:
The professional practice of primary health care professionals with their 
patients that use alcohol is influenced by their knowledge and understanding. 
What is not as well understood is the relationship between their own personal 
use of alcohol and their professional practice. Every day, primary healthcare 
professionals face patients who need specific attention related to alcohol and 
tobacco addictions, but  in most part of the cases they do not know what to do 
or do not have a network to deal with the situation. One of the factors that can 
influence professional practice of primary healthcare professionals  is their own 
use of alcohol and tobacco. The main objective of this study is to describe the 
pattern of alcohol use and uncover its meaning as it relates to the professional 
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practice of primary health care professionals.  Guided by Symbolic Interactionism 
and Grounded Theory, a mixed method design was employed in this study 
situated in five small towns in the South of Brazil. A cross sectional survey 
with 500 healthcare professionals was realized to determine the prevalence 
of alcohol and tobacco use for comparison with the general population. 
This was followed with in-depth interviews and direct observation of 39 
primary healthcare professionals. To analyze the quantitative data was used 
a descriptive analysis. Preliminary analysis determined the presence of alcohol 
and tobacco use at rates lower than in the general population.  Preliminary 
qualitative analysis has revealed  that the meanings of alcohol and tobacco use 
are different between who use and who do not use the substances, but, in both 
cases, healthcare professionals realize that their alcohol use behavior should 
be a model for clients. These meanings influence the way in which  healthcare 
professional approach the clients, and its caused by social interactions with 
themselves, family and colleagues. Also suffers interference from their training 
to assist alcohol and tobacco users. As consequences, healthcare professionals 
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Fernanda Fiel Peres is currently an MSc student at Universidade Federal de 
São Paulo (UNIFESP), Department of Pharmacology. Her MSc research involves 
preventive pharmacological treatments in animal models of schizophrenia. 
She obtained her Bachelor’s degree in Biomedicine from UNIFESP in 2012, and 
has been a member of the Interdisciplinary Lab of Clinical Neurosciences at 
the Department of Psychiatry of UNIFESP. To date, she has co-authored two 
publications in refereed journals.
SUMMARY PROJECT:
PUBERTAL CANNABIDIOL TREATMENT PREVENTS THE EMERGENCE OF 
BEHAVIORAL ABNORMALITIES IN AN ANIMAL MODEL OF SCHIZOPHRENIA
Schizophrenia is a severe mental disorder associated to the neurodevelopmental 
process whose pharmacological approaches remain unsatisfactory. Developing 
preventive strategies is, therefore, of extreme importance. Cannabidiol, a non-
psychotomimetic compound of Cannabis sativa, has been reported to present an 
atypical antipsychotic profile in rodents and humans; however, so far no study 
has investigated its possible preventive role. Recently, we have characterized 
the SHR (Spontaneously Hypertensive Rats) strain as a potential animal model 
of schizophrenia since it presents decreased social interaction, hyperlocomotion 
and deficits in pre-pulse inhibition (PPI) and contextual fear conditioning (CFC) 
tasks, thus mimicking negative, positive and cognitive schizophrenia symptoms. 
Those behavioral alterations are specifically ameliorated by antipsychotics and 
potentiated by proschizophrenia manipulations. The aim of this study was to 
evaluate the potential preventive effect of a chronic pubertal treatment with 
cannabidiol on the behavior abnormalities presented by adult SHR strain as 
well as possible collateral effects.
Male SHR and Wistar rats (WR) (10/strain/drug) were treated with vehicle, 
0.5, 1.0 or 5.0 mg/kg canabidiol (CBD) from 30 to 60 postnatal days. Four 
weeks after treatment cessation, the rats were submitted to the evaluation of 
locomotor activity, CFC, PPI and social interaction. Potential side effects were 
analyzed during the pubertal treatment (body weight gain and catalepsy), and 
forty-eight hours and one month after treatment interruption (oral dyskinesia). 
All experimental procedures were approved by our local ethics committee and 
are in accordance with the U.S. Public Health Service’s Policy on Humane Care 
and Use of Laboratory Animals.
SHR treated with vehicle presented a decrease in social interaction time, an 
increase in locomotion, a deficit in PPI and impairment in CFC when compared 
to WR. The administration of 0.5 mg/kg cannabidiol during adolescence 
prevented hyperlocomotion as well as deficits in PPI and CFC in the adult 
SHR, although it didn’t modify social interaction time. In addition, pubertal 
cannabidiol treatment didn’t induce any of the side effects evaluated. In 
summary, our results indicate that cannabidiol can prevent the emergence of 
positive and cognitive schizophrenia symptoms without inducing side effects 
commonly seen with antipsychotics.
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BIO SKETCH:
I am a biomedical graduated at Universidade Federal de Sao Paulo (UNIFESP) in 
2004. I concluded my Master’s in Sciences at the Laboratory of Neurotransmitters 
at Departamento de Farmacologia (UNIFESP) in 2007. From undergraduate to 
Master’s I was involved with basic research. Between 2001 and 2003 I was 
studying the nephrotoxicity of antibiotics in mice mesangial cell culture at 
the Laboratory of Nephrology(UNIFESP). From 2003 to 2007 I studied animal 
models of dyskinesia, memory and sleep deprivation. I received sponsorships 
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from CNPq (undergraduate) and FAPESP (Master’s degree). After this time, I 
worked at the Laboratory of Immunogenetics, AFIP/UNIFESP as biomedical 
analyst (2007-2009).Nowadays, I am a Ph.D. Student at the Departamento de 
Psicobiologia (UNIFESP) and I have a FAPESP sponsorship. My study focuses on 
probable participation of sleep and sleep-wake pattern in early clinical stages 
of schizophrenia and bipolar disorder. This work is part from a broad study of 
early clinical stages headed by Dr. Rodrigo Bressan from Departamento de 
Psiquiatria (UNIFESP).At the same time, I have collaborated as a teacher in XII 
and XIII “Curso de Verão em Psicobiologia”, in 2012 and 2013. I conversed on: 
chronobiology, circadian rhythms, and sleep history.Since my undergraduate, I 
have participated in national and international scientific meetings, with work 
presentations. My last events were: 8th International Conference on Early 
Psychosis, 2012, poster; 26thAnnual Meeting of the Associated Professional 
Sleep Societies, 2012, oral presentation; IICongresso de Clínica Psiquiátrica, 
2012, listener; XIIICongresso Brasileiro do Sono, 2011, oral presentation; World 
Association of Sleep Medicine, 2011, oral presentation.I have authored, and co-
authored six publications, plus two submitted papers.
SUMMARY PROJECT:
Study of sleep and sleep-wake cycle patterns as possible predictors of 
psychosis and bipolar disorder development in individuals in ultra-high risk The 
study of early clinical stages of severe mental diseases  shows more and more 
importance. These stages have been called at-risk mental state-ARMS. Recent 
evidences suggest being possible identifying it based on clinical evolution, 
although the current knowledge lacks of efficient prediction mechanisms. 
Behavioral data support the idea that psychosis and bipolar disorder associate 
with sleep disturbances. In addition, sleep and sleep-wake cycle alterations 
relate to emotional responses and several events, increasing the chance of 
a vicious cycle between these alterations and emotional imbalance. It is 
possible that sleep disturbances are present in ARMS and could participate 
in its prediction.  This study is part from a thematic project: Prevention in 
Schizophrenia and Bipolar Disorder, whose principal investigator is Dr. Rodrigo 
Bressan. The idea is recognizing possible predictors of psychosis and bipolar 
disorder in the individuals with ARMS. Aim: Evaluate if there is a participation 
of sleep pattern and/or sleepwake cycle pattern in the prediction of psychosis 
and bipolar disorder in individuals with ARMS. Methods: Fifty individuals of 
both genders, between 12-25 years old, will be distributed in two groups(25 
volunteers with  ARMS, and  25 healthy control volunteers).Instruments: sleep 
questionnaires, complete  full-night polysomnography, and  actigraph. Partial 
results: Eleven individuals(7 men,4 women) fulfill ultra-high risk criteria based 
on Comprehensive Assessment ofAt-Risk Mental State (CAARMS).The mean 
age ±SD was 18.7±1.1 years; the body mass index(kg/m²) ±SD was 22.4±1.3 
in men and 18.5±0.8 in women. Both genders are eutrophic. Data pointed 
out an increase of N1 and N3 percentages(6.8±1.4 and 29.1±2.2,respectively) 
while a decrease was observed in the REM stage percentage(14.3±2.3).
These preliminary results seem indicating relevant changes in the normal sleep 
distribution in  ARMS. Expected outcomes: Our study is ongoing and partial 
results encouraged us about the next ones, mainly regarding to other parameters 
that will be investigated, such as microstructure of sleep and actigraphy. 
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Letícia Maria Nery Spíndola is biomedicine graduate and came to Genetics 
Division of the Department of Morphology and Genetics of Federal University 
of Sao Paulo (UNIFESP) to do a Scientific training. Born in São Paulo, Letícia 
explains that she went into biomedicine because she became interested 
in etiology and treatment of human disorders. She received an degree from 
Universidade Federal de São Paulo (UNIFESP) in 2012. In 2013, she will start 
her Master degree at Genetics Division of UNIFESP. She will work with high risk 
children for mental disease. 
SUMMARY PROJECT:
EFFECT OF DRD1 rs4532 AND DRD2 rs1799732 POLYMORPHISMS ON TREATMENT 
RESISTANT SCHIZOPHRENIA
Dysregulation of dopaminergic neurotransmission is involved in the 
pathophysiological processes of schizophrenia and, hence, some studies 
have investigated the role of genes  encoding dopamine receptors. Regarding 
therapeutics aspects, the overall treatment response is still limited and it is 
estimated that 20-30% of patients who have  schizophrenia do not respond 
to treatment with conventional antipsychotics. The aim of this study was to 
investigate the association between DRD2 rs1799732 (-114C Ins/Del)  and DRD1 
rs4532 (A/G) polymorphisms with schizophrenia diagnosis and treatment 
resistant (TR) schizophrenia. In the case-control study, we have analyzed 208 
patients with schizophrenia and 262 healthy controls. For investigate the effect 
of those polymorphisms on TR schizophrenia, we have analyzed 134 patients. 
The subjects were genotyped for rs1799732 and rs4532 polymorphisms by 
TaqMan probe based real time PCR assay and PCR-RFLP methods, respectively. 
Considering DRD1 polymorphism, we found an association between G-allele 
and TR schizophrenia (p=0.002; OR=2.58; 95% CI=1.41-4.71). Reinforcing this 
finding, for genotypes, we found a dose-response gradient with risk increasing 
with the number of G-allele copies: GG-homozygous presented a five-fold risk 
compared to AA-homozygous (p=0.017; OR=4.758; 95% CI=1.319-17.161) 
and an intermediate result for AG-genotype (p=0.058; OR=2.282; 95% 
CI=0.973-5.354), setting the common AA-genotype as reference. On the other 
hand, there was no significant difference in the allele (p=0.272) and genotype 
(p=0.403) frequencies of rs1799732 between patients and controls. Moreover, 
we have not found association between rs1799732 genotypes (p=0.998) or 
alleles (p=0.300) and TR schizophrenia. Although we have not find association 
between rs4532 polymorphism and schizophrenia (p=0.883), our result 
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suggests a possible role of DRD1 rs4532  polymorphism on TR schizophrenia, 
with G-allele being the genetic risk factor.  Therefore, rs4532 polymorphism 
may be a feasible pharmacogenetic marker for treatment response to 
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Lucas Rizzo is currently Phd student at Universidade Federal de São Paulo 
(UNIFESP), Department of Psychiatric and Medical Psychology. His PhD research 
involves immunology and aging in sub chronic and chronic bipolar patients. He 
has 3 years of experience in the psychiatric field as scientific initiation student 
in the Laboratory of Immunossenescence at Pontifícia Universidade Católica 
do Rio Grande do Sul (PUCRS), and his Final Paper was about early aging in 
patients with bipolar disorder. To date, he has authored or co-authored four 
publications in refereed journals, one book chapter.
SUMMARY PROJECT:
BACKGROUND: Bipolar disorder (BD) has been associated with increased low-
grade inflammation and premature cell senescence, as shown by reduced 
telomere length (TL). The human cytomegalovirus (CMV) promotes a latent 
asymptomatic infection in immunocompetent adults, and it has increasingly 
been involved with accelerated immunosenescence in aging studies. Here, 
we investigated the CMV serology and its relationships with cell senescence 
markers including TL and lymphocyte subsets in type 1 BD and healthy controls. 
RELEVANCE FOR THE FIELD: Despite the concept of accelerated cell aging 
may be a key role factor for the pathophysiology of bipolar disorder, it is still 
under-investigated. MAIN OBJECTIVES: To investigate the CMV serology and 
its relationships with cellular senescence markers including telomere lengths 
(TL) and lymphocyte subsets in euthymic patients with type 1 BD and healthy 
controls. METHODOLOGY:  Peripheral blood mononuclear cells and DNA were 
isolated and TL measured in twenty-two euthymic female BD type 1 patients 
and 17 age-matched controls by RT-qPCR. CMV-IgM and IgG titers were 
assessed by chemiluminescent assays. Lymphocyte subsets (T, NK, NKT) were 
phenotyped by flow cytometry. RESULTS OR EXPECTED RESULTS: BD patients 
had shorter TL but increased CMV-IgG levels than controls (all p < 0.01). The 
CMV-IgG levels were inversely correlated with shorter the telomeres. None of 
the subjects showed IgM reactivity for CMV, excluding acute viral infection. 
CMV-IgG levels were associated with expansion of senescent CD8+CD28- T 
cells and NK cells, involved with viral control. CONCLUSIONS OR EXPECTED 
OUTCOMES: These data concur to the hypothesis early accelerated aging in BD 
as shown by shortened telomeres and expansion of senescent T cells. This study 
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BIO SKETCH:
Marcos Santoro is currently PhD student at Morphology and Genetics 
Departament of São Paulo Federal University (UNIFESP). His research involves 
epigenetic and genetic aspects of schizophrenia, focusing in the prodromal 
phase of the disease. His Bachelor’s degree in Biomedicine was obtained at 
Universidade Estadual Paulista in 2009 and his Master’s degree in Morphology 
and Genetics was concluded in 2012, at Universidade Federal de São Paulo. The 
student is a member of the Interdisciplinary Lab of Clinical Neurosciences at the 
Department of Psychiatry of UNIFESP, and at the moment, he is the co-author 
of 3 publications.
SUMMARY PROJECT:
Schizophrenia and bipolar disorder (BD) are neurodevelopmental illnesses 
that cause an enormous burden of suffering, high morbidity and mortality 
rates. Both are complex diseases characterized by alteration in multiple 
genes, combined with epigenetic modifications and environmental factors. 
Since these disorders are diagnosed, the patients need care and treatment for 
the rest of their lives. Therefore, it is very important to study these disorders 
before transition to psychosis to better understand the pathophysiology of 
schizophrenia and BD, and also to find out biomarkers that can predict this 
transition. The aim of the present study is to analyze the gene expression of 28 
mRNAs and 88 miRNAs related to neurotransmission in four groups: 80 health 
subjects; 80 patients in first episode of psychosis; and 80 subjects Ultra High 
Risk (UHR) for psychosis, 20 of them with DiGeorge syndrome. Besides, it is 
expected a transition rate of 25% to psychosis in a follow up of two years, 
in which we will also analyze the gene expression of mRNA and miRNA. The 
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gene expression will be verified through Real Time qPCR technology. With this 
study, we expect to find differential expression of mRNA and miRNA, in order 
to discover new biomarkers of progression and transition to psychosis. To our 
knowledge, there is no such study investigating gene expression of mRNA or 
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BIO SKETCH:
I was Graduated in Psychology at Universidade Federal de Uberlandia (2009) 
and got a Master Degree in Science (Psychobiology) at the University of São 
Paulo (2012). During this time I gained experience in clinical psychology on 
cognitive behavioral approach and neuropsychological assessment, and later 
in the area of psychobiology and translational research. It is worth mentioning 
that in my Master’s research, we got interesting results showing that the 
expression of two glutamate transporters proteins in the brain of rats reared 
in social isolation since weaning through adulthood was altered. Currently I am 
a doctoral student in the Graduate Program in Mental Health, Department of 
Neuroscience and Behaviour, Faculty of Medicine of Ribeirao Preto, on Professor 
Dr. Mario Juruena supervision.  My  actual research  is on the neuropsychological 
and neuroendocrinological alterations in adulthood caused by early-life stress. 
We intend to perform a translational work correlating clinical and basic 
research data. Unfortunately, since my research is at an early stage, we have 
not yet results to show.  My research area includes: Psychiatric Disorders of 
Neurodevelopment; Neurobiology of Stress and Depression, Stress Effects of 
Early adulthood and Neuropsychology.
SUMMARY PROJECT:
The early stress is considered a risk factor for psychiatric disorders. Evidence 
indicates that adverse experiences early in life combined with genetic 
background culminate in increased sensitization of certain circuits, especially 
related to the pathophysiology of depression.  Studies have described the 
effects of early-life stress with different focuses, such as on HPA activity, 
changes of emotional behavior and cognition, or the plasticity of the 
hippocampus. However, it is not known to what extent and what are the 
mechanisms through which all these points are associated. In this regard, the 
combination of experimental techniques and translational studies may help to 
clarify those issues. Considering that, the aim of this work is to investigate the 
HPA axis activity and cognitive functions mediated by the hippocampus and 
prefrontal cortex in subjects with depression and a history of early life stress. 
The  methods proposed for this investigation include a translational model that 
will integrate experimental studies using rats submitted to maternal separation 
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Patricia Silva is currently a post doc student at Psychiatry Department of São 
Paulo Federal University (UNIFESP). Her research involves epigenetic and 
genetic aspects of schizophrenia, and response to pharmacological treatment 
in schizophrenia. Her Bachelor’s degree in Biology/Biotechnology was obtained 
at Universidade do Vale do Itajaí in 2004 and her Master’s degree in Morphology 
and Genetics was concluded in 2007, at Universidade Federal de São Paulo. Her 
PhD degree in Functional and Structural Biology was obtained in 2012, also at 
Universidade Federal de São. The student performed part of her PhD research 
at the King’s College London, under supervision of Dr. Jonathan Mills. The 
student is a member of the Interdisciplinary Lab of Clinical Neurosciences at 
the Department of Psychiatry of UNIFESP, and at the moment, she is the author 
of 8 publications.
SUMMARY PROJECT:
Schizophrenia is the most severe and debilitating mental illness among the 
psychiatric disorders. It’s a complex disease characterized by alterations in 
multiple susceptibility genes, which possibly act together with epigenetic 
and environmental processes. The current project aims to investigate gene 
expression of candidate genes for the development of schizophrenia and/or the 
response to  pharmacological treatment. Moreover, we aim to evaluate miRNAs 
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levels to investigate a possible epigenetic regulation of the genes evaluated in 
this project and others described in literature, as well as investigate the role of 
miRNA in treatment resistant schizophrenia (TRS). Eighty patients being treated 
with antipsychotics will be evaluated, 40 of them  are responders to treatment 
(non-TRS), and the other 40 are nonresponders (TRS). Peripheral blood samples 
will be collected from all subjects and RNA will be extracted from white blood 
cells. Gene expression will be performed with PCR array and will investigate 
28 genes involved in neurodevelopment, myelination, neuroplasticity and 
neurotransmission. Simultaneously, miRNA levels will be quantified  inpatients 
non-TRS and TRS using a commercial plate with 84 miRNAs sequences, related 
to neurodevelopment and neurotransmission.  The miRNAs investigation on 
response to pharmacological treatment of schizophrenia will provide new 
data on literature, and the results may provide a more effective treatment of 
schizophrenia, as well as a decrease on time of non-treated cases.
Pedro Mario PaN 
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Pedro Mario Pan has graduated in medical school in 2007 at PUC-Paraná, Brazil 
and has finished psychiatry residence program in 2010 at Universidade Federal 
de Sao Paulo (UNIFESP), Brazil. Currently, Pedro is a MSc student at Universidade 
Federal de Sao Paulo and at the National Institute of Developmental Psychiatry 
for Children and Adolescent (INPD) taking part in the  “High Risk Cohort Study 
for the Development of Childhood Psychiatric Disorders – the Prevention 
Project”. This study is a large community school-based cohort which combines 
psychopathology, cognitive neuroscience, genetics and neuroimaging. In the 
Prevention Project, Pedro is particularly interested in evaluating the trajectory 
of Bipolar Symptoms in childhood and early adolescence. He has authored or 
co-authored six publications in prominent peer-reviewed journals, such as 
Psychological Medicine and JAACAP.
SUMMARY PROJECT:
MANIA-LIKE SYMPTOM DIMENSIONS AND LATENT STRUCTURE IN CHILDHOOD 
AND EARLY ADOLESCENCE: ASSOCIATIONS WITH PARENTAL PSYCHOPATHOLOGY 
AND
Background: The phenomenology of pediatric bipolar disorder remains 
controversial.  To facilitate accurate diagnosis, it is important to define the 
dimensional structure of mania-like symptoms in non-clinical pediatric 
populations and the associations of these symptoms with functional 
impairment and familial risk. Bearing in mind that high risk and prodromal 
research of Bipolar Disorder is far from the development reached by the 
psychosis field (symptoms groups, criteria definitions, prospective evaluation), 
we aim to enhance the knowledge of subthreshold bipolar symptoms in young 
individuals. 
Methods: We have assessed parent-reported mania-like symptoms with 
Development and Well Being Assessment (DAWBA) in 2,512 children (6-
12 years-old). This sample was selected from 9,937 subjects screened in 
57 Brazilian public schools. Individuals positively screened for “episodes of 
going abnormally high” completed a specific BD section (n=479; 19.1%). 
Confirmatory Factor Analysis was used to test the model fit of a two-factor 
solution previously found: “Under-controlled (UC)” and “Exuberant (EX)”. We 
also used Latent Class Analysis (LCA) to identify groups of individuals affected 
by mania-like symptoms at different degrees of severity and  Item Response 
Theory investigated the severity and discrimination ability of each symptom. 
The associations of both latent constructs with psychiatric comorbidity, 
psychosocial impairment, and family history of psychopathology were tested.
Results: The two-factor model provided a good-fit to the previously proposed 
model. Multivariate analysis revealed that only UC dimension was independently 
associated with other psychiatric diagnosis and psychosocial impairment. The 
LCA yielded a small group of children with high levels of manic symptoms and 
a distinct profile of psychiatric comorbidity and impairment, called the “High-
symptom group”. Further, we identified significant associations between the 
UC dimension and the “High-symptom group” with parental history of affect-
related disorders (Depression, Mania, and Suicide Attempts); but not with 
family history of ADHD and Substance-Use Disorders. Both UC and EX items 
discriminate subjects across the “mania-like” latent trait, but EX items lay at the 
mild end of the severity spectrum while UC item lay at the severe end. 
Conclusions: In a large community-based sample, we extended previous 
findings of meaningful mania-like dimensions in childhood and early 
adolescence, and demonstrate specific familial associations with affect-related 
disorders. These latent constructs may be a proxy for the development of full BD 
and constitute an ‘at-risk’ group for the disorder. Analysis of the already collected 
data on cognition, neuroimaging and blood biomarkers, altogether with ongoing 
longitudinal assessments in this sample will provide information concerning the 
stability of mania-like symptoms and conversion to full-blown BD. 
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SUMMARY PROJECT:
A TRAINING OF CHILD AND ADOLESCENT FOR PRIMARY CARE PROVIDERS - 
PILOT STUDY
Rosane Lowenthal, Cristiane Silvestre de Paula, Chao Lung Wen
Providers from Primary Care Centers (UBS) must assist all individuals from a 
certain region, including child mental health problems. However, no specific 
mental health training is provided to professionals from UBS. Thus, the aims of 
this study are to develop, implement and evaluate an education model via tele-
education on child mental health to train health professionals from Primary 
Care Centers (UBS). It is a pilot study to test a training model structured in 
two modules: distance learning environments and face-to-face classes. Twenty 
five professionals, 12 doctors and 13 nurses, from five UBSs from São Paulo 
city, were trained. For the distance module, interactive tools were used. The 
face –to-face components were based on a structured training to promote 
better communication between health professionals, parents and children/ 
adolescents. The professionals were evaluated before and after training, 
according to (1) Specific Knowledge questionnaire (SK) and (2) a Knowledge, 
Attitude and Practice survey (KAP). Overall, there were a statistically significant 
improvement in mental health knowledge after training, in comparison to the 
knowledge before training (p<0.01). The mean was 6.03 and changed to 6.70 
after distance module. No differences were identified between doctors and 
nurses. Besides, there were positive results in all three domains assessed by the 
KAP survey: knowledge, 21.09 to 27.04 (p<0.01); attitude, 10 x 26.61 (p<0.01), 
and practice 58.13 to 63.22 (p=0.02). This pilot study shows that the developed 
model, including distance and face- to-face modules, is feasible and able to 
improve KAP among primary care providers from Sao Paulo city, Brazil. 
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SUMMARY PROJECT:
PILOT-STUDY _AUTISM DIAGNOSIS: THE PARENT’S PATHWAY BETWEEN THE 
FIRST CONCERNS ABOUT SIGNS OF AUTISM AND THE LATER DIAGNOSIS: THE 
BRAZILIAN REALITY
A fundamental component of medical practice is parent appraisal of child 
development. Developmental history taking, including elicitation of parental 
concerns is used to alert physicians to the possibility of conditions requiring 
further evaluation. As the incidence of autism spectrum disorders increased, 
concerns about the possibility of this condition occur among their siblings 
is becoming very frequent. Early identification of autism is paramount but, 
despite efforts, there are children who are being identified at a later age 
Retrospective studies indicate that parents recognize signs of autism far earlier 
than it is diagnosed, sometimes before the first birthday. 
Objective: To study the relationship between parents concern about 
development in the first years and later autism identification and to establish a 
training program for screening early detection and intervention strategies such 
as instructions to pediatricians and primary care clinicians. 
Method: Parent concerns questionnaire about first development will be 
collected for people with autism, using a retrospective longitudinal study 
design. Parents will be asked about the time of developmental concerns and 
what signs they observed until the time of diagnosis and what they did, which 
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medical services were consulted and also what was the intervention choice. 
Participants were recruited at an out-patient unit, the “Cognition Social 
Ambulatory”, at Federal University of São Paulo. The sample was comprised by 
194 children and adolescents with autism (29 females and 165 males) whose 
diagnosis was confirmed by the Social Communication Questionnaire (SCQ) 
and a clinical interview by a psychiatrist. 
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Taciana Costa Dias graduated in Medicine from Universidade Federal de 
Uberlândia, Uberlândia, MG, Brazil, in January/2006. She completed residency 
in Psychiatry at Universidade Estadual de Maringá (Maringá, PR, Brazil) 
in January/2008, and in Child and Adolescent Psychiatry at Hospital das 
Clínicas da Faculdade de Medicina de Ribeirão Preto – USP (Ribeirão Preto, SP, 
Brazil) in January/2009. She then went to Portland, OR, USA, where she did 
a Master of Clinical Research at Oregon Health & Science University (OHSU), 
getting her degree in June/2011. At OHSU, Dr. Costa Dias worked under 
the supervision of Dr. Joel Nigg and Dr. Damien Fair, interested in applying 
neuroimaging techniques, especially resting-state functional connectivity 
MRI, to study psychiatric disorders in childhood, in particular  attention deficit/
hyperactivity disorder (ADHD). Dr. Costa Dias recently returned to Brazil and 
is now a Ph.D. student at Universidade de São Paulo, Institute of Psychiatry, 
under Dr. Guilherme Polanczyk’s mentorship. Her project aims to evaluate 
the interaction/connectivity between brain regions of the reward system and 
its relationship with behavior in children with disruptive disorders and with 
typical development.  Dr. Costa Dias has published 4 papers in leading journals, 
such as Frontiers in Systems Neuroscience, Biological Psychiatry, Frontiers in 
Psychiatry and European Neuropsychopharmacology. She is the first author of 
this last one, which is related to her master’s degree project. Dr. Costa Dias 
has also participated in numerous international meetings and conferences in 
the field of psychiatry and neuroscience, where she presented her work as 
posters or short talks. Examples of meetings she participated are: EUNETHYDIS 
International ADHD Conference (2012), Organization of Human Brain Mapping 
(2011), Meeting of the American Academy of Child and Adolescent Psychiatry 
(2010). She has received 2 awards for work she has presented: Best Post-Doc 
Poster Presentation (SfN – Oregon Chapter, 2010) and Outstanding Research 
Employee Presentation (OHSU Research Week, 2012). 
SUMMARY PROJECT: 
DISTINCT COMMUNITIES OF CHILDREN WITH AND WITHOUT ADHD BASED ON 
FUNCTIONAL CONNECTIVITY PATTERNS OF THE REWARD SYSTEM
Introduction: An obstacle likely limiting our ability to clarify ADHD etiology 
is heterogeneity in the population. Graph theory and community detection 
techniques, combined with brain functional connectivity, may assist to 
overcome this obstacle. We aimed to evaluate whether distinct subgroups in 
a sample of children with and without ADHD could be determined based on 
functional connectivity patterns of the reward system – a system hypothesized 
as being highly involved in ADHD.Methods: The region most selectively 
associated with reward in the functional MRI literature was determined by 
an automated brain-mapping meta-analysis platform (Yarkoni, Poldrack, 
Nichols, Van Essen, & Wager, 2011) (consistent with left nucleus accumbens 
– NAcc). We applied a community detection procedure to the functional 
connectivity maps (using the reward region as a seed) of 106 children with 
and without ADHD (aged 7-12), to identify groups based on connectivity 
patterns.Results: Three distinct communities were identified: group A (24 
controls, 9 ADHD), group B (29 controls, 17 ADHD), and group C (11 controls, 
15 ADHD). In group A, NAcc was positively connected to the default network 
and negatively connected to the task positive network; in group B, NAcc was 
negatively connected to the fronto-parietal network; and in group C, NAcc was 
strongly negatively connected to the cinguloopercular network. Within group 
A, compared to typically developing children, children with ADHD had weaker 
functional connectivity between NAcc and posterior cingulate cortex. Within 
group B, children with ADHD had weaker negative connectivity to the parietal 
cortices. Within group C, the ADHD group had weaker negative connectivity 
to regions of the cingulo-opercular network.Conclusions: Our findings show 
that children with ADHD and typically developing children can be classified 
into distinct subgroups according to brain functional connectivity. Thus, 
combining neuroimaging data and community detection techniques might be 
an important tool to elucidate heterogeneity in ADHD etiology.
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psychotic experiences in a large sample of 2,400 community-based children 
and adolescents at increased risk for  mental disorders. Tais obtained her 
degree in Medicine from UNIFESP in 2003 and made her specialty training in 
Psychiatry and subsequently in Child and Adolescent Psychiatry in the same 
University. Since 2008 she has acted as the coordinator of the outpatients clinic 
for children and adolescents with early onset  psychosis from UNIFESP (PAPIA). 
She started her research career studying mental health problems associated 
with neurological disorders and obtained a Master’s degree in science 
from UNIFESP in 2010 for  her work on the association of social phobia and 
Parkinson’s disease; during her MsC she co-authored 9 indexed publications on 
the association of mental health problems and physical illness and some other 
publications in psychiatry. Since 2009 she is getting increasingly involved with 
developmental psychiatry and has being working in this field as a researcher in 
the Interdisciplinary Laboratory of Clinical  Neuroscience (LiNC- UNIFESP), in the 
National Institute of Developmental Psychiatry for Children and  Adolescents 
(INPD- CNPq) and in the Research Support Center on Neurodevelopment and 
Mental Health (NAP-N&SM- USP). 
SUMMARY PROJECT:
Subclinical psychotic experiences (PE) during adolescence and childhood may 
represent the behavioral expression of liability for psychosis. Children, however, 
are expected to have certain level of difficult in distinguishing reality and fantasy 
and disproportional fear of specific situation happens in normal development. 
If the presence of PE confers increased risk for mental disorders than the 
assessment of this symptoms should be routinely made in clinical practice. Our 
aim is to investigate to which extent PE in children and adolescents represents 
a consistent phenotype and if it is associated with psychiatric morbidity and 
functional impairment. We evaluated 2,400 community-based children 
recruited based on their family history for mental disorders. All children were 
assessed for the presence of 20 PE using self-report (SR) and item level clinical 
judgment (CJ); risk factors; cognitive skills; DSMIV diagnosis; family history of 
mental disorders; global functioning. SR and CJ hadacceptable to good internal 
consistence. Exploratory factorial analysis showed self reported items to best 
fit a two factors model, one comprising delusions and the other sensorial 
experiences. Frequencies of at least one PE are higher for SR than for CJ  (80% 
vs 14%) but individual’s rank according to SR has good resemblance with that 
of CJ. Both self-reported and clinically rated PE are associated with higher 
SDQ difficult and impact scores, less positive behaviors, worse organization 
of speech,higher parents rated CBCL scores in all dimensions, and were more 
likely to haveseparation anxiety and ADHD inattentive subtype. Main caregiver 
diagnosis of anxiety and mood disorders but not of other mental disorders was 
associated with children PE. Family history of generalized anxiety disorder 
and social phobia but not of other mental disorders predicted PE in children. 
Going to daycare centers before the age of 3 and having spent less time of life 
in contact or living with the father predisposed to PE. Traumatic life events 
involving intention to harm but not accidents were associated with PE. CAPE scores 
were also associated with higher differences between verbal and non-verbal IQ 
and with basic processing deficit but not with other cognitive tasks. All reported 
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SUMMARY PROJECT:
Despite the large number of genetic studies in schizophrenia, little is 
known about how genes expressed in blood relate to the disease diagnosis 
or treatment response. In this pilot study, we compared the expression of 
neurotransmitter receptor and regulatory genes in whole blood of ten drug-
naïve first-episode psychosis (FEP) patients and nine healthy controls. Whole 
blood was drawn from patients during clinical evaluations at admission and 
after 8 weeks of risperidone treatment. Gene expression was assessed with a 
RT ProfilerPCR Array System, which interrogates 84 neurotransmitter receptors 
and regulatory genes. Genes with undetected expression were excluded and a 
preliminary analysis was performed using Mann-Whitney U test (FEP x control) 
and Wilcoxon (after treatment-AF x FEP). Fourteen genes were undetectable in 
all three groups: CHRNB4, GABRA2, GABRA3, GABRB2, GABRE, GABRG1, GABRP, 
QRFPR, NPFFR2, GRIA1, HTR2A, NPY1R, NPY2R, and SSTR1. In addition, some 
genes that could not be classified as expressed or non-expressed may have 
their expression regulated by psychosis condition or risperidone treatment, 
thus, they are good candidates for investigation in larger samples (DRD2, CHAT 
and PROKR1).This result would be important to future studies. Regarding the 
expressed genes, none of the association remained after Bonferroni correction 
for multiple comparisons. We believe that the report of preliminary results can 
be very helpful to future studies to define the best investigation techniques in 
terms of equipment and target tissue.
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